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IMAGING OF TYRAMINE-SUBSTITUTED HYDROGELS  
FOR TISSUE REPLACEMENT  
 
EDIUSKA V. LAURENS 
ABSTRACT 
Novel tyramine-based hyaluronan (HA) and collagen hydrogels have been 
developed in which cross-linking is accomplished via peroxidase-mediated 
dityramine linkages allowing direct cross-linking in vivo. These TB hydrogels 
possess advantageous physical properties, which include excellent biocompatibility 
and the ability to mimic the biological, structural and mechanical properties of 
normal, healthy tissues, including cartilage, and thus provide for synthetic, 
implantable biomaterials suitable for a wide range of tissue types. The efficacy of 
these TB-hydrogels has been previously tested in a number of clinically relevant 
animal models, which have evaluated their applicability for the repair/replacement of 
various tissues, including cartilage. Nevertheless, there exists a fundamental need 
for non-destructive methods to identify, distinguish, quantify and trace these 
biomaterials in vivo. Magnetic Resonance Imaging (MRI) is a broadly used non-
invasive clinical imaging methodology that allows direct visualization of soft tissues. 
Our results indicated that T1 and T2 mapping can differentiate and measure 
changes in HA and collagen concentration both alone and in combination with 
composite materials, composed of HA and collagen at the concentrations found in 
cartilage resulting in T1 values representative of cartilage. Furthermore, the 
dGEMRIC technique was able to quantify the HA concentration in phantoms of 
known HA concentration. These MRI techniques could detect and differentiate the 
tyramine-based hydrogels in implanted joints, and accurately quantify their volumes. 
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CHAPTER I 
BACKGROUND 
 
1.1 Macromolecules in Cartilage 
Cartilage is an avascular tissue consisting of cells (chondrocytes) in an extensive 
extracellular matrix (ECM) composed mainly of proteoglycans (PG), collagen, 
and water. The properties of the tissue depend on the structure and organization 
of the macromolecules in the ECM. The collagen, primarily type II, but also type 
IX and XI, forms a dense fibrillar network that is embedded in a high 
concentration of PGs (up to 100 mg/ml), Fig 1.1. The PG, because of its 
polyanionic glycosaminoglycan (GAG) chains, creates a large osmotic pressure 
that draws water into the tissue and expands the collagen network. The balance 
between the osmotic swelling pressure of the PGs and the tension in the 
collagen fibers produces the compressive properties characteristic of this tissue. 
The biomechanical properties of cartilage are critically dependent on the integrity 
of the collagen network and on the maintenance of a high concentration of PGs
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within the matrix [21]. Hence, any loss of, for instance, PG from the cartilage 
matrix due to physiologic or pathologic processes must be balanced by de novo 
synthesis of PGs by the chondrocytes. Failure of this compensatory synthesis 
and decrease of the effective concentration of PGs within the matrix will cause 
alteration of the biomechanical properties of the tissue, thereby affecting the 
biologic function of cartilage, as in osteoarthritis [46].  
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Figure 1.1. Molecular Organization of the Extracelullar Matrix of 
Articular Cartilage [34]. 
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The most abundant PG in cartilage is aggrecan, which consists of a long, 
extended protein core with up to 100 chondroitin sulfate (CS) and 50 keratan 
sulfate (KS) GAG chains covalently bound to the protein core. At the N-terminal 
end of the protein core, one of the globular domains (G1) has the specific 
function of binding to hyaluronan (HA). The functions of the other domains of 
aggrecan are unknown. The link protein (LP), which is a separate smaller 
molecule, binds to both the G1 domain of aggrecan and HA, stabilizing the bond, 
and subsequently forming the aggrecan-HA-LP complexes referred to as PG 
aggregates (Fig 1.2). Aggregation helps stabilize the aggrecan molecules within 
the ECM, and since each HA chain is long and unbranched, many aggrecan 
molecules can bind to a single HA to form a large PG aggregate (Fig 1.3) [34].   
HA is a linear, non-sulfated GAG composed of repeating disaccharide units 
linked with β-1-4, β-1-3 bonds between D-glucuronic acid and N-acetyl-D-
glucosamine (Fig 1.4).  
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Figure 1.2. Aggrecan and its Binding to Hyaluronan. The protein core has several globular 
domains (G1, G2, and G3), with other regions containing the keratan sulfate and chondroitin sulfate 
glycosaminoglycan chains. The N-terminal G1 domain is able to bind specifically to hyaluronan and 
is stabilized by link protein [34]. 
 
 
 
 
 
 
 
Figure 1.3. Aggrecan Molecules Arranged as a Proteoglycan Aggregate [34]. 
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Figure 1.4. Chemical Structure of the Repeat Disaccharide of 
Hyaluronan. 
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The HA in cartilage has repeating carboxyl (COOH) (Fig 1.4). In solution, these 
groups become ionized (COO-), and in the physiologic environment, they attract 
positive counterions such as Ca2+ and Na+ to maintain overall electroneutrality. 
These free-floating ions within the interstitial water are present at a higher 
concentration than that found in the surrounding fluids (i.e. synovial fluid) giving 
rise to an osmotic pressure (Donnan pressure). Normally, ions flow out of a 
tissue to equilibrate their concentration with the surrounding fluid, but in cartilage 
they are prevented from doing so by the fixed nature of their negative counter 
ions (i.e. the COO- groups on the HA), and the need to maintain electroneutrality. 
Alternatively, water would flow into the tissue from the surrounding fluids thus 
equilibrating the tissue’s free-floating positive counter ion concentration with that 
in the surrounding fluids. However, additional swelling is again resisted by the 
inextensible nature of the collagen meshwork. In addition, the tight packing of the 
cartilage aggregates, causes their fixed-negative charge groups to be spaced 
only 10 to 15 angstroms apart, resulting in strong charge-to-charge repulsive 
forces (electrorepulsive forces). As with the Donnan effect, the tendency to swell 
to lessen these repulsive forces is resisted by the inextensible nature of the 
collagen meshwork. Upon compression, the distance between the fixed-negative 
charge groups on the GAGs decrease, which increases the charge-to-charge 
repulsive forces as well as increasing the concentration of the free-floating 
positive counter ions [34]. Thus both the Donnan and electrorepulsion effects are 
intensified by compression. Both effects contribute to the swelling pressure of 
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articular cartilage and its ability to resist deformation and absorb compressive 
loads [4,33,39,50]. 
Articular cartilage is often described as a viscoelastic, biphasic material, 
composed of a solid phase (cartilage aggregates and collagen) and a fluid phase 
(water and dissolved ions) [13,17,16,27]. An important feature of articular 
cartilage is how the organization of its ECM is designed to deflect the forces 
applied during loading from the load susceptible solid phase of the tissue to the 
Ioad resistant fluid phase of water. This phenomenon is referred to as stress 
shielding of the solid matrix, and results as follows. The nature of the cartilage 
ECM produces a material with very low permeability (very small pores), which 
creates drag during interstitial fluid flow. Interstitial fluid pressure is thus 
generated during compressive loading, and during dynamic loading it is the 
primary force responsible for supporting the applied load while matrix 
compression is a minor factor. During compression, the porosity is reduced 
further, which increases the already high frictional drag forces. Under constant 
load, creep due to the exit of water from the tissue continues (Fig 1.5) until the 
load support is gradually transferred from the fluid phase (as the fluid pressure 
dissipates) to the solid phase.  
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Figure 1.5. Biphasic Creep Behavior of Articular Cartilage During 
Compression. The rate of creep is controlled by the rate of fluid 
exudation from the tissue [34]. 
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Typically, for normal cartilage, this equilibration process takes 2.5 to 6.0 hours to 
achieve. At equilibrium the fluid pressure subsides, and load support is provided 
entirely by the compressed collagen-aggrecan solid matrix (Fig 1.5). However, 
because of the long equilibration time required for relaxation, articular cartilage is 
normally dynamically loaded under physiologic conditions, that is, no equilibrium 
state is reached. Thus, fluid pressurization will always exist within the tissue. 
Thus in normal articular cartilage, fluid pressurization is the dominant physiologic 
load-support mechanism in diarthrodial joints. This unique behavior of cartilage 
occurs only because the solid matrix has a very low permeability. Thus, one 
reason that articular cartilage is able to provide its unique and essential 
biomechanical function for eight decades or more is that nature has devised a 
material in which most of the destructive forces encountered are supported by 
water and not by the biological material itself. Obviously any artificial or synthetic 
matrix designed to reproduce the mechanical properties and longevity of articular 
cartilage must have a similar ability to deflect compressive loads to water 
[7,33,39,50]. 
In designing biomaterials for cartilage replacement, a unique technology has 
been developed that chemically modifies the GAGs and collagen 
macromolecules, normally present in cartilage, as they are proven by nature to 
produce a mechanically functional cartilage tissue. The chemistry involved in this 
technology will be described next.  
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1.2 Tyramine-Based Hydrogels 
Most of the chemical modification strategies for HA target the carboxyl or 
hydroxyl groups of the sugar moieties [54]. In our laboratory, the focus is on 
chemical modification of the carboxyl groups of both HA and collagen with 
tyramine [11]. For the tyramine-based hyaluronan (TB-HA) hydrogels, hydrogel 
formation is produced in two stages involving two separate chemistries. Step 1 
involves substitution of carboxyl groups located on the glucuronic acid (glcA) 
residues of repeating disaccharides of HA (box, Fig. 1.4) with the amine group of 
tyramine (Fig. 1.6) through the formation of an amide bond using conventional 
carbodiimide chemistry. After purification of the tyramine-substituted HA (TS-HA), 
hydrogels are produced in Step 2 by means of the enzymatic cross-linking of 
hydroxyphenyl groups on tyramine adducts on adjacent HA molecules.   
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B. Tyramine
HO CH CH NH2 2  2
 
 
 
Figure 1.6. Chemical Structure of Tyramine. 
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Step 1: Carbodiimide Chemistry or Tyramine Substitution Reaction  
HA is chemically substituted with tyramine through conventional carbodiimide 
chemistry, in which the carboxyl groups within the glucuronic acid (glcA) residues 
of the HA are reacted with the amine group of tyramine to form an amide bond 
(Fig 1.7). The reaction consists of activating the carboxyl group with the 
carbodiimide, 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) to produce a 
reactive O-acylisourea intermediate. The desired amine bond, which covalently 
anchors tyramine to the HA molecule, is created by nucleophilic attack of the 
electron rich amine group of the now electron deficient carbonyl carbon of glcA. 
The EDC is converted to the unreactive acylurea, 1-ethyl-3-(3-
dimethylaminopropyl)urea (EDU). The catalyst N-hydroxysuccinimide is 
introduced to improve the EDC reaction by formation of an active ester at more 
moderate pHs of 6 to 6.5, which diminishes the unproductive hydrolysis of EDC 
to EDU. Macromolecular TS-HA, produced through the carbodiimide reaction, is 
then dialyzed as a way of purifying from small molecular weight reagents and 
reaction products.  After sterilization through filtration, the TS-HA is lyophilized 
and then resuspended at the desired concentrations in a proper sterile 
physiologic buffer.  
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 Figure 1.7.  Schematic of Carbodiimide Chemistry. The carbodiimide-mediated 
formation of an amide bond from the primary amine of tyramine and a carboxyl group on a 
disaccharide of HA is shown, where R1 = CH2CH3, R2 = CH2CH2CH2NH+(CH3)2Cl- and R3 
= CH2CH2.Reaction A: activation of the carboxyl group with the carbodiimide, EDC, to 
create a reactive O-acylisourea intermediate.  Reaction B: nucleophilic attack by the 
electron rich amine group of tyramine on the now electron deficient carbonyl carbon 
forming the desired amide bond between tyramine and HA.                      
 
 
 
 
 
 14
Step 2: Peroxidase Catalyzed Oxidation of Tyramine to Dityramine 
(Cross-linking Reaction) 
Peroxidase in the presence of dilute hydrogen peroxide has the ability to 
preferentially remove the phenolic hydroxyl hydrogen atom from tyramine, 
leaving the phenolic hydroxyl oxygen with a single unshared atom acting as an 
extremely reactive free radical. The free radical isomerizes to one of the two 
equivalent ortho-position carbons, and afterward two such structures dimerize to 
create a covalent bond cross-linking the structures, which after enolizing, 
produces dityramine as show in Fig 1.8. The multiple formation of dityramine 
cross-links between adjacent HA molecules results in the formation of a three-
dimensional network or hydrogel, which at the appropriate HA concentration 
functions as a biomimetic for cartilage ECM. It is important to note that the TS-
HA is not the substrate for the peroxidase, but rather the peroxide. The cross-
linking reaction is induced by the free radicals, produced from the reaction of the 
peroxide with the peroxidase, preferentially being accepted by the hydroxyphenyl 
group of tyramine.  
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Figure 1.8. Schematic of the Proposed Mechanism for Peroxidase Catalyzed 
Oxidation of Tyramine on TS-HA to Form Dityramine Cross-links. 
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In producing TB-CO hydrogels, collagen in the commercial form of gelatin (GE) is 
utilized. GE is a mixture of water soluble, large polypeptides derived from 
denatured collagen. Traditionally, GE is produced by extraction from collagen-
rich tissues, such as bovine or porcine skin or bone. Porcine skin GE was utilized 
for our experiments. The polypeptides have the same amino acid composition as 
the parent type I collagen, and they cover a very broad distribution range of 
molecular weights [32]. The tyramine substitution and hydrogel formation of TB-
GE hydrogels follow the equivalent two step chemistry described above, except 
that the carboxyl groups involved in the tyramine substitution of Step 1 are on the 
side chains of the amino acids, aspartate and glutamate shown in Fig 1.9. 
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 Figure 1.9. Aspartate and Glutamate Showing the Carboxyl 
Group Involved in Tyramine Substitution. 
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Table I displays the amino acid composition by residue and mole percent of the 
porcine GE material utilized for our experiments. During acid hydrolysis of the GE 
sample prior to derivatization, separation and detection of individual amino acids 
by HPLC, the amide side chains of asparagine and glutamine residues are 
hydrolyzed releasing ammonia and generating aspartate and glutamate, residues 
respectively. Thus the mole percents for aspartate (Asp) and glutamate (Glu) 
listed in Table I include the mole percents for both aspartate and asparagine 
(Asn), and glutamate and glutamine (Gln), respectively. It is therefore impossible 
to determine from amino acid analysis the actual number of available carboxyl 
groups on GE for tyramine substitution, however, the ratio of the moles of 
tyramine to the moles of Asp and Glu does allow for comparison of the 
effectiveness of the tyramine substitution reaction from one GE preparation to 
another. 
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Amino Acid Residue 
Unsubstituted Gelatin 
Mole % 
Tyramine‐substituted 
Gelatin Mole % 
Asp  5.21  5.13 
Thr  1.83  1.8 
Ser  3.66  3.6 
Glu  8.02  7.9 
Pro  13.91  13.71 
Gly  38.72  38.15 
Ala  12.40  12.22 
Cys  0  0 
Val  2.46  2.42 
Met  0  0 
Ile  1.04  1.03 
Leu  2.62  2.58 
Tyr  0.19  0.19 
Phe  1.51  1.49 
Lys  2.88  2.84 
His  0.57  0.56 
Arg  4.98  4.9 
Tyramine  0  1.47 
 
Table I. Amino acid composition as mole percent for type I gelatin (Sigma, 
St. Louis, MO; 300 bloom) both unsubstituted and tyramine substituted. 
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Figure 1.10 shows the amino acid sequence predicted for human type I collagen 
based on its DNA sequence.  For comparison purposes, the human type I 
collagen and porcine GE sequences are expected to be highly conserved, and 
thus closely resemble the GE material used for our experiments. The human type 
I collagen sequence in Figure 1.10 gives a predicted isoelectric point (pI) of 9.3 
using both the scansite molecular weight and isoelectric point calculator and the 
protein calculator v3.3 programs [42,40]. This result is indicative of a basic or 
positively charged protein. We may assume this property for the gelatin used in 
our experiments. However, we also need to consider the fact that the chemistry 
for tyramine-substitution of GE neutralizes a portion of the negatively charged 
carboxyl groups on the aspartate and glutamate residues in GE by the mole 
percent of tyramine substitution, making the protein more positive after tyramine 
substitution. 
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 G P M G P S G P R G L P G P P G A P G P Q G F Q G P P G E P  
G E P G A S G P M G P P G P P G P P G K N G D D G E A G K P  
G R P G E R G P P G P Q G A R G L P G T A G L P G M K G H R  
G F S G L D G A K G D A G P A G P K G E P G S P G E N G A P 
G Q M G P P G L P G E R G R P G A P G P A G A R G N D G A T  
G A A G P P G P T G P A G P P G F P G A V G A K G E A G P Q  
G P R G S E G P Q G V R G E P G P P G P A G A A G P A G N P  
G A D G Q P G A K G A N G A P G I A G A P G F P G A R G P S  
G P Q G P G G P P G P K G N S G E P G A P G S K G D T G A K 
G E P G P V G V Q G P P G P A G E E G K R G A R G E P G P T  
G L P G P P G E R G G P G S R G F P G A D G V A G P K G P A  
G E R G S P G P A G P K G S P G E A G R P G E A G L P G A K  
G L T G S P G S P G P D G K T G P P G P A G Q D G R P G P P  
G P P G A R G Q A G V M G F P G P K G A A G E P G K A G E R  
G V P G P P G A V G P A G K D G E A G A Q G P P G P A G P A  
G E R G E Q G P A G S P G F Q G L P G P A G P P G E A G K P  
G E Q G V P G D L G A P G P S G A R G E R G F P G E R G V Q  
G P P G P A G P R G A N G A P G N D G A K G D A G A P G A P  
G S Q G A P G L Q G M P G E R G A A G L P G P K G D R G D A  
G P K G A D G S P G K D G V R G L T G P I G P P G P A G A P  
G D K G E S G P S G P A G P T G A R G A P G D R G E P G P P  
G P A G F A G P P G A D G Q P G A K G E P G D A G A K G D A  
G P P G P A G P A G P P G P I G N V G A P G A K G A R G S A  
G P P G A T G F P G A A G R V G P P G P S G N A G P P G P P  
G P A G K E G G K G P R G E T G P A G R P G E V G P P G P P 
G P A G E K G S P G A D G P A G A P G T P G P Q G I A G Q R  
G V V G L P G Q R G E R G F P G L P G P S G E P G K Q G P S 
G A S G E R G P P G P M G P P G L A G P P G E S G R E G A P 
G A E G S P G R D G S P G A K G D R G E T G P A G P P G A P 
G A P G A P G P V G P A G K S G D R G E T G P A G P A G P V  
G P A G A R G P A G P Q G P R G D K G E T G E Q G D R G I K 
G H R G F S G L Q G P P G P P G S P G E Q G P S G A S G P A 
G P R G P P G S A G A P G K D G L N G L P G P I G P P G P R  
G R T G D A G P V G P P G P P G P P G P P G P P  
 
 
Figure 1.10. Human Type I Collagen Sequence. 
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1.2.1 Measurement of Percent Substitution of Tyramine 
The percent substitution of tyramine on HA can be calculated from the molar ratio 
of covalently bound tyramine residues to the total carboxyl groups on HA. Due to 
its hydroxyphenyl group, tyramine strongly absorbs UV light at a maximum of 275 
nm. Thus, the molar concentration of tyramine associated with a TS-HA 
preparation can be easily determined by measuring its absorption at 275 nm 
relative to a tyramine standard curve as shown previously by our group [11]. 
Additionally, the molar concentration of total carboxyl groups in TB-HA is easily 
measured spectrophotometrically utilizing the standard hexuronic acid assay [4] 
routinely used for quantification of microgram quantities of GAG. The percent 
substitution of tyramine in TB-HA is consistently between 4 to 6%, which 
maintains the physiological properties of the native HA. 
An estimate of the amount of tyramine covalently bound within a TS-GE and the 
molar concentration of total carboxyl groups in a given TS-GE preparation can be 
calculated through the recovery of nanomoles of amino acids obtained from 
Amino Acid Analysis (AAA) utilizing Cation Exchange Chromatography, as 
described in Appendix A. The percent substitution of tyramine in the TB-GE 
prepared for our experiments was consistently 11 to 13%. As mentioned above 
this is an underestimate of the actual tyramine substitution as the mole percent of 
Asp and Glu reported for GE upon its hydrolysis also contains Asn and Gln, 
respectively. 
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1.2.2 Detection of Dityramine Cross-links 
Another advantageous spectrophotometric property is that the dityramine cross-
links fluoresces blue-green upon exposure to UV light with an excitation 
maximum of 285 nm and an emission maximum of 415 nm. This property permits 
assessment of the degree of cross-linking within TB-HA hydrogels both 
qualitatively and quantitatively. Qualitatively, the fluorescence properties allow 
the visualization of hydrogels to assess both the initiation of the cross-linking 
reaction and its propagation all through the volume of a hydrogel form associated 
with peroxide diffusion. This is accomplished through the observation of 
hydrogels formation once placed on a UV light box. Quantitatively, the total 
fluorescence can be determined relative to a dityramine standard curve, and 
normalized to the total of hexuronic acid (carboxyl groups) content as described 
above for measurement of tyramine substitution [11]. This can be performed 
using either intact hydrogels, which are optically clear, or hydrogels that have 
been initially solubilized by hyaluronidase treatment.  
Furthermore, our group has been able to identify methods for definitive 
characterization and quantification of the products of both the tyramine 
substitution (Step1) and cross-linking (Step 2) reactions involved in hydrogel 
formation, which includes NMR spectroscopy, Flourophore-Assisted 
Carbohydrate Electrophoresis (FACE) analysis and those based on 
spectrophotometric and fluorescent properties of the tyramine and dityramine 
adducts [11]. While in vitro methods of characterization have been identified, the 
identification of methods for characterization and quantification of these 
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chemically modified GAG and collagen macromolecules in vivo remain to be 
developed. The development of such methods is critical to facilitate the 
monitoring of these biomaterials in tissues. Hence, we focus on clinically 
established magnetic resonance imaging modalities already used to detect and 
analyze the macromolecular composition of cartilage so as to define and 
advance these methods.  
 
1.3 Imaging Techniques for Cartilage Assessment 
Evaluation of the ECM constituents of articular cartilage, GAG and collagen, is of 
particular interest to the study of degenerative joint disease such as osteoarthritis 
(OA). OA is a chronic degenerative disease characterized primarily by the loss of 
articular cartilage. Loss of articular cartilage may lead to inflammation, pain and 
associated pathology such as growth of new vasculature, osteophyte growth and 
joint space narrowing. Conventionally, OA has been diagnosed by these 
secondary indicators of cartilage loss via radiographic examination, in which a 
planar X-ray is used to assess the presence or absence of osteophytes and the 
width of the joint space. Determination of pathology is based on indirect 
measures of surrounding anatomical structures. While this is an effective 
approach, radiographs tend to be limited to the detection of OA only at later 
stages of disease progression because they lack the ability to directly image soft 
tissues [51].  
Furthermore, radiographs are relatively insensitive to biochemical changes, 
which are essential for early diagnosis and treatment of much pathology. For 
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instance, during the OA disease process, the PG content is reduced, the cells 
and collagen fibers are highly altered, and the collagen network is disrupted [9].  
Noninvasive imaging techniques such as magnetic resonance imaging (MRI), 
computed tomography (CT), and ultrasound (UI) have demonstrated the potential 
to assess biochemical markers of cartilage integrity, each with its own intrinsic 
limitations.  
The capabilities of MRI in the assessment of biochemical changes have 
prompted an increasing interest in employing this technique in the hopes of early 
diagnosis and treatments of OA.  MRI has all of the distinct advantages conferred 
from being a non-invasive assessment technique. In addition, it can assess 
cartilage morphology directly and has shown promise for the detection of soft 
tissue changes. For instance, lesions found in T2-weighted images and T2 maps 
have been correlated with degradation of cartilage matrix (i.e. decreased 
collagen content, fibrillation, clefts), T1ρ relaxation times with PG depletion and 
T1 values using delayed-gadolinium enhanced  MRI of cartilage (dGEMRIC) with 
PG content of cartilage [51].  
Constrast-enhanced CT has also been proposed as an alternative to dGEMRIC. 
However, because detection of the contrast agent is accomplished directly via 
measurements of increased X-ray attenuation, this method requires increased 
amount of contrast agent to be injected into the patient prior to imaging and 
consequently an increased risk of complications related to contrast 
administration. Despite this limitation, CT methods are attractive because the 
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imaging procedure is quick and can generate images with hgh-resolution and 
isotropic voxel dimensions [51].  
Although MRI allows direct evaluation of cartilage, this technique can detect only 
major OA changes due to its low resolution. Hence, high-frequency ultrasound 
has been proposed as a method for detecting articular cartilage fibrillation that is 
characteristic of early signs of OA.  The cartilage surface fibrillation is believed to 
originate from the breakdown of the collagen fibril network, and it can be 
detected from ultrasound images by means of qualitative evaluation or 
quantitative analysis. Qualitatively, fibrillation is assessed visually as a decrease 
in sharpness and echogenicity or increase in the irregularity of the cartilage 
surface. In quantitative analysis, the reflected ultrasound signal from the cartilage 
surface is typically analyzed in time or frequency domain and parameters such 
as signal amplitude or reflection coefficient are calculated [45].  
In the wake of the development of the current and new imaging methods for 
assessment of cartilage biochemistry, there is a need for a careful, systematic 
comparison of the proposed imaging methods to assess the sensitivity of each to 
the macromolecular content of cartilage (GAG and collagen). Although CT 
produces higher resolution images compared to MRI, MRI has the advantage of 
assessing changes in GAG and collagen within cartilage with no radiation 
exposure to patients and the use of less administered contrast agent, in the case 
of contrast-based imaging techniques. Hence, with the prospects of future clinical 
trials involving TB-hydrogels, MRI was preferred as the imaging technique to be 
utilized for this study. Furthermore, because we have the ability to formulate 
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synthetic GAG and collagen biomaterials, this investigation focused on the 
evaluation of T1 and T2 mapping, standard clinical contrast (T1-weighted, T2-
weighted) imaging sequences, and contrast-enhanced dGEMRIC technique and 
their dependency and specificity to GAG and collagen concentrations.  
 
1.4 Basis of Magnetic Resonance Imaging (MRI) [6] 
The spinning proton or “spin” is classically considered to be like a bar magnet 
with north and south poles; nonetheless, the magnetic moment of a single proton 
is extremely small and not detectable by standard means. A vector 
representation (amplitude and direction) is helpful when contemplating the 
additive effects of many protons.  
Thermal energy agitates and randomizes the direction of the spins in the tissue 
sample, and as a result there is no net tissue magnetization (Fig 1.11 A). Under 
the influence of a strong magnetic field, Bo, however, the spins are more 
organized and can be generally characterized: alignment with (parallel to) the 
applied field at a low-energy level, and alignment against (antiparallel to) the field 
at slightly higher energy level (Fig. 1.11 B).  
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Fig 1.11. Simplified Distribution of “Free” Protons without and with External 
Magnetic Field. A: Without an external magnetic field, a group of protons assumes 
a random orientation of magnetic moments, producing an overall magnetic moment 
of zero. B: Under the influence of an applied external field, B0, the protons assume 
a nonrandom alignment in tow possible orientations: parallel and antiparallel to the 
applied magnetic field. A slightly greater number of protons exist in the parallel 
direction, resulting in a measurable sample magnetic moment in the direction if B0. 
[6].  
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A slight majority of spins exist on the low-energy state, the number of which is 
determined by thermal energy of the sample (at absolute zero, 0 degrees Kelvin 
(K), all protons would be aligned in the low-energy state).  For magnetic field at 
higher strength, the energy separation of the low and high energy levels is 
greater, as is the number of excess protons in the low-energy state. The number 
of excess protons in the low energy state at 1T is about 3 spins per million (3x10-
6) at physiologic temperatures and is proportional to the external magnetic field. 
Although this does not seem significant, for a typical voxel volume in MRI there 
are about 1021 protons, so there are 3 x 10-6 x 1021 , or approximately 3 x 1015, 
more spins in the low-energy state [6]. This number of protons produces an 
observable magnetic moment when summed.  
In addition to energy separation of the spin states, the protons also experience a 
torque from the applied magnetic field that causes precession, in much the same 
way a spinning top wobbles due to the force of gravity (Fig 1.12 A). The direction 
of the spin axis is perpendicular to the torque’s twisting. This precession occurs 
at an angular frequency (number of rotations/sec about an axis of rotation) that is 
proportional to the magnetic field strength Bo.  
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 Figure 1.12. A: A single proton precesses about its axis with an angular frequency, 
ω, that is proportional to the externally applied magnetic field strength, according to 
the Larmor equation. B: A group of protons in the parallel and antiparallel energy 
states generates an equilibrium magnetization, M0, in the direction of the applied 
magnetic field B0. The protons are distributed randomly over the surface of the cone 
and produce no magnetization in the perpendicular direction [6]. 
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The Larmor equation describes the dependence between the magnetic field, Bo, 
and the precessional angular frequency, ω0: 
ω0   = γ Bo 
or, with respect to linear frequency:  
f0 = (γ/ 2π) Bo 
where γ is the gyromagnetic ratio unique to each element, Bo  is the magnetic 
field strength in tesla, f is the linear frequency in MHz (where ω = 2πf : linear and 
angular frequency are related by 2π rotation about a circular path), and γ/ 2π is 
the gyromagnetic ratio expressed in MHz/T. Because energy is proportional to 
frequency, the energy separation, ΔE, between the parallel and antiparallel spins 
is proportional to the precessional frequency, and larger magnetic fields generate 
higher precessional frequencies. Each element has a unique gyromagnetic ratio 
that allows the discrimination of one element from another, based on the 
precessional frequency in a given magnetic field strength. In other words, the 
choice of frequency allows the resonance phenomenon to be tuned to a specific 
element [6].  
The millions of protons precessing in the parallel and antiparallel directions 
results in a distribution that can be represented by two cones with the net 
magnetic moment equal to the vector sum of all the protons in the sample in the 
direction of the applied magnetic field (Fig 1.12 B). At equilibrium, no magnetic 
field exists perpendicular to the direction of the external magnetic field because 
the individual protons precess with a random distribution, which effectively 
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averages out any net magnetic moment. Energy (in the form of radiofrequency 
electromagnetic radiation) at the precessional frequency (related to ΔE) is 
absorbed and converts spins from the low-energy, parallel direction to the higher-
energy, antiparallel direction. As the perturbed system goes back to its 
equilibrium state, the MRI signal is generated.  
Typical magnetic field strengths for imaging range from 0.1 to 7T (1,000 to 
70,000 G). For protons, the precessional or Larmor frequency is 127.74 MHz in a 
3.0 T magnetic field (e.g. f = 42.58 MHz/T x 3T) [6]. This will also be the Larmor 
frequency for a proton in the imaging studies involved in this dissertation work as 
a 3T magnetic field was used. The frequency increases or decreases with 
increases or decreases of magnetic field strength. Accuracy and precision are 
crucial for the selective excitation of a given nucleus in a magnetic field of known 
strength. Spin precession frequency must be known to an extremely small 
fraction (10-12) of the precessional frequency for modern imaging systems.  
 
1.4.1 Generation and Detection of the Magnetic Resonance Signal  
Application of radiofrequency (RF) energy synchronized to the precessional 
frequency of the protons causes displacement of the tissue magnetic moment 
from equilibrium conditions (e.g., more protons are in the antiparallel orientation). 
Return to equilibrium results in emission of MR signal proportional to the number 
of excited protons in the sample, with a rate that depends on the characteristics 
of the tissue. Excitation, detection, and acquisition of signals constitute the basic 
information necessary for MRI [6].  
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The interactions of spins with their surroundings are modeled in the presence of 
external field effects by the phenomenological Bloch equation. In physics, 
specifically in MRI, the Bloch equations are a set of macroscopic equations that 
are used to calculate the nuclear magnetization M = (Mx, My, Mz) as a function 
of time when relaxation ( T1 and T2 ) is present. These are phenomenological 
equations that were introduced by Felix Bloch in 1946 [20].  
Let M(t) = (Mx(t), My(t), Mz(t)) be the nuclear magnetization. Then the Bloch 
equations are given by [20]: 
 
 
 
where γ is the gyromagnetic ratio and B(t) = (Bx(t), By(t), B0 + ΔBz(t)) is the 
magnetic field experienced by the nuclei. In MRI, the magnetic field (B) is parallel 
to the z-axis, which makes the vector product of the last equation equal to zero. 
Therefore, integration of the last equation yields the formula for the z-
magnetization (Mz) as a function of time (T1 relaxation): 
Mz (t) = M0 (1 – e-t/T1) 
The first and second equations are coupled differential equations and their 
solution is: 
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Mx (t) = e –t/T2   (Mx (0)cosω0 t + My (0)sinω0 t ) 
My (t) = e –t/T2   (My (0)cosω0 t – Mx (0)sinω0 t ) 
with ω being the Larmor frequency. This computation of the length of 
magnetization vector in the xy-plane yields the well known T2 relaxation relation: 
Mxy (t) = M0 e –t/T2 
Thus the Bloch equations are simply a general formulation to describe spin 
behavior, which in the especial situation of MRI leads to the equations for T1 and 
T2 relaxation [20]. 
 
1.4.2 Free Induction Decay: T2 Relaxation [6] 
The 90º RF pulse produces phase coherence of individual protons and generates 
the maximum possible transverse magnetization (Mxy) for a given sample 
volume. As Mxy rotates at the Larmor frequency, the receiver antenna coil is 
induced to produce a damped sinusoidal electronic signal known as the free 
induction decay (FID) signal.  
The “decay” of the FID envelope is the result of the loss of phase coherence of 
the individual spins caused by a combo of spin-spin interactions and magnetic 
field variations. Micromagnetic inhomogeneities intrinsic to the structure of the 
sample cause a spin-spin interaction, whereby the individual spins precess at 
different frequencies due to slight changes in the local magnetic field strength 
caused by other spins. Some spins travel faster and some slower, resulting in the 
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loss of phase coherence. External magnetic field inhomogeneities arising from 
imperfections in the magnet or disruptions in the field by paramagnetic or 
ferromagnetic materials accelerate the dephasing process. Exponential 
relaxation decay, T2, represents the intrinsic spin-spin interactions that cause 
loss of phase coherence. The elapsed time between the peak transverse signal 
and 37% of the peak level (1/e) is the T2 decay constant (Fig 1.13).  
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Figure 1.13. The loss of Mxy phase coherence occurs exponentially and is 
caused by intrinsic spin-spin interactions in the tissues, as well as extrinsic 
magnetic field inhomogeneities. The exponential decay constant, T2, is the time 
over which the signal decays to 37% of the maximal transverse magnetization 
(e.g. after a 90° pulse) [6]. 
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Mathematically, this exponential relationship is expressed as follows:  
Mxy (t) = M0 e –t/T2 
Where Mxy is the transverse magnetic moment at time t for a sample that has M0 
transverse magnetization at t = 0. When t = T2, then e-1 = 0.37, and Mxy = 0.37 
M0. An analogous comparison to T2 decay is that of radioactive decay, with the 
exception that T2 is based on 1/e decay instead of half-life (1/2) decay. This 
means that the time for the FID to reach half of its original intensity is given by t = 
0.693 x T2.  
T2 decay mechanisms are determined by the molecular structure of the sample. 
Mobile molecules in amorphous liquids (e.g., cerebral spinal fluid [CSF]) exhibit a 
long T2, because a fast rapid molecular motion reduces or cancels intrinsic 
magnetic inhomogeneities. As the molecular size increases, constrained 
molecular motion causes the magnetic field variations to be more readily 
manifested and T2 decay to be more rapid. Hence, large nonmoving structures 
with stationary magnetic field have a very short T2.  
 
1.4.3 Return to Equilibrium: T1 relaxation [6] 
The loss of transverse magnetization (T2 decay) occurs relatively quickly, 
whereas the return of the excited magnetization to equilibrium (maximum 
longitudinal magnetization) takes a longer time. Individual excited spins must 
release their energy to the local tissue (the lattice). Spin-lattice relaxation is a 
term given for the exponential regrowth of Mz, and it depends on the 
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characteristics of the spin interaction with the lattice (the molecular arrangement 
and structure). The T1 relaxation is the time needed to recover 63% of the 
longitudinal magnetization, Mz, after 90º pulse (when Mz = 0). The recovery of 
Mz versus time after the 90º RF pulse is expressed mathematically as follows: 
Mz (t) = M0 (1 – e-t/T1) 
where Mz is the longitudinal magnetization that recovers after a time (t) in a 
material with a relation constant T1. Figure 1.14 illustrates the recovery of Mz. 
When t = T1, then 1 – e-1 = 0.63, and Mz = 0.63 M0. Full longitudinal recovery 
depends on the T1 time constant. For instance, at a time equal to 3 x T1 after a 
90º pulse, 95% of the equilibrium magnetization is reestablished. After a period of 
5 x T1, the sample is considered to be back to full longitudinal magnetization.  
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Figure 1.14. After a 90° pulse, longitudinal magnetization (Mz) is converted 
from a maximum value at equilibrium to zero. Return of Mz to equilibrium 
occurs exponentially and is characterized by the spin-lattice T1 relaxation 
constant. After an elapsed time equal to T1, 63% of the longitudinal 
magnetization is recovered. Spin-lattice recovery takes longer than spin-spin 
decay (T2) [6]. 
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T1 relaxation depends on the dissipation of absorbed energy into the surrounding 
molecular lattice. The relaxation time varies substantially for different tissue 
structures and pathologies. From a classical physics perspective, energy transfer 
is most efficient when the precessional frequency of the excited protons overlaps 
with the “vibrational” frequencies of the molecular lattice. Large, slowly moving 
molecules exhibit low vibrational frequencies that concentrate in the lowest part 
of the frequency spectrum. Moderately size molecules (e.g. proteins) and viscous 
fluids produce vibrations across an intermediate frequency range. Small 
molecules have vibrational frequencies with low, intermediate, and high-
frequency components that span the widest frequency range. Hence, T1 
relaxation is strongly dependent on the physical characteristics of the tissues.  
As a result, for solid and slowly moving structures, low frequency variations exist 
and there is little spectral overlap with Larmor frequency.  A small spectral 
overlap also occurs for unstructured tissue and fluids that exhibit a wide 
vibrational frequency spectrum but with low amplitude. In either situation, the 
inability to release energy to the lattice results in a relatively long T1 relaxation. 
One interesting case is that of water, which has an extremely long T1, but the 
addition of water-soluble proteins produces a hydration layer that slows the 
molecular vibrations and shifts the high frequencies in the spectrum to lower 
values that increase the amount of spectral overlap with the Larmor frequency 
and result in a dramatically shorter T1. Moderately sized molecules, such as 
lipids, proteins, and fats, have more structured lattice with a vibrational frequency 
spectrum that is most conductive to spin-lattice relaxation. For biologic tissues, 
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T1 ranges from 0.1 to 1 sec in soft tissues, and from 1 to 4 sec in aqueous 
tissues (e.g., CSF) and water.  
T1 relaxation increases with higher field strengths. A corresponding increase in 
the Larmor precessional frequency reduces the spectral overlap of the molecular 
vibrational frequency spectrum, resulting in longer T1 times. Contrast agents, 
such as complex macromolecules containing gadolinium are effective in 
decreasing T1 relaxation time by allowing free protons to become bound and 
create a hydration layer, thus providing a spin-lattice energy sink and rapid return 
to equilibrium. Even a very small amount of gadolinium contrast in pure water 
has a dramatic effect on T1, decreasing the relaxation from a couple of seconds 
to tens of milliseconds.  
 
1.4.4 Comparison of T1 and T2 [6] 
T1 is always longer than T2. For instance, in a soft tissue, a T1 time of 500 msec 
has a corresponding T2 time that is typically 5 to 10 times shorter (i.e. 
approximately 50 msec). Molecular motion, size, and interactions influence T1 
and T2 relaxation (Fig 1.15). Molecules can be classified roughly into three size 
groups: small, medium, and large; with corresponding fast, medium, and slow 
vibrational frequencies. For reasons, described in the previous two sections, 
small molecules exhibit long T1 and long T2, and intermediate-sized molecules 
have short T1 and short T2; however, large, slowly moving or bound molecules 
have a long T1 and short T2 relaxation times. Because most tissues of interest in 
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MR imaging consist of intermediate to small-sized molecules, a long T1 usually 
infers a long T2, and a short T1 infers a short T2.  
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Figure 1.15. Factors affecting T1 and T2 relaxation times of 
different tissues are generally based on molecular motion, size 
and interactions. The relaxation times (vertical axis) are different 
for T1 and T2 [6]. 
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Magnetic field strength influences T1 relaxation but has an insignificant impact on 
T2 decay. This is related to the dependence of the Larmor frequency on the 
magnetic field strength and the degree of overlap with the molecular vibration 
spectrum. A higher magnetic field strength increases the Larmor frequency (ω0   
= γ Bo), which reduces the amount of spectral overlap and produces a longer T1.  
To summarize, T1 > T2, and the specific relaxation times are a function of the 
tissue characteristics. T1 and T2 decay constants are fundamental properties of 
tissues, and therefore, these tissue properties can be exploited by MRI to aid in 
the diagnosis of pathologic conditions such as cartilage degeneration in 
osteoarthritis.  
 
1.5 Applied Magnetic Resonance Imaging (MRI) Techniques 
This investigation employed delayed gadolinium-enhanced MRI of cartilage, T1 
and T2 Mapping, and standard clinical contrast (T1-weighted, T2-weighted) 
imaging sequences to evaluate TB-hydrogels. These MRI methodologies are 
further explained below: 
 
1.5.1 dGEMRIC 
The major solid components in cartilage are proteoglycans (PG) and collagen. 
PGs consist of numerous GAG side chains that are negatively charged, providing 
the ECM with the majority of its fixed charge, the concentration of which is 
referred to as the tissue fixed charge density (FCD). This fixed charge density is 
relatively high in cartilage, on the order of – 200 mM or – 100 mg/ml [22,15]. An 
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early feature of OA is the loss of GAG, and hence FCD, from the tissue. Hence, 
dGEMRIC is an MRI method developed for monitoring the charge in the tissue as 
a means of detecting early cartilage degradation [2]. 
This approach follows a paradigm pioneered by Maroudas and colleagues 
[37,35]. It depends on the fact that GAG macromolecules contain numerous 
highly negatively charged ionized side groups. The principle is that a negatively 
charged ion is relatively excluded from normal cartilage containing a high 
concentration of (the highly negatively charged) GAG. This relative exclusion 
would not occur when GAGs are lost as part of degenerative processes, since 
the negative charge that they confer to cartilage also is lost. A measurement of 
concentration of the anionic contrast agent gadopentetate dimeglumine (Gd-
DTPA2-) should serve as a surrogate for measurement of GAG concentration as 
Gd-DTPA2- is expected to distribute proportionally into depleted areas of cartilage 
at a higher concentration than that in non-depleted areas. Since the 
concentration of gadolinium compounds can be determined from an MR 
measurement of T1, variations in tissue GAG concentration can be measured 
[1].  
Now, if absolute FCD is desired, a model must be used to calculate FCD from 
tissue/sample Gd-DTPA2- concentration. One model, that has been successfully 
used to quantify FCD from tissue Na+ concentration, is based on principles of 
electroneutrality within the cartilage tissue and electrochemical equilibrium 
between tissue and its surrounding tissue. Electroneutrality states that the total 
amount of negative charge in the tissue must equal the total amount of positive 
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charge. Electrochemical (Donnan) equilibrium relates the internal tissue ion 
concentrations to external bath concentrations [36,41].  
In the simplest model, the tissue is assumed to be a homogeneous composite 
containing electrolyte and an ionized solid matrix bathed in an electrolyte solution 
(e.g. saline, culture, medium, or synovial fluid). Assuming that the tissue/sample 
is equilibrated in a NaCl solution containing Gd-DTPA2- (where the concentration 
of Gd-DTPA2- and other minor constituents is negligible as compared with the 
NaCl concentration), electroneutrality is given by:  
Bath :    [Na+]b – [Cl- ]b = 0   (1.1) 
Tissue:   [Na+]t – [Cl- ]t + FCD = 0  (1.2) 
Where subscript b stands for bath and subscript t stands for tissue.  
Ideal electrochemical equilibrium requires that [36,41] (1.3):  
 
Equations (1) through (3) can be solved to calculate FCD from either the 
measured tissue [Na+]t or tissue [Gd-DTPA2- ]t  and known bath ionic 
concentration: 
Using measured Na+ concentration (1.4): 
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Using measured Gd-DTPA 2- concentration (1.5): 
 
The use of equations (1.4) and (1.5) to compute fixed charge density was first 
introduced by Maroudas [36] and has subsequently been used to compute FCD. 
The use of equation (5) required that [Gd-DTPA2- ]t be computed from tissue T1. 
The T1 values are converted to Gd-DTPA2- concentration by calculating the 
difference between the relaxation rate of the sample with Gd-DTPA2-  (1/T1post-Gd) 
and the relaxation rate of the sample without Gd-DTPA2- (1/T1pre-Gd) by using 
equation (1.6):  
 
 
where R1 is the relaxivity of the Gd-DTPA2-  contrast agent in (mM-sec)-1 .  
Furthermore, the T1-weighted images are obtained with an inversion-recovery 
turbo spin-echo acquisitions with inversion times (TI) systematically increased 
from 25 to 1600 msec to permit the calculation of T1 relaxation times. 
Subsequently, T1 maps are computed from the above image series and color-
encoded to a standard scale to create the GAG index. The color-encoded T1 
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maps are then superimposed on morphological images for display, as seen in 
Fig 1.16 [30]. 
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 Figure 1.16. Color-Encoded T1 Map of Cartilage. This T1 map was 
obtained from a set of 7 STIR images with inversion times ranging from 
50 to 1,650 msec superimposed on a gray-scale image of the knee. T1 
values of repair tissue (arrowheads) in ACI site is 83% of that of adjacent, 
native articular cartilage of medial femoral condyle, indicating a slightly 
lower concentration of GAG within the repair tissue. Lower T1 values 
within superficial articular cartilage of medial femoral condyle and tibial 
plateaus indicate loss of GAG [43]. 
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A strong correlation between T1 values obtained using dGEMRIC and PG 
concentration in ex vivo bovine cartilage specimens have been extensively 
reported in the literature [2]. The major drawback of this technique is the long 
equilibrium period between contrast agent administration and when imaging can 
start, which is required to allow diffusion of the contrast into the cartilage (usually 
90 minutes).  Another problem is the relatively long acquisition time needed to 
acquire sufficiently high spatial resolution images at multiple inversion times to 
create the T1 maps, during which time the subject must remain motionless [30]. 
 
1.5.2 T1 and T2 Mapping  
T1 maps are generated with the same inversion recovery sequence used in the 
dGMERIC technique. T2 maps utilize a multisection, multiecho spin-echo 
sequence, and can be displayed as color-encoded images as are the T1 maps. 
An example of a T2 map of articular cartilage in Fig 1.17 identified early OA as 
regions of increased T2 value. There has been dispute in the literature regarding 
sensitivity and specificity of T2 maps for the detection and quantitation of the 
early changes of OA in cartilage treated with enzymatic degradation. Most 
investigators have concluded that collagen rather than PGs is the major 
contributor to T2 in cartilage and that the earliest changes in OA are the loss of 
PGs. However, it is also well known that cartilage swelling occurs prior to loss of 
PGs. Thus increase in mobile water most likely is the cause of increased T2 
relaxation times rather than the loss of PGs in the earliest stages of OA. Almost 
all commercial MRI systems include multisection, multiecho spin-echo 
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sequences suitable for measurement of in vivo T2 values. T2 maps can be 
acquired in a somewhat shorter period of time (<15 minutes) compared to 
measurement of T1 maps [30]. 
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Figure 1.17. T2 Map of Articular Cartilage. The T2 map from 
a 53-year-old asymptomatic female demonstrates elevated T2 
values near the articular surface of the femoral cartilage and 
increased heterogeneity in the spatial distribution of T2 values. 
This appearance is compatible with loss of structural 
organization of the cartilage collagen matrix seen with early OA. 
(Image courtesy of Timothy Mosher, MD, Hershey, PA, USA.) 
[30]. 
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The main drawback to T2 mapping is the lack of specificity in the relationship 
between T2 relaxation times and the changes in the macromolecular matrix than 
has been established for dGEMRIC. A recent publication presents a sequence 
that can produce both T1 and T2 maps that is intended to be used in conjunction 
with more contrast to enable the dGEMRIC technique [52]. 
 
1.5.3 MR Image Contrast  
The signal intensity on the MR image is determined by the basic parameters of 
proton density, T1 relaxation time, and T2 relaxation time. Proton density is the 
concentration of protons in the tissue in the form of water and macromolecules 
(e.g. proteins and fat). The T1 and T2 relaxation time constants define the 
exponential recovery and decay curves of the longitudinal and transverse 
magnetization, respectively. The contrast on the MR image can be manipulated 
by changing the pulse sequence parameters. The most common image contrasts 
used clinically are proton density (PD), T1-weighted, and T2-weighted spin-echo 
or fast spin echo acquisitions. T1-weighted contrast uses a short TR and short 
TE (TR < 800 msec, TE < 20 msec). T2-weighted contrast uses a long TR and 
long TE (TR > 2000 msec, TE > 80 msec). T2-weighted contrast can be 
employed as a dual echo acquisition. The shorter echo (TE < 15 msec) being the 
proton density (PD) contrast [6]. 
T1-weighted image contrast is based on emphasizing the T1 characteristics of 
tissues by de-emphasizing T2 contributions. The relatively short TR is used to 
maximize the differences in longitudinal magnetization during the return to 
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equilibrium, and a short TE to minimize T2 decay during signal acquisition. When 
TR is chosen to be 400 to 600 msec, the difference in longitudinal magnetization 
relaxation times (T1) between tissues is emphasized. For instance, fat, with a 
short T1, has a large signal, because the short T1 value allows rapid recovery of 
the Mz vector. The short T1 value means that the spins rapidly reassume their 
equilibrium conditions. White and gray matter have intermediate intensities or 
intermediate T1 values, and cerebrospinal fluid (CSF) has the lowest intensity or 
longest T1 value, Fig 1.18 [6]. 
Proton density image contrast relies mainly on differences in the number of 
protons per volume of tissue. At thermal equilibrium, those tissues with a greater 
proton density exhibit a larger longitudinal magnetization. Tissues such as lipids 
and fats have a high proton density compared with soft tissues; aqueous tissues 
such as CSF also have a high proton density. The long TR is used to minimize 
the T1 differences of the tissues, which allows longitudinal recovery so that the 
transverse magnetization differences result from variations in proton density 
(CSF>fat>gray matter<white matter). Since the TE is shorter (<15 msec) the 
amount of T2 decay signal acquisition is also minimized. In these conditions, fat 
and CSF display as relatively bright signal, and a light contrast inversion between 
white and gray matter occurs, Fig 1.18 [6].  
T2-weighted image contrast is achieved by reducing T1 effects with a long TR, 
and accentuating T2 differences with a long TE. The T2 weighted contrast is 
usually the second echo of a dual echo acquisition. Compared with T1-weighted 
contrast, T2-weighted image contrast inverts tissue contrast (CSF is brighter than 
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fat instead of darker), because short T1 tissues usually have a short T2 values, 
and long T1 tissues have a long T2 value. Tissues with a long T2 such as CSF 
maintain transverse magnetization longer than short T2 tissues, and 
subsequently result in higher signal intensity, Fig 1.18. A T2-weighted image 
demonstrates the contrast inversion and high tissue contrast features, compared 
with the T1-weighted image [6].  
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Figure 1.18. (A) T1-Weighted Axial Brain Image. Image obtained with TR = 549 msec and TE 
= 11 msec demonstrates bright image intensity for short-T1 tissues (white matter and fat) and 
dark intensity for long-T1 tissue (CFS). (B) Proton Density-Weighted Axial Brain Image. Image 
obtained with TR = 2,400 msec and TE = 30 msec, shoes reduced contrast compared with the 
T1-weighted image, but an overall higher signal amplitude. Tissues with higher proton 
concentration (e.g. fat, CSF) have higher image intensity. (C) T2-Weighted Axial Brain Image. 
Image obtained with TR = 2,400 msec and TE = 90 msec, has bright image intensity for long-
T2 value tissues such as CSF and dark intensity for short T2 value tissues such as matter and 
fat [6].  
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Cartilage contains a significant amount of water, approximately 80% in healthy 
tissue, with a relatively short transverse relaxation time, T2 (~40 msec) and 
intermediate T1 value (~700 -1000 msec). This water is the “observable” proton 
signal in an MR image of cartilage, Fig 1.19 [5]. Thus, the most obvious and 
direct way to measure water content is with proton density images. 
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Figure 1.19. Axial Proton Density MR Image of a 
Specimen of Bovine Patella. A groove was cut into 
the articular surface to divide the cartilage in half [5]. 
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CHAPTER II 
PRELIMINARY DATA 
The experiments described in this chapter were previously performed in our 
laboratory.  The results from these studies established the mechanical properties 
of TB-hydrogels by means of confined and unconfined compression tests; 
improved methods of cross-linking by means of the development of a dual 
syringe/needle injector device; and identified the need for alternative methods to 
evaluate the in vivo performance of the TB-hydrogels due to technical issues with 
histological analysis. This information has motivated and shaped the design of 
some of the experiments included in this dissertation work.  
 
2.1 Mechanical Properties of TB-Hydrogels [10] 
The mechanical properties of the TB-HA hydrogels have been measured through 
both confined and unconfined compression tests and using cylindrical plugs at 
concentrations of 6.25, 12.5, 25, 50, and 100 mg/ml of HA (Fig 2.1). This 
concentration range was selected because the 6.25 mg/ml TB-Hydrogel was 
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the minimum concentration of hydrogel that could be mechanically tested. The 
concentration was doubled until reaching the maximum concentration of 100 
mg/ml, which is the concentration of GAG in cartilage. 
Five cylindrical plugs, approximately 7.1 mm in diameter and 3 mm in thickness, 
at each HA concentration were made for confined compression testing using a 
custom built polycarbonate confining chamber (Fig. 2.2), and the freeze-thaw 
cross-linking technique. 
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Figure 2.1. Photograph of TB-HA Hydrogels (6.25, 12.5, 25, 50, 
and 100 mg/ml).  
 
 
Figure 2.2.Custom Built Confined Compression Testing Apparatus. 
Wells measured 7.1 mm in diameter and 3 mm in thickness.   
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Five of the six cylindrical cavities of the confining chamber were filled with 
replicate aliquots of the desired formulation containing 10 U/ml of horseradish 
peroxidase and frozen on dry ice. The chamber was then immersed in an excess 
(200 ml) of room temperature hydrogen peroxide solution (0.03%) to allow for 
thawing of the frozen hydrogel plugs and dityramine cross-linking throughout the 
plugs. Cross-linking was determined to be complete once the last visual evidence 
of ice had melted at the center of the forming hydrogel plugs (~5 minutes).  The 
chamber was then removed and blotted dry prior to testing.  For samples to be 
tested in unconfined compression, five cylindrical plugs (7.1 mm in diameter, and 
3 mm in thickness) were cast using an unconfined sample mold (no bottom) and 
the same freeze-thaw technique as described above. 
 
2.1.1 Confined Compression Test [10] 
Confined compression testing was performed using a porous polypropylene filter 
platen (20 µm pores, 20% porosity).  All testing was performed using an Instron 
5543 (Instron Corp., Canton, MA) testing machine under computer control, which 
recorded the time-displacement-load data at a frequency of 10 Hz.  A +5 N or 
+50 N load cell (Sensotec) was used as appropriate to monitor load throughout 
each test.    A step of 30 µm (30 µm/sec), representing 1% strain, was applied 
and held until the sample reached equilibrium [25].  Equilibrium was defined as a 
relaxation rate that slowed to less than 10 mN min-1, at which time the next step 
was automatically started, until 20 cycles (representing approximately 20% 
strain) were completed (Fig 2.3.A) [25].  The thickness of each sample tested in 
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both confined and unconfined compression was determined by measurement of 
the displacement at which the initial load was observed, relative to the bottom 
(zero displacement) of the single empty chamber [25].  The measured thickness 
was used to calculate the strain percentage for each step.   Load data was 
normalized by sample cross-sectional area (39.6 mm2) to compute stress.  The 
equilibrium stress was plotted against the applied strain for each material 
formation (Fig 2.3.B). For each material, the aggregate modulus was defined as 
the slope of the equilibrium stress-strain data in the linear range between 5% and 
20% strain [25]. 
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Figure 2.3. (A) Graph Showing Output Data of Load vs. Time. This data 
attained in confined compression over 20 cycles (approximately 20% strain) 
for the 25 mg/ml TB-HA hydrogel. This output data is representative of that 
obtained for all hydrogels tested in confined and unconfined compression.  
Each step is comprised of a 30 µm displacement to load (a), a period of 
stress relaxation (b), and finally equilibrium (c).  (B) Stress Strain Curves 
for TB-HA Hydrogel Plugs under Confined Compression. The 
respective aggregate moduli were determined from the linear region, which 
is represented by the fitted lines for each individual material formulation and 
concentration [25]. Unconfined stress-strain curves were similarly 
evaluated. 
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TB-HA Concentration (mg/ml) Aggregate Modulus (Kpa) 
6.25 24.1 + 14.9 
12.5 72.3 + 24.4 
25 482 + 131 
50 1020 + 164 
100 1240 + 352 
 
Table II. Aggregate modulus (KPa) values for each hydrogel 
formulation. 
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Table II shows that the hydrogels exhibited a range of aggregate moduli as result 
of varying GAG concentration as well as characteristic stress relaxation 
responses typical of viscoelastic materials. The aggregate moduli for the 25 – 
100 mg/ml TB-HA samples were in the range of those previously reported for 
articular cartilage (470-1240 KPa) [25,31,38,24] with the 100 mg/ml and the 50 
mg/ml TB-HA samples having moduli, which were equal to or exceeded those of 
previously reported values for articular cartilage in confined compression 
[25,31,38,24]. 
 
2.1.2 Unconfined Compression Test [10] 
Unconfined compression testing was performed to determine the uniaxial 
unconfined compressive properties of hydrogel constructs. A similar protocol was 
followed for the unconfined compression stress relaxation tests as was followed 
for confined compression [25]. Concurrently, each sample was visualized (Fig 
2.4) during the test at an image capture frequency of 1 Hz using a video system 
consisting of a 570 line black and white CCD camera (Model KP-M2U, Hitachi 
Denshi, Ltd., Tokyo, Japan) fitted with a 6.5X zoom lens with 12 mm fine focus 
and adjustable aperture, 1X short adapter and 0.5X auxiliary lens (Navitar, Inc., 
Rochester, NY). The camera and lens interfaced with a video capture board 
(DT3155 Frame Grabber, Data Translation, Inc., Marlboro, MA) and a standard 
microcomputer. A custom image capture software package interfaced with the 
microcomputer and the Instron 5543 testing system. 
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Figure 2.4. A Hydrogel Plug Visualized During Unconfined Compression 
as Used to Measure Poisson's Ratio. 
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Each sample was placed between two stainless steel loading platens, connected 
to the Instron testing machine (Fig 2.4).  A step of 30 µm (30 µm/sec), 
representing 1% strain, was applied until the sample reached equilibrium as 
defined previously.  The temporal change in the lateral dimensions of each 
sample was determined from the optical image using the image capture software 
for each strain percentage step and used to determine Poisson’s ratio at 
equilibrium (Fig 2.4). The axial force was normalized by the sample cross-
sectional area for each step to compute stress.  The stress was plotted against 
the applied strain for each material formation, and Young’s modulus was defined 
as the slope of the stress-strain data between 5% and 20% strain [25]. 
Shear modulus (G) was calculated using the measured values for Poisson’s 
ration (υ) and Young’s modulus (E) and equation 7 [25]. Quantitative agreement 
between the two different testing methods was determined by using the values 
directly measured of aggregate modulus (H) and Young’s modulus to calculate 
the value for Poisson’s ratio from equation 8 [25], and then comparing this 
calculated value of Poisson’s ratio to the value measured optically during 
unconfined compression testing [25]. 
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TB-HA Conc.  
(mg/ml) 
Young's 
Modulus 
(Kpa) 
Shear 
Modulus 
(Kpa) 
Poisson's 
Ratio 
(unconfined 
test) 
Poisson's 
Ratio (Eq) 
6.25 9.53 +  4.14 3.68 + 1.94 0.29 + 0.077 0.42 + 0.11 
12.5 28.2 + 6.23 10.5 + 3.02 0.34 + 0.031 0.42 + 0.059 
25 81.7 +  26.6 30.3 + 12.9 0.35 + 0.029 0.47 + 0.072 
50 178 + 44.2 65.1 + 19.9 0.37 + 0.11 0.47 + 0.049 
100 549 + 129 202 + 60.4 0.37 + 0.077 0.41 + 0.053 
Table III. Young’s modulus, shear modulus, and poisson’s ratio values for each 
material formulation. 
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The values for Young’s modulus, shear modulus, the measured Poisson’s ratio 
and calculated Poisson’s ratio are seen in Tables III. In contrast to the confined 
compression testing, only the 100 mg/ml TB-HA hydrogel displayed a Young’s 
modulus in the range of those values previously reported for articular cartilage 
(445-800 KPa) [25,44,26]. While the shear moduli of all hydrogels tested were 
below the range of those values previously reported for articular cartilage (370-
1100 KPa) [23,14], the 100 mg/ml TB-HA hydrogel had the highest shear 
modulus of the hydrogels tested. The measured values for Poisson’s ratio were 
in the range of those previously reported for articular cartilage (0.15 – 0.62) 
[25,44,26,29].  There was no significant difference found between the measured 
and calculated values of Poisson’s ratio for the 100 mg/ml TB-HA hydrogel.  
Differences were seen between the measured and calculated values at lower 
concentrations.  This is probably due to the difficulty in measuring values of 
Poisson’s ratio in hydrogels of low polymer concentration due to increasingly 
non-uniform deformation at the lateral edges of these samples.  
At concentrations similar to those in cartilage, the data presented here support 
preservation of sufficient negative charge on the tyramine-substituted GAGs to 
produce the high charge density required to recreate the swelling pressure and 
low matrix porosity characteristic of articular cartilage, but in an artificial cartilage 
substitute.  The dityramine cross-links between GAG chains in the TB-HA 
constructs are designed to serve a similar function to those normally found in the 
collagen meshwork, while the use of HA chains provides the Donnan and stress 
shielding effects needed for cartilage function and durability. From the confined 
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and unconfined mechanical testing data, it was determined that the 100 mg/ml 
TB-HA sample exhibited the values of aggregate modulus, Young’s modulus and 
Poisson’s ratio, which were in the range of those previously reported for articular 
cartilage.  
 
2.2 Dual Syringe/Needle Injector Device [10] 
A porcine cartilage repair model had been previously used by our laboratory to 
test in a live surgical venue the concept of in situ (in vivo) cross-linking of the TB-
hydrogel using the 100 mg/ml TB-HA formulation, the optimal formulation based 
on the results of the mechanical testing described above. These experiments 
used a compress applied to the repair site surface to diffuse hydrogen peroxide 
through the TS-HA plug and cause cross-linking. While these experiments 
confirmed the in vivo tolerance of the cross-linking reagents and TS-HA materials 
on the joint, the primary observation form these experiments was that reliance on 
hydrogen peroxide diffusion for cross-linking of the TS-HA plug was unreliable, 
and mainly responsible for the resulting poor fixation and longevity seen in the 
porcine study.  The viscous nature of the 100 mg/ml TS-HA did not allow for 
complete diffusion, resulting in incomplete cross-linking using the procedure 
described above.  Furthermore, blood flow from the subchondral bone at the 
repair site, while not interfering with filling of the defect, may also have interfered 
with the ability of the hydrogen peroxide to completely cross-link the TS-HA. The 
development of a methodology to ensure complete cross-linking and fixation 
within the in vivo repair site was a preferred solution.  In order to insure complete 
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cross-linking and ensure fixation, a dual syringe/needle injection device was 
developed to simultaneously deliver controlled volumes of TS-HA and hydrogen 
peroxide.  In addition, an adhesive strength test was developed in order to 
quantify the fixation between the TB-HA hydrogel and the surrounding cartilage 
matrix when using various defect treatment protocols that take advantage of the 
unique chemistry of the cross-linking reaction to optimize fixation.  
The injector device was designed and developed to take advantage of the 
chemistry behind the tyramine-based hydrogels. The device consists of two 
syringe barrels (10 ml and 1 ml volumes), a 16 gauge outer diameter dual 
needle, and a delivery system to drive both syringe plungers simultaneously (Fig 
2.5).   
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Figure 2.5. Dual Syringe/Needle Device Assembly. This includes actuator, barrels, 
plungers and dual needle. 
 
 
 
 
 
 
 
 
Figure 2.6. Alternative View. Syringe barrels, plungers and dual needle assembly 
without the actuator. 
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The 10 ml syringe (barrel 1) is filled with the desired solution of TS-HA, 
thoroughly mixed with HRP, while the 1 ml syringe (barrel 2) contains a solution 
of hydrogel peroxide.  The diameter of the TS-HA containing syringe has an 
internal radial area 12.5 times greater the internal radial area of the hydrogen 
peroxide containing syringe.  A single actuator is used to drive two corresponding 
plungers at the same longitudinal rate through both barrels, and results in the 
constant proportional extrusion of 12.5 volumes of the TS-HA solution from barrel 
1, compared to one volume of hydrogen peroxide from barrel 2. This ratio was 
chosen to deliver a minimum volume of hydrogen peroxide that would ensure 
cross-linking of TS-HA.  Attached to the ends of both barrels is a needle-inside-a-
needle device designed to accept the extruded solutions from barrels 1 and 2 
(Fig 2.6). The internal radial areas of the needles were designed to maintain the 
proportional extrusion of the two solutions created by the syringe barrels as the 
solutions are extruded from the end of the dual needle.  The TS-HA solution 
within the lumen of the larger needle (needle 1) is directed to the outside of 
smaller needle (needle 2) that contains hydrogen peroxide, while keeping both 
solutions separate (Fig 2.7) until final extrusion from the needle device. This is 
necessary due to the extremely fast rate of cross-linking time for the TS-HA 
hydrogel, which results in clogging of the needle lumen if allowed to mix prior to 
extrusion at the needle tip.   
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Figure 2.7.  Schematic of the Extrusion of Solutions from Dual Needles. 
Orientation of needle 1 (contains TS-HA/HRP) and needle 2 (contains 
hydrogen peroxide) within dual needle device.  
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A screw driven actuator was chosen in order to attain the mechanical advantage 
required to deliver highly viscous TS-HA solutions, such as the 100 mg/ml used 
for cartilage repair, while allowing for a single control mechanism to deliver the 
contents of both syringes (Fig 2.5). The materials used in the design of the entire 
assembly including actuator, barrels, plungers and needle, were chosen from 
commercially available supplies, which could tolerate pressures generated due to 
the viscous nature of the TS-HA, and to allow for easy sterilization. It was 
determined from in vitro testing and observation that the dual syringe/needle 
design resulted in the easy delivery of cross-linked TB-HA hydrogel.  
 
2.3 In Vivo Validation of Dual Syringe/Needle Injector Device [10] 
Both ex vivo cross-linked press fit plugs and in situ cross-linked plugs formed 
using the dual syringe/needle injection device described above were evaluated in 
a rabbit defect repair model for 1 week and 1 one month to test initial fixation. 
Press fit plugs were chosen as this is the standard used in current clinical 
cartilage repair procedures involving implantation of cartilage plugs. Two rabbits 
were used for each treatment condition, and for each time point, for a total of 8 
animals.  The goals of the rabbit repair model were to evaluate the two strategies 
for initial fixation, their effect on longevity and wear characteristics within the joint, 
and the ease of use of the dual syringe/needle injection device in a live surgical 
setting. Dual osteochondral defects were created in the medial trochlear facet 
using a 2.8 mm (1/8 inch) drill bit which had been pre-sterilized. The depth of drill 
insertion was 5 mm.  The defects were then filled by either insertion of the pre-
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formed press fit plugs into the defects, or filling of the defects using the dual 
syringe/needle injection device.  
All of the rabbits used in this study returned to full weight bearing immediately 
following surgery and showed no ill effects from the surgical procedure.  
Significant bleeding was encountered during surgery, but this did not interfere 
with the ability to fill the defect space with TS-HA using the delivery device.  The 
entire procedure for filling each defect with both the press fit plugs and the device 
was determined to be relatively quick and simple by the surgeons involved in the 
study.  Following euthanization, macroscopic inspection of the surgical repaired 
knees and joint space for both the press fit defect group (Fig 2.8 A) and the 
device filled group (Fig 2.8 B) revealed no evidence of inflammatory reaction, or 
any chronic reaction to the biomaterial and cross-linking agents used.  For both 
groups both the proximal and distal lesions were completely filled with a 
transparent material, indicating the presence of the TB-HA.  The surrounding 
articular cartilage and opposing articular surface did not show any evidence of 
abnormal wear for both one week and one month animals.  Upon physical 
examination, both the press fit and the device filled group, exhibited repairs that 
contoured grossly with the surrounding articular surface.  Furthermore, the only 
distinction that could be made between the repair surface and the surrounding 
cartilage was the fact that the repair site displayed a qualitatively more slippery 
surface texture to the surgeon.  No distinction could be made between the one 
week and one month time points based on the gross examination described 
above. 
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Figure 2.8.  Repaired Cartilage Sites. Representative photographs 
following sacrifice at one month for:  (A) the press fit group; (B) the device 
filled group. 
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Thus, from the results of the gross examination of the rabbit model it was 
determined that the press fit and device filled treatment strategies appeared 
stable after one month. These results indicate that the single most important 
factor in determining success may be complete cross-linking of the TB-HA 
hydrogel, since both the press fit and device filled plugs did not appear to 
perform differently at one month of time.  Additional differences between time 
points may be revealed through histological examination of the repair sites.  
Unfortunately, histological evaluation of the defects has been wrought with 
challenges due to the difficulties that occur when using conventional histological 
processing techniques on hydrogel samples.  An example of the poor histological 
results is shown in Figure 2.9 for a repair site which has been treated with a 
preformed press fit plug at one month following surgery, with similarly poor 
results seen independent for the device filled cross-linking method.  
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Figure 2.9.  Histological Evaluation. Representative histological photographs (12x 
magnification) of a press fit plug repair site at one month stained with:  A) H&E or B) 
or alcian blue.  
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Upon visualization under low magnification (12x), following staining with either 
H&E (Fig 2.9 A) or alcian blue (Fig 2.9 B), a void can be seen where the TB-HA 
hydrogel plug is expected to appear. Increased magnification (40x) shows 
fragments of hydrogel remaining at or near the defect borders (not shown).  
Gross dissection of the same sample confirms the presence of the TB-HA, as 
seen in Figure 2.10, and demonstrates that the hydrogel portion of the repair site 
is being lost following sectioning, during the dehydration steps of the staining 
process, in which the hydrogel with its exceptionally high water content shrinks 
disproportional to the surrounding tissue.    
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Figure 2.10. Photograph of Cartilage Repair Site. Following gross dissection of 
the press fit plug repair site seen in Figure 2.9. 
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These results highlight the need for methods that allow for visualization of the 
TB-hydrogels that is representative of their in vivo orientation to surrounding 
tissues. Hence, this study to utilize noninvasive imaging techniques such as MRI 
that permits to evaluation of the efficacy of TB-hydrogels in large animal models 
as it is required for FDA approval and clinical trial testing. 
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CHAPTER III 
 
CHALLENGES IN SAMPLE PREPARATION 
 
This chapter explains some of the issues encountered during this investigation in 
terms of sample preparation, and how they were addressed in order to meet the 
objectives of this dissertation work. 
 
3.1 Shrinking and Swelling of TB-hydrogels 
When the TB-hydrogels are cross-linked in water, they form solid, stable 
hydrogels in the absence of measurable shrinking or swelling. However, when 
the TB-hydrogels are either cross-linked directly in PBS, or are equilibrated with 
PBS following cross-linking in water shrinking or swelling of the hydrogel mass 
occurs depending on the initial HA or GE concentration. For the experiments 
described in this thesis, all TB-hydrogels were cross-linked first in water followed 
by equilibration in PBS as described in Appendix A. Initial cross-linking of the 
TB-hydrogels in water allowed for formation of homogeneous solid hydrogel 
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masses that were not always obtained when cross-linking directly in PBS. 
Subsequent equilibration of the TB-hydrogels in PBS allowed for acquisition 
imaging data under conditions of ionic strength, pH, etc. similar to those of the 
human body.  
When cross-linking in water then equilibrating in PBS, it was noticed that the TB-
HA hydrogels at 6.25, 12.5, and 25 mg/ml of HA shrank about 30-35 % of their 
original volumes; while the TB-HA hydrogels at 50 and 100 mg/ml of HA swelled 
about 10% or less of their original volumes. Shrinking of the TB-GE hydrogels 
was even more dramatic as the hydrogels were reduced to 70 to 90 % of their 
original volumes. The hydrogels formed from equal concentration of HA and GE 
or TB-CO shrank or swelled similar to the TB-HA. This shrinking or swelling 
effect in PBS induces significant changes in the concentrations of the material. 
Hence, correlation curves of initial versus final concentrations for all the materials 
were made. These curves allowed for preparation of TB-hydrogels of predictable 
final concentrations after PBS equilibration (Fig 3.1 A, B, C). Because the 50 and 
100 mg/ml were swelling rather than shrinking, they were simply adjusted to 50 
and 100 mg/ml concentration by addition of the appropriate fluid volume following 
concentration on vacuum concentrator. 
 
6.3
12.5
25.3
48
92.3
y = 0.883x + 3.928
R² = 0.999
0
10
20
30
40
50
60
70
80
90
100
0 10 20 30 40 50 60 70 80 90 100
Fin
al C
on
c. (
mg
/m
l)
Initial Conc. (mg/ml)
Final Conc. vs. Initial Conc. of TB‐HA A
 
60.9 60.9 60.9
71.1
79.0
90.9y = 1.353x + 45.95
R² = 0.938
0
20
40
60
80
100
120
0 5 10 15 20 25 30 35
Fin
al C
on
c. (
mg
/m
l)
Initial Conc. (mg/ml)
Initial Conc. vs. Final Conc. of TB‐GE B
 
6.2
12.2
26.6
43.5
90.4
y = 0.853x + 3.934
R² = 0.996
0
10
20
30
40
50
60
70
80
90
100
0 10 20 30 40 50 60 70 80 90 10
Fin
al C
on
c. (
mg
/m
l)
Initial Conc. (mg/ml)
Initial Conc. vs. Final Conc. of TB‐CO
0
C
 
Figure 3.1. Correlation Curve of Initial Versus Final Concentrations for TB-HA (Panel A), 
TB-GE (Panel B), and TB-CO (Panel C). The correlation of initial versus final concentration is 
much higher for the TB-HA and TB-CO samples, than for the TB-GE samples.The standard 
deviations in each plot (A, B, C) are an average of 4 samples per concentration of TB-HA, TB-
GE, and TB-CO that were used for the experiments involved in this study. 
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As seen in Figure 3.1 A, the TB-HA hydrogels displayed a nice linear correlation 
between the initial and final concentrations.  The small standard deviations in TB-
HA hydrogels are indicative of the high reproducibility of formation of these 
materials. In the case of the TB-GE (Fig 3.1 B), the final concentration as a 
function of the initial concentration is far less linear with much wider standard 
deviations indicative of a lower reproducibility of formation compared to the TB-
HA. This effect on TB-GE mirrors the properties of collagen and its function in 
cartilage. The cartilage matrix collapses in the absence of sufficient PG 
concentration, as the PGs are responsible for maintaining the swelling pressure 
that expands the collagen network. On the other hand as seen in Figure 3.1 C, 
the TB-CO composed of both HA and GE (collagen) similar to that of cartilage 
ECM behaved more like the TB-HA with a linear fit and a high coefficient of 
correlation (0.99). Once again, because the HA or GAG content is incorporated 
into these materials with the HA having similar strong charge-to-charge repulsive 
forces as PGs, the matrix integrity is preserved. Based on these results, TB-HA 
and TB-CO hydrogels cross-linked in water, and then equilibrated in PBS were 
formed at the desired concentrations of 6.25, 12.5, 25, 50 and 100 mg/ml; while 
only TB-GE hydrogels cross-linked in water could be formed at 6.25, 12.5, 25, 50 
and 100 mg/ml. TB-GE hydrogels cross-linked in water and then equilibrated in 
PBS could only be formed at 60, 70, 80 and 90 mg/ml. 
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3.2 Diffusion of Hydrogen Peroxide  
Diffusion of hydrogen peroxide through the entire material volume is required to 
obtain fully cross-linked hydrogels. This was restricted when the concentration 
and volume of the samples increased. This is explained by a decrease in the 
porosity of the material with increasing concentration of HA or GE, which reduces 
matrix porosity slowing the diffusion of the hydrogen peroxide to the point that the 
embedded enzyme (HRP II) can deplete the hydrogen peroxide before it fully 
diffuses throughout the hydrogel mass. 
Di-tyramine cross-links fluoresce blue-green upon exposure to UV light. Figure 
3.2 shows an example of the limited diffusion of hydrogen peroxide in the 
presence of higher concentrations of TS-HA and increased volumes of the 
materials. This figure shows how the hydrogen peroxide diffused through most of 
the volume of 12.5 mg/ml TB-HA hydrogels that were made at increasing 
volumes of 200, 400, 600, 800 and 1000 μl. On the other hand, the hydrogen 
peroxide hardly diffused through TB-HA hydrogels at 25 mg/ml, cross-linking only 
the top surface of the material. 
 
 
 
 
 
  
 
 
 
Figure 3.2. Hydrogen Peroxide Diffusion. The photos were taken under UV-light 
immediately after adding hydrogen peroxide to initiate cross-linking. A: TB-HA at 12.5 mg/ml 
prepared in 5 different volumes (1-5) of 200, 400, 600, 800, 1000 μl, respectively. The 5 
samples were spiked with a 0.3 % hydrogen peroxide solution that diffused quickly through 
the hydrogel volume. B: The same as panel A, except that the TB-HA is at 25 mg/ml 
concentration. The 0.3 % hydrogen peroxide solution diffused through only about 5% of the 
hydrogel volume. 
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Hence, a hydrogel was determined to be fully cross-linked after adding the 
hydrogen peroxide, if it fluoresced uniformly blue-green throughout its entire 
volume when exposed to UV-light. Otherwise, the hydrogel was considered 
partially cross-linked and inadequate for our studies. 
This dependence of hydrogel cross-linking on diffusion of hydrogen peroxide at 
concentrations of 25 mg/ml or higher correlates well with previous results for 
mechanical testing. Figure 2.3 B in Chapter II showed the equilibrium stress 
plotted against the applied strain for TB-HA hydrogels at various HA 
concentrations, with the slope of the lines the aggregate moduli or compressive 
strength of the materials. The slope of the line for the 6.25 and 12.5 mg/ml TB-
HA hydrogels are similarly low. However, when the concentration is increased to 
25 mg/ml, the slope becomes much steeper, and this steepness increases even 
further with the 50 and 100 mg/ml concentrations. This increase in aggregate 
modulus or the ability of the materials to absorb energy is dependent upon the 
matrices ability to influence the flow of water through its pores, which occurs 
between the 12.5 and 25 mg/ml HA concentration as with the hydrogen peroxide. 
The difficulty with partial cross-linking was overcome by using the dual/syringe 
needle injector device described in Chapter II. The injector device was 
determined to be the best method suited for attaining fully cross-linked TB-HA 
and TB-GE hydrogels at 25, 50 and 100 mg/ml concentrations as well as for the 
composite materials (TB-CO) from 6.25, 12.5, 25 and 50 mg/ml). The exception 
to this was the TB-CO hydrogel composed of both the 100 mg/ml TB-HA and 
100mg/ml TB-GE concentration. The viscosity of this composite material 
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exceeded the maximum pressure that the injector device could generate to 
extrude the cross-linked hydrogel. Hence, the composite materials at this 
particular concentration were cross-linked by mechanically mixing the combined 
TS-HA and TS-GE containing the enzyme with the hydrogen peroxide in 
increments of 100 μl up to 1 ml volumes. 
 
CHAPTER IV 
 
DETERMINATION OF T1 AND T2 MAGNETIC RESONANCE IMAGING (MRI) 
PROPERTIES OF TYRAMINE-BASED  
HYALURONAN AND COLLAGEN HYDROGELS  
 
4.1 Introduction 
Tyramine-based (TB) HA and collagen hydrogels are new biomaterials in the 
process of commercial development for a variety of clinical applications [45]. 
Collagen and glycosaminoglycans (GAGs) such as HA are major components of 
most tissue extracellular matrices (ECMs), and MRI techniques have been 
developed for non-invasive imaging and assessment of these two 
macromolecular constituents.  Many MRI imaging sequences are known to be 
influenced by matrix composition, in particular collagen and GAG content. Many 
of these approaches claim more specificity for a particular molecular species 
over that of others, for example: T2 mapping sequences correspond to collagen 
content, and T1 mapping sequences and charge-based imaging techniques such 
as Gadolinium Enhanced MRI of Cartilage (dGEMRIC) correspond to GAG 
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content [46]. While these measurements have been validated in cartilage, the 
sensitivities of these MRI techniques to collagen and GAG content within 
cartilage are not generally independent [46]. The objective of this study was to 
apply these MRI methods to a controlled system of synthetic ECM composed of 
TB-HA and TB-collagen molecules and evaluate their sensitivity and specificity, 
as well as their qualitative and quantitative accuracy for measuring matrix 
composition. This work provides a scientific basis to better understand the 
relationship between these MRI methods and tissue composition, and to detect, 
distinguish, characterize and quantify the TB-hydrogels. 
 
4.2 Experimental Design 
T1 and T2 acquisitions were employed in these experiments. HA and collagen 
(as gelatin, GE) equilibrated in PBS were imaged independently at 
concentrations of 0, 6.25, 12.5, 25, 50 and 100 mg/ml and 0, 60, 70, 80 and 90 
mg/ml, respectively. Additionally, GE in water was imaged at 0, 6.25, 12.5, 25, 50 
and 100 mg/ml. Composite materials, a combination of HA and GE, equilibrated 
in PBS were imaged at 0, 6.25, 12.5, 25, 50 and 100 mg/ml of both HA and GE. 
These materials were prepared in 1 ml volumes, and under 3 different 
formulations: 1) unsubstituted; 2) tyramine-substituted; and 3) tyramine-
substituted plus enzyme and hydrogen peroxide (cross-linked). The series of 15 
samples under the 3 different conditions (45 samples) were imaged 2 to 5 times 
using each MRI technique at different time points (test-retest measurement 
reproducibility) using a clinical 3T MRI system.  The mean T1 and T2 values 
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were compared first as a function of concentration, then as a function of the three 
different formulations. 
Initially the contribution of the HRP enzyme to the MRI signal of TB-HA and TB-
GE hydrogels was thought potentially significant, as the iron containing porphyrin 
ring of the HRP was predicted to have some measurable magnetic properties. 
However, T1 and T2 values of HRP in PBS alone at 5, 10 and 20 u/ml, which 
bracketed the 10 u/ml of HRP used to prepare all the cross-linked hydrogels 
used in this dissertation, were found to be the same as for PBS control samples 
(Fig 4.1). Therefore it was concluded that the addition of HRP would have no 
effect on the imaging properties of the TB-hydrogels, and hence, the imaging of 
tyramine-substituted samples with HRP only was eliminated from our studies. 
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 Figure 4.1. T1 Map of Horse Radish Peroxidase (HRP) Solutions. HRP at 5, 
10, and 20 u/ml, agar at 0.5, 1, 2,  and 4 weight percent, Magnevist (Gd-DTPA) 
at 0.125, 0.25, 0.5, 1 and 2 mM, unsubstituted gelatin (GE) and unsubstituted 
hyaluronan (HA) at 6.25, 12.5, 25, 50, and 100 mg/ml and PBS controls. The 
HRP alone (yellow circle on the left) imaged similar to the PBS control (yellow 
circle on top right). HRP at 5, 10 and 20 u/ml had T1 values of 2,456, 2,552, 
and 2,628 msec while PBS had a T1 value of 2,642 msec. 
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The materials and methods for the synthesis of TS-HA and TS-GE and their 
hydrogel formation or cross-linking are described in Appendix A.  Table IV 
represents the hydrogel biomaterials that were prepared for these experiments. 
In addition to these samples, calibration curves of agar and Magnevist (Gd-
DTPA-2) contrast agent were prepared along with a second concentration curve 
of cross-linked GE without saline equilibration (in water). 
Samples & 
controls Description Concentrations (mg/ml) 
Total N° of 
samples
HA Unsubstituted Hyaluronan 6.25, 12.5, 25, 50, 100 5
GE Unsubstituted Gelatin 6.25, 12.5, 25, 50, 100 5
TS-HA Tyramine-Substituted Hyaluronan 6.25, 12.5, 25, 50, 100 5
TS-GE Tyramine-Substituted Gelatin 6.25, 12.5, 25, 50, 100 5
TB-HA Tyramine-Based Hyaluronan (Cross-linked) 6.25, 12.5, 25, 50, 100 5
TB-GE/      
TB-Gew
Tyramine-Based Gelatin (Cross-linked)/ 
Tyramine-Based Gelatin (Cross-linked) in Water
60, 70, 80, 90 (PBS)/6.25, 
12.5, 25, 50, 100 (Water)
4 (PBS)/5 
(Water)
CO Unsubstituted Hyaluronan/Gelatin (Composite) 6.25, 12.5, 25, 50, 100 5
TS-CO
Tyramine-Substituted Hyaluronan/Gelatin 
(Composite) 6.25, 12.5, 25, 50, 100 5
TB-CO
Tyramine-Based Hyaluronan/Gelatin (Cross-
linked Composite) 6.25, 12.5, 25, 50, 100 5
Ag Agar (Calibration Curve) 0.5, 1, 2, 4 (weight %) 4
Gd-DTPA-2 Gadolinium (Calibration Curve) 0.125, 0.25, 0.5, 1, 2 (mM) 5
58
 
Table IV: Description of the hydrogel biomaterial compositions used for imaging. All samples were prepared in PBS unless otherwise 
indicated. 
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After material formulation, 1 ml of each material was transferred to a 1.5 ml 
cryotube, and all tubes arranged in a rack to form a grid. The pattern of the grid is 
composed of the 58 samples described in Table IV plus 5 control samples (4 of 
PBS and 1 of water), for a total of 63 samples (Figs 4.2 and 4.3). 
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Figure 4.2 Schematic of the Grid for Imaged Samples. From left to right, columns A - J 
contain: unsubstituted hyaluronan (HA), tyramine-substituted HA (TS-HA), cross-linked HA 
(TB-HA), unsubstituted gelatin (GE), tyramine-substituted GE (TS-GE), cross-linked GE in 
water (TB-GEwater), cross-linked GE in PBS (TB-GE), unsubstituted HA/GE composite (CO), 
tyramine-substituted HA/GE CO (TS-CO), cross-linked HA/GE CO (TB-CO). Controls 
included: PBS (column M), water (column M), agar (column L), and Magnevist (Gd-DPTA, 
column K). All samples were at the concentrations indicated. 
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Figure 4.3 Actual Grid of Imaged Samples. A: Samples contained in padded boxes used for imaging. The controls were positioned outside 
the sample set to create asymmetry used in sample identification/validation. B: Shows the samples properly leveled allowing imaging of a 
single circumferential cross-section of all samples in one single MRI slice for subsequent analysis. 
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Figure 4.3 shows the samples and controls contained in the boxes used for 
imaging. This arrangement allowed all the samples to be placed at the same 
level (Fig 4.3 B), which facilitated localizing all the samples in a single T1 or T2 
acquisition slice. Additionally, each set of samples was imaged between 2 and 5 
times on different days for test-retest reproducibility as shown in Table V. 
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Sample Set  May 14 '09  Aug 21 '09  Sept 13 '09  Oct 01 '09  Oct 07 '09 
Total N° 
of 
Imaging 
HA  x  x  x  x  x  5 
GE  x  x  x  x  x  5 
TS‐HA     x  x  x  x  4 
TS‐GE     x  x  x  x  4 
TB‐HA     x  x  x  x  4 
TB‐GE     x  x  xx  xx  4/2 
CO     x  x  x  x  4 
TS‐CO           x  x  2 
TB‐CO           x  x  2 
Ag  x  x  x  x  x  5 
Gd  x  x  x  x  x  5 
Table V:  Frequency of re-imaging for the different hydrogel sample sets. 
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4.3 T1 and T2 Mapping 
All of the MRI evaluations described in this dissertation were performed at room 
temperature using a standard quadrature head coil in a 3 T MRI system (Tim 
TRIO; Siemens Medical Solutions, Erlangen, Germany). 
First, gradient echo localizer images were used to identify a coronal slice that 
included all samples within the grid enabling them to be imaged simultaneously.  
The spatial resolution for the grid MRI acquisitions was provided; the specimen 
spatial resolution was sized proportional. Next, T1 and T2 image series were 
acquired using the following parameters: 
 T1 sequence:  An inversion recovery fast (turbo) spin echo sequence was used 
to measure T1 with a repetition time (TR) = 6000 msec; inversion time (TI) = 23 
msec, 75 msec, 150 msec, 300 msec, 750 msec, 1,400 msec, 2,000 msec and 
2,800 msec; echo time (TE) = 10 msec; field of view (FOV) = 260 x 130 mm; 
slice thickness = 1.9 mm; matrix = 256 x 128, and 1 average. The inversion 
recovery imaging sequence produced 8 images from a single slice location, each 
with a different TI. 
T2 sequence: T2 relaxation time of the samples was measured using a spin 
echo based Carr-Purcell-Meiboom-Gill (CPMG) imaging sequence with a TR = 
6,000 msec and 32 echoes [47].  Two spin echo sequences were performed to 
be able to cover both the materials with very short T2 values and the materials 
with very long T2 values. The first spin echo started at TE: 15 msec with a 
maximum of 480 msec, followed by a second one started at TE = 30 msec with a 
maximum of 960 msec.  All images were obtained from a single slice with a FOV 
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= 260 x 130 mm; slice thickness = 1.9 mm; matrix size = 256 X 128, and 1 
average. The CPMG imaging sequence produced 32 images from a single slice 
location, each with a different TE. 
Post-Processing Image: The images were reviewed and exported using 
DicomWorks. Then, T1 and T2 maps were computed using MRIMapper (MIT, 
Cambridge, MA) and MATLAB (Mathworks, Natick, MA). For both the T1 and T2 
maps, this process began by loading the images into the MRIMapper with the 
appropriate parameters. The MRIMapper produced a T1 or a T2 image that could 
be analyzed by drawing regions of interest (Fig 4.4). 
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Figure 4.4. Example of T1 Image Produced by the MRIMapper. Left: Inversion 
recovery image at TI = 23 msec displayed by the MRIMapper. This image is used to 
draw regions of interest (ROI) for analysis. Right: T1 image with 4x4 ROIs 
superimposed. The artifact between samples observed was caused by the foam in 
which the samples were contained (see Fig 3.1), and does not interfere with analysis. 
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Regions of interest (ROI) for analysis were selected as a 4x4 to 6x6 set of pixels 
from the center of each hydrogel sample as shown in Fig 4.4. Then, the 
MRIMapper generated T1 maps by curve-fitting to a three-parameter exponential 
fit Mxy = Mo (1–2Ae–TI/T1 + e–TR/T1), where Mxy is the pixel signal intensity 
from the image obtained as a function of TI, Mo is the signal intensity that would 
be obtained from the sample in the fully relaxed state, and A = 1-cosθ is the flip 
angle of the inversion pulse. T2 maps are generated by fitting logarithmically to 
My = Mo exp (-TE/T2), where My is the pixel signal intensity from the image 
obtained as a function of TE, and Mo is as defined above. The calculated T1 or 
T2 value was an average of the pixels from the ROI of each sample. The T1 or 
T2 map was displayed superimposed onto the corresponding inversion recovery 
or spin echo images, as shown in the results section. 
The T1 and T2 mean values were utilized to calculate material relaxivity R1 and 
R2, respectively. R1 and R2 values were calculated, using a least-squares fit, as 
the slope of [1/T1 (or 1/T2) – 1/T1pbs (or 1/T2pbs)] vs. concentration of each 
sample, where T1 or T2 is the T1 or T2 of the sample and T1pbs or T2pbs is the T1 
or T2 of PBS. For instance, the R1 of unsubstituted HA was computed by 
determining the 1/T1 – 1/T1pbs for each concentration of HA as shown in Table 
VI. After these values are calculated, the R1 is calculated by plotting the 1/T1 – 
1/T1pbs values against the sample concentrations as shown in Fig 4.5. 
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Sample   [mg/ml]  T1  1/T1‐ 1/T1PBS 
 PBS    2469 ± 178.8   0 
HA 6.25   6.25  2219 ± 112  0.00005 
HA 12.5   12.5  2183± 132  0.00005 
HA 25   25  2051 ± 158  0.00008 
HA 50   50  1835 ± 133  0.00014 
HA 100  100  1482 ± 48  0.00027 
 
Table VI. Calculation of 1/T1-1/T1pbs for HA. 
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Figure 4.5. Relaxivity of T1 (R1) for HA. Slope (R1) of the linear relationship of  
1/T1 – 1/T1pbs vs. HA concentration.  
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4.4 Results and Discussion 
For the purpose of describing the results for these experiments, the T1 and T2 
data acquired from the last imaging day (11/07/09) is used as example. This was 
necessary due to a drift observed in the magnet values from day to day (Fig B–I. 
in Appendix B). The T1 and T2 data collected for all 5 days is shown in 
Appendix B. 
 
4.4.1. T1 and T2 Mapping 
As anticipated, the T1 and T2 maps differentiated changes in HA and GE 
concentration that could be represented both qualitatively and quantatively. 
Qualitatively, the T1 and T2 color-coded maps resulted in a color gradient that 
differentiated the various concentrations of either HA or GE as shown in Fig 4.6. 
Both T1 and T2 decreased with increasing concentrations of the materials. T1 
values for unsubstituted HA (HA), tyramine-substituted HA (TS-HA), and cross-
linked HA (TB-HA) hydrogels were within a range of 1,370 to 2,730 msec (green 
to light blue). T1 values for the unsubstituted composite (CO), tyramine-
substituted composite (TS-CO) and cross-linked composite (TB-CO) hydrogels 
were within a range of 684 to 2,730 msec (orange to light blue). The T1 values 
for the unsubstituted GE (GE), tyramine-substituted GE (TS-GE) and cross-
linked GE (TB-GE) hydrogels in water were in the same range as the HA 
materials or from 1,370 to 2,730 msec (green to light blue). As expected, the Gd 
control samples had short T1 values, while the agar, PBS and water control 
samples all had long T1 values. 
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T2 values for unsubstituted HA (HA), tyramine-substituted HA (TS-HA) and 
cross-linked HA (TB-HA) hydrogels were within a range of 200 to 1,170 msec 
(light red to green). T2 values for unsubstituted composite (CO), tyramine-
substituted composite (TS-CO) and cross-linked composite (TB-CO) hydrogels 
were within a range of 100 to 1,170 msec (dark red to green). The T2 values for 
unsubstituted GE (GE), tyramine-substituted GE (TS-GE) and cross-linked GE 
(TB-GE) hydrogels in water were within a range of 391 to 1,560 msec (orange to 
light blue). As expected, the Gd and agar control samples had short T2 values, 
and the PBS and water contol samples had long T2 values. 
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Fig 4.6. T1 and T2 Maps. Left Panel: T1 map with a mapping range of 0 to 3,500 
msec (colored bar on right). T1 decreases with increasing concentration for all the 
samples. The unsubstituted hyaluronan (HA), tyramine-substituted HA (TS-HA), and 
cross-linked HA (TB-HA) samples are located at the bottom in decreasing 
concentration from left to right. The unsubstituted composite (CO), tyramine-
substituted CO (TS-CO), and cross-linked CO (TB-CO) samples are also located at 
the bottom in decreasing concentration from left to right. The unsubstituted gelatin 
(GE), tyramine-substituted GE (TS-GE), and cross-linked GE in water (TB-GE 
water) samples are located at the top with decreasing concentration from left to right 
starting with the second column (right of red box). The cross-linked GE (TB-GE) in 
PBS is at the top left in the red box with decreasing concentration from top to 
bottom. The gadolinium (Gd) samples are located at the top with decreasing 
concentration from left to right starting with the second column (right of red box). 
The agar (Agar) samples are located at the top right in the red box with decreasing 
concentration from top to bottom. PBS and water control samples are circled in red. 
Right Panel: T2 map with a mapping range of 0 to 2,000 msec (colored bar on 
right). T2 decreases with increasing concentration for all the samples. Samples are 
as indicated for the left panel. 
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4.4.2. Relationship of Materials and Magnetic Properties 
Quantitatively, the T1 and T2 values and their respective R1 and R2 values were 
measured for each material. First, the magnetic properties of gadolinium (Gd) 
controls used in this study were consistent with those found in the literature 
(48,49).  The T1 and T2 values (Table VII) and respective R1 and R2 values 
(Table VIII) for Gd are within the range of values typical for this contrast agent at 
a 3T field strength [48,49]. The T1 and T2 values (Table VII) and respective R1 
and R2 values (Table VIII) for Agar are within the range of values expected for 
this material at 3T. However, direct comparison with the literature could not be 
performed for agar because this material has been imaged at concentrations and 
conditions different from our experiments. Furthermore, these results validate the 
T1, T2, R1 and R2 values concurrently obtained for the hydrogel materials 
descibed below. 
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Control  Weight %  T1 (msec)  T2 (15 msec)  T2 (30 msec) 
Agar 0.5  0.5  2173±177  288±5  283±5 
Agar 1  1  2033±105  162±3  157±4 
Agar 2  2  1942±191  85±2  82±3 
Agar 4  4  1646±78  44±3  44±6 
   mM          
Gd 0.125  0.125  1036 ± 30  661±15  708±10 
Gd 0.25  0.25  634 ± 13  441±8  459±10 
  Gd 0.5  0.5  352 ± 7  260±4  268±6 
Gd 1  1  189 ± 4  142±3  146±5 
Gd 2  2  98 ± 3  76±3  78±4 
1 T1PBS value on this imaging day was 2,469±178.8 msec   
 
 
 
Table VII. T1 and T2 values for agar and Gd-DTPA-2 controls. These T1 and T2 values 
are comparable to previously reported literature values for Gd-DTPA-2 at 3T [48, 49]. 
Controls  R1 (mM‐1 s‐1)  r2  R2 (mM‐1 s‐1)  r2  R2 (mM‐1 s‐1)  r2 
Agar  0.05  0.98  5.50  1  5.52  1 
Gd‐DTPA‐2  5.31  1  6.22  1  6.09  1 
 
 
 
Table VIII. R1 and R2 (15 and 30 msec echo spacing) values for agar and Gd-DTPA-2 
calculated using units of concentration previously reported in the literature. R1 and 
R2 values of Gd-DTPA-2 at 3.0 T are comparable to the values found in the literature of 
4.5 and 5.0 mM-1 s-1, respectively, using a wider range of Gd-DTPA-2 concentrations than 
previously reported. [48, 49]. 
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As explained in Chapter I, the longitudinal relaxation time or spin-lattice 
relaxation time T1 is influenced by the characteristics of the spin interaction with 
the lattice, the molecular arrangement and structure. Whereas the transverse 
relaxation time or  spin-spin relaxation time is influenced by the intrinsic spin-spin 
interactions that cause loss of phase coherence due to the intrinsic magnetic 
properties of the sample. Even though the rate of exponential recovery and 
decay of T1 and T2 respectively is affected by different factors, both T1 and T2 
decreased with increasing concentrations as shown in Table IX. For the purpose 
of explaining the impact of T1 and T2 in the various materials independent of the 
hydrogel chemistry, Table IX only includes values for the unsubstituted HA, GE 
and CO materials. The same pattern is observed in the tyramine-substituted and 
cross-linked samples. 
Based on those characteristics (i.e. molecular size, motion and molecular 
interaction) that affect the length of T1 and T2 (see Figure 1.14), agar is 
considered a large, slow, bound molecule, and as predicted for a compound with 
these characteristics, exhibits a long T1 (>1,500 msec) and a short T2 (<700 
msec). The Magnevist (Gd) control showed T1 and T2 values characteristic of an 
intermediate molecule according to Figure 1.14 with a short T1 and a short T2, 
even though this compound is a small molecule expected to have a fast 
molecular motion and free molecular interactions.  This incongruity contributes to 
the utility of Magnevist as an MRI contrast agent. Conventionally, HA and GE are 
regarded as slow moving, large, bound structural molecules, and therefore based 
on Figure 1.14 would be expected to exhibit a long T1 and short T2 similar to 
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agar. However, at lower concentrations they exhibit a long T1 and T2 
characteristic of fast moving, small, free molecules. However, with increasing 
concentration and at the same concentration (~25 mg/ml) that these materials 
transition in terms of their ability to influence the flow of water (see effect on 
aggregate modulus, Figure 2.3B), or hydrogen peroxide (see effect on cross-
linking efficiency, Figure 3.2) through their pores, they also transition to short T1 
and T2 values characteristic of more intermediate molecules. This maybe due to 
the free mobile water that decreases with increasing concentration of these 
materials with the 100 mg/ml CO samples having T1 and T2 values characteristic 
of cartilage. 
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 Sample   [g/L]  T1 (msec)  T2 (15 msec)  T2 (30 msec) 
HA 6.25   6.25  2219±112  1144±26  1195±35 
HA 12.5   12.5  2183±132  1008±22  1057±20 
HA 25   25  2051±158  821±13  816±14 
HA 50   50  1835±133  536±7  516±8 
HA 100  100  1482±48  309±5  294±5 
Sample             
GE  6.25  6.25  2332±126  1169±33  1247±26 
GE 12.5  12.5  2305±195  1075±27  1146±15 
GE 25   25  2177±218  976±17  980±15 
GE 50   50  1751±84  607±24  584±27 
GE 100  100  1122±49  264±9  249±12 
Sample             
CO  6.25   12.5  2311±204  1079±20  1182±25 
CO 12.5  25  2137±138  855±67  879±71 
CO 25   50  2257±107  474±6  468±7 
CO 50   100  1371±135  287±31  274±26 
CO 100   200  760±279  77±10  76±10 
Control             
Agar 0.5  5  2173±177  288±5  283±5 
Agar 1  10  2033±105  162±3  157±4 
Agar 2  20  1942±191  85±2  82±3 
Agar 4  40  1646±78  44±3  44±6 
Control             
Gd 0.125  0.12  1036 ± 30  661±15  708±10 
Gd 0.25  0.23  634 ± 13  441±8  459±10 
Gd 0.5  0.47  352 ± 7  260±4  268±6 
Gd 1  0.94  189 ± 4  142±3  146±5 
Gd 2  1.88  98 ± 3  76±3  78±4 
1 T1PBS value on this imaging day was 2,469±178.8   
 
 
 
Table IX. T1 and T2 values for unsubstituted hyaluronan (HA), gelatin (GE) and HA/GE 
composite (CO) materials as well as agar (Agar) and gadolinium (Gd) controls. T1 and 
T2 values for the Agar and Gd controls are the same as in Table VII, but the concentrations 
have been converted to g/L. 
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The relationship between the T1 values and material concentration in Table IX is 
best illustrated graphically in Fig 4.7 along with the calculated relaxivity values 
(R1) or slopes calculated using linear regression.  For instance, Magnevist (Gd) 
has the highest impact on T1 using a small range of concentrations, as expected 
for an effective MRI contrast agent. It exhibits a linear relationship with an 
extremely high coefficient of correlation (r2 = 1) (Fig. 4.7 A). Agar also results in 
high linearity and coefficient of correlation (Fig 4.7 B); however with a much 
lesser impact on T1 compared to the Magnevist. When the R1 of the 
unsubstituted HA, GE and CO materials are compared (Fig 4.7 C), HA has the 
smallest R1 value; while GE and CO have similar R1, which may indicate that the 
collagen present in the GE and CO materials plays a more prominent role in their 
magnetic properties than HA. 
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Figure 4.7. Relationship of T1 versus Concentration (g/L) for Unsubstituted Hyaluronan 
(HA), Gelatin (GE) and HA/GE Composite (CO) Materials as Well as Agar and 
Gadolinium (Gd) Controls. The relaxivity of T1 values (R1) and coefficients of correlation (r2) 
for each relationship are provided (boxes). A: Linear relationship between Gd-DTPA-2 
concentration and T1 values with a high coefficient of correlation (r2 = 1). B: Linear relationship 
between Agar concentration and T1 values with a high coefficient of correlation (r2 = 0.96). C: 
Linear relationship between HA, GE and CO material concentration and T1 values with a high 
coefficients of correlation (r2 >0.95). Note the differences in the y-axis scales. 
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When the T1 values of HA, GE, CO, Agar and Magnevist are plotted versus 
concentration together on the same scale, the significant effect of incremental 
increases in concentration on T1 produced by the Magnevist MRI contrast agent 
is clearly noticeable (Fig 4.8). For ease of comparison, Fig 4.8 includes a table of 
the calculated minimum concentration required for each material to generate a 
significant impact on T1. Since PBS produces the longest T1 value (2,469 msec), 
the concentration of each material was calculated assuming a T1 value of half 
the T1pbs value (1,234.5 msec) and using the linear relation between 1/T1 – 
1/T1pbs vs. concentration of the material represented by each of the plots in Figs. 
4.7 and 4.8. As shown in the table in Fig 4.8, Magnevist (Gd) required a material 
concentration three orders of magnitude less than that required for the other 
material tested in order to reduce the T1 to half the T1PBS. This is consistent with 
its role as an MRI contrast agent. Agar, GE, CO or HA all had values of the same 
order of magnitude with the HA value greater than the GE value greater than the 
CO value greater than the Agar value These results clearly show that the 
differences in magnetic properties represented by the various effects of each 
material on the relaxation time, T1, are commanded by the intrinsic properties of 
each material. 
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Figure 4.8. Comparison of Relaxivity of T1 Values (R1) for Unsubstituted Hyaluronan 
(HA), Gelatin (GE) and HA/GE Composite (CO) Materials as Well as Agar and 
Gadolinium (Gd) Controls Using the Same Y-Axis Scale. Gd (Gd-DTPA-2), as a MR 
contrast agent, has the largest R1 value, and thus the highest impact on T1 with each 
incremental increase of its concentration. The HA, GE, CO and Agar materials all having 
similar R1 values, and thus similar impacts on T1 with each incremental increase of their 
concentrations. The inset table shows the calculated concentration of each material required 
to achieve half the T1 value of PBS. As a MR contrast agent, the concentration of Gd required 
is three orders of magnitude lower than the concentration of Agar, GE, CO or HA, which are 
all of the same order of magnitude with the HA value greater than the GE value greater than 
the CO value greater than the Agar value. 
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4.4.3. Relaxivity of T1 (R1) and Relaxivity of T2 (R2) 
In order to determine whether or not the low tyramine substitution and di-
tyramine cross-linking used in our chemistry had an effect on the imaging 
properties of the HA, GE and CO materials, the values for R1, R2 measured 
using echo spacing 15 msec, and R2 measured using echo spacing 30 msec 
were calculated for HA, GE, and CO unsubstituted, tyramine-substituted, and di-
tyramine cross-linked. 
Table X shows the R1 and R2 values obtained for unsubstituted HA, GE and CO 
materials. As described before, R1 or R2 is the slope of a best fit line relating T1 
or T2, respectively, to the concentration of the materials. The results indicate that 
the unsubstituted GE had the highest R1 value, followed by unsubstituted CO, 
and then unsubstituted HA; while the unsubstituted CO material, a combination 
of HA and GE, had the highest R2 value, followed by unsubstituted GE, and then 
unsubstituted HA.  The high coefficients of correlation (r2 > 0.95) for the fits of 
unsubstituted HA, GE and CO materials are indicative of the high correlation 
between both T1 and T2 and material concentration. 
 
Sample   R1   r2  R2 (15 ms)  r2  R2 (30 ms)  r2 
HA  0.0025  0.99  0.025  1  0.027  1 
GE  0.0049  0.98  0.030  0.97  0.033  0.98 
CO  0.0046  0.98  0.060  0.96  0.062  0.97 
 
Table X. R1 and R2 (15 msec and 30 msec) values for unsubstituted hyaluronan (HA), gelatin (GE), and 
HA/GE composite (CO) materials.  
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To verify whether or not tyramine-substitution had an effect on the imaging 
properties of the HA, GE and CO materials, Tables XI– XIII and Figs 4.9 – 4.11, 
respectively, provide direct comparison of the relaxivities of unsubstituted and 
tyramine-substituted materials. For HA, the slope or R1 and R2 (15 and 30 msec 
echo spacing) values increased with tyramine-substitution of HA (TS-HA) (Table 
XI , Fig 4.9). In the case of GE, tyramine-substitution decreased R1 and R2 (15 
and 30 msec) values (Table XII, Fig 4.10). This is presumably due to the fact 
that GE intrinsically gels in its unsubstituted form, and tyramine substitution 
disrupts this intrinsic gelling with an associated decrease in R1 and R2 values. 
Tyramine substitution also decreased R1 and R2 (15 and 30 msec) in the CO 
materials (Table XIII, Fig 4.11) presumably for a similar reason. 
Another objective of this study was to determine whether the second step of our 
chemistry that involves di-tyramine cross-linking had any consequence to the 
imaging properties of the materials. Hence, Tables XI - XIII and Figs 4.9 – 4.11 
also include the R1 and R2 values of the cross-linked materials (TB-HA, TB-GE 
and TB-CO, respectively) for comparison to unsubstituted and tyramine-
substituted materials. Table XI and Fig 4.9 shows that the R1 and R2 values 
increase further upon cross-linking (TB-HA) of the TS-HA. These changes in 
relaxivity are actually more pronounced in the R2 values. Table XII and Fig 4.10 
demonstrate a recovery (increase) in R1 and R2 values for the GE material upon 
cross-linking (TB-GE) of the TS-GE as the loss in ability to intrinsically gel is 
partially overcome by the gelling caused by dityramine cross-linking; although it 
could not fully recover to that of the unsubstituted GE material. Also, high 
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coefficients of correlation (r2 > 0.95) were obtained for the HA, GE and CO 
materials under the three conditions of unsubstituted, tyramine-substituted, and 
cross-linked, which is indicative of a high correlation between T1 and T2 and 
concentration of these materials. This was not the case for the post PBS 
equilibrated TB-GE material (r2 = 0.65), which was not an unexpected result due 
to the inconsistency observed in the final concentrations observed for the TB-GE 
when equilibrated in PBS as described in Chapter III. The relaxivity values 
further decreased with cross-linking (TB-CO) of the TS-CO material as illustrated 
in Table XIII and Fig 4.11. Additionally, the CO, TS-CO and TB-CO materials at 
100 mg/ml (Appendix B), which all contain GAG and collagen concentrations 
found in cartilage, had T1 values in the ~700 to 1,000 msec range typical of 
cartilage [50]. Therefore, these biomaterials replicate both the mechanical and 
imaging properties of cartilage. 
 
 
 
 
 
 
Sample   R1   r2  R2 (15 ms)  r2  R2 (30 ms)  r2 
HA  0.0025  0.99  0.025  1  0.027  1 
TS‐HA  0.0028  1  0.028  0.99  0.033  0.99 
TB‐HA  0.0031  1  0.039  0.98  0.049  0.97 
Table XI. R1 and R2 (15 msec and 30 msec) values for unsubstituted hyaluronan (HA), tyramine-substituted 
hyaluronan (TS-HA), and cross-linked hyaluronan (TB-HA) materials. 
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Figure 4.9. R1 (panel A), R2 at 15 msec (panel B) and R2 at 30 msec (panel C) Values for 
HA (blue), TS-HA (red), and TB-HA (yellow). In panel B and C, HA and TS-HA had similar 
slopes (R2 values); therefore, the TS-HA curves overlay the HA curves. 
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Sample   R1   r2  R2 (15 ms)  r2  R2 (30 ms)  r2 
GE  0.0049  0.98  0.030  0.97  0.033  0.98 
TS‐GE  0.0021  0.99  0.017  1  0.017  1 
TB‐GEw  0.0033  1  0.018  0.99  0.019  1 
TB‐GE  0.0024  0.65  0.018  0.97  0.018  0.97 
 
Table XII. R1 and R2 (15 msec and 30 msec) for unsubstituted gelatin (GE), tyramine-tubstituted 
gelatin (TS-GE), and cross-linked gelatin in PBS (TB-GE) and water (TB-GEw) materials. 
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Figure 4.10. R1 (panel A), R2 at 15 msec (panel B) and R2 at 30 msec (panel C) Values 
for GE (blue), TS-GE (red), and TB-GE (yellow). 
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 Sample   R1   r2  R2 (15 ms)  r2  R2 (30 ms)  r2 
CO  0.0046  0.98  0.060  0.96  0.062  0.97 
TS‐CO  0.0043  1  0.049  0.98  0.054  0.99 
TB‐CO  0.0031  0.99  0.030  0.97  0.034  0.97 
 
Table XIII. R1 and R2 (15 msec and 30 msec) values for unsubstituted HA/GE composite (CO), tyramine-
substituted HA/GE composite (TS-CO), and cross-linked HA/GE composite (TB-CO) materials. 
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Figure 4.11. R1 (panel A), R2 at 15 msec (panel B) and R2 at 30 msec (panel C) Values 
for CO (blue), TS-CO (red), and TB-CO (yellow). 
 130
As mentioned before, the 3.0 T MR that we used to image the various materials 
was inconsistent from day to day. To illustrate this variability, the R1 and R2 (15 
msec and 30 msec) values obtained from the acquired T1 and T2 values on the 
different days have been averaged for each material formulation and provided 
with their standard deviations in Tables XIV – XVI, respectively. This 
inconsistency was brought to the attention of Siemens Corporation, which is in 
the process of trying to identify the source of this issue. 
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 R1  
Sample  May 14' 09  Agu 21' 09  Sep 13 '09  Oct 1' 09  Oct 7 '09  Average R1  SD (±) 
HA  0.0025  0.0023  0.0031  0.0029  0.0025  0.0027  0.0003 
TS‐HA     0.0026  0.0035  0.0030  0.0028  0.0030  0.0004 
TB‐HA     0.0029  0.0037  0.0034  0.0031  0.0033  0.0003 
GE  0.0023  0.0026  0.0027  0.0034  0.0049  0.0032  0.0010 
TS‐GE     0.0016  0.0024  0.0023  0.0021  0.0021  0.0004 
TB‐GE           0.0028  0.0024  0.0026  0.0003 
TB‐Gew     0.0020  0.0030  0.0034  0.0033  0.0029  0.0006 
CO     0.0053  0.0056  0.0070  0.0092  0.0068  0.0018 
TS‐CO           0.0085  0.0085  0.0085  0.0000 
TB‐CO           0.0061  0.0062  0.0062  0.0001 
Agar  0.018  0.016  0.029  0.021  0.046  0.026  0.012 
Gd‐DTPA‐2  4.92  5.23  5.82  5.31  5.31  5.32  0.32 
 
 
Table XIV. Average of R1 values for all materials imaged on the different days. 
R2 (15 msec echo spacing) 
Sample  May 14' 09  Agu 21' 09  Sep 13 '09  Oct 1' 09  Oct 7 '09  Average R2  SD (±) 
HA  0.028  0.026  0.021  0.027  0.025  0.025  0.003 
TS‐HA     0.028  0.024  0.029  0.028  0.027  0.003 
TB‐HA     0.044  0.033  0.030  0.039  0.036  0.006 
GE  0.016  0.020  0.016  0.018  0.030  0.020  0.006 
TS‐GE     0.014  0.016  0.016  0.017  0.016  0.001 
TB‐GE           0.016  0.018  0.017  0.001 
TB‐Gew     0.014  0.014  0.014  0.018  0.015  0.002 
CO     0.093  0.089  0.103  0.121  0.101  0.014 
TS‐CO           0.098  0.099  0.099  0.000 
TB‐CO           0.062  0.061  0.062  0.001 
Agar  6.23  5.93  5.26  6.62  5.50  5.91  0.55 
Gd‐DTPA‐2  5.49  5.84  6.62  6.09  6.22  6.05  0.42 
 
 
Table XV. Average of R2 (15 msec echo spacing) values for all materials imaged on 
the different days. 
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R2 (30 msec echo spacing) 
Sample  May 14' 09  Agu 21' 09  Sep 13 '09  Oct 1' 09  Oct 7 '09  Average R2  SD (±) 
HA  0.029  0.028  0.023  0.026  0.027  0.027  0.002 
TS‐HA     0.031  0.026  0.031  0.033  0.030  0.003 
TB‐HA     0.048  0.036  0.034  0.049  0.042  0.008 
GE  0.015  0.020  0.016  0.019  0.033  0.021  0.007 
TS‐GE     0.014  0.016  0.017  0.017  0.016  0.002 
TB‐GE           0.016  0.018  0.017  0.002 
TB‐Gew     0.015  0.015  0.015  0.019  0.016  0.002 
CO     0.095  0.090  0.105  0.124  0.104  0.015 
TS‐CO           0.100  0.108  0.104  0.006 
TB‐CO           0.053  0.067  0.060  0.010 
Agar  6.06  6.25  5.27  6.62  5.52  5.94  0.55 
Gd‐DTPA‐2  5.14  5.78  6.53  6.19  6.09  5.95  0.53 
 
 
Table XVI. Average of R2 (30 msec echo spacing) values for all materials imaged on 
the different days. 
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In summary, the outcome of this study suggests that both T1 and T2 were 
equally sensitive to incremental changes in both HA and collagen concentration. 
HA was expected to have a larger impact than collagen on T1. However, they 
showed a similar impact on T1. Collagen was expected to have a larger impact 
than HA on T2. Yet, GE and HA showed a comparable impact on T2. The 
greatest impact on both T1 and T2 was produced by the combination of HA and 
collagen or the composite (CO) materials. Molecular motion, size and interaction 
are factors affecting T1 and T2 relaxation times. It has been previously stated 
that slow, large, bound molecules have a long T1 and short T2; fast, small, free 
molecules have a long T1 and T2; and intermediate molecules have a short T1 
and T2 (see Chapter I). Nonetheless, this study implies that this criterion is not 
always followed.  It seems as if molecular interaction has the greatest effect on 
T1 and T2, regardless of the molecular size and motion. Tyramine substitution 
and di-tyramine cross-linking produced some effects on R1 and R2 compared to 
the unsubstituted materials. The relaxivity of HA slightly increased with tyramine-
substitution and then again with cross-linking. By contrast for GE, the relaxivity 
decreased upon tyramine-substitution of GE, and then increased with 
subsequent cross-linking, as a result of first disruption of intrinsic gelation of the 
GE, and then synthetic gelation of the GE through formation of dityramine 
bridges during the HRP catalyzed cross-linking reaction. 
Additionally, this study demonstrated the differences in magnetic properties of 
Magnevist (Gd), as an MRI contrast agent, compared to agar and the HA, GE 
and CO hydrogel biomaterials. Magnevist had the ability to generate a significant 
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effect on T1 with a concentration as small as 0.087 g/L compared to the other 
materials (HA, GE, CO and Agar), which required from 800 to 1,500 times the 
concentration of Magnevist to have a similar effect. 
The T1 and T2 values decreased with increasing concentration of all materials. 
The T1 or T2 value differences between 6.25 and 12.5 mg/ml concentrations 
were about 30-90 msec. However, once the concentration reached 25, 50 and 
100 mg/ml the T1 or T2 values dropped by 200-900 msec (Appendix B). These 
substantial differences in the imaging properties between the low and high 
concentration materials correspond with the results seen in the mechanical 
testing data for these biomaterials.  The aggregate modulus for the 6.25 and 12.5 
mg/ml hydrogels is between 20-70 Kpa, while the 25, 50 and 100 mg/ml have 
modulus of 400-1,200 Kpa, as shown in Table I.  Hence, a pronounced change 
in the mechanical properties of these materials is noticed when reaching the 25 
mg/ml concentration, and this can also be observed through the imaging 
properties of these materials. 
The T1 and T2 values of TB-hydrogels are much longer than those of native 
articular cartilage, thus they could be readily distinguished from the surrounding 
tissue. The composite materials at 100 mg/ml, which have T1 value in the ~ 700 
to 1,000 msec range that is representative of cartilage [50], could also be 
distinguished as its T2 values are higher than native articular cartilage (T2 of 
cartilage 20 – 40 msec) [50].  Lastly, this study has successfully applied MRI 
methods to a controlled system of synthetic ECM composed of TB-HA and TB-
collagen molecules and evaluated their sensitivity and specificity for measuring 
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matrix composition. This work has provided a better understanding of the 
relationship between these MRI methods and tissue composition that can now be 
used to improve these MRI techniques for detection and measurement of GAG 
and collagen content in cartilage. Additionally, we now have the ability to detect, 
distinguish, and characterize the TB-hydrogels through MRI. We have identified 
the T1 and T2 values of TB-hydrogels at various concentrations, hence any in 
vivo changes in HA or collagen content in the materials can be easily detected 
through MRI.  This is certainly a valuable tool that will allow evaluation of the 
performance of TB-hydrogels in vivo with time, which could not be achieved 
through histological procedures due to hydrogel dehydration, as explained in 
Chapter II. 
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CHAPTER V 
GLYCOSAMINOGLYCAN (GAG) MEASUREMENT IN TYRAMINE-BASED 
HYDROGELS THROUGH DELAYED GADOLINIUM ENHANCED MRI OF 
CARTILAGE (dGEMRIC) TECHNIQUE 
 
5.1 Introduction 
The theory behind the dGEMRIC technique for measurement of GAG content in 
articular cartilage is based on a negatively charged contrast agent such as Gd-
DTPA (Magnevist, Bayer Healthcare Pharmaceuticals, Park Ridge, NJ) 
distributing within cartilage inversely to the concentration of negatively charged 
GAG molecules [52]. It is expected that this same charge-based imaging 
technique should also distinguish and quantify the GAG content in the TB-
hydrogels. The equation used in this charge-based imaging technique to 
calculate the Gd-DTPA concentration in a sample, and hence the GAG index 
requires knowledge of the spin-lattice relaxivity (R1) of the contrast agent in the 
tissue or material being analyzed. The R1 for Gd-DTPA in intact cartilage and in 
solution have been previously determined at 8.45 T and shown to be 
independent of GAG concentration [53]. Nevertheless, recent work by Stanisz 
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[52] has suggested that relaxivity is sensitive to macromolecular content at lower 
(e.g. clinical) field strengths. The objective of this investigation was to use the 
dGEMRIC technique to quantify GAG concentration in TB-hydrogels as well as to 
verify the dependency of Gd-DTPA relaxivity on the environmental 
macromolecular content using a defined-system of TB-hydrogels at lower field 
strengths. 
 
5.2 Experimental Design 
dGEMRIC uses T1 inversion recovery images measured before (pre) and after 
(post) equilibration in defined solutions of Gd-DTPA to compute the GAG index. 
The T1 inversion recovery sequences have already been described in Chapter 
IV. The MRI acquisition method was similar to that used clinically to probe the 
macromolecular composition of cartilage. Imaging of TB-HA at concentrations of 
6.25, 12.5, 25, 50 and 100 mg/ml, TB-GE at concentrations of 60, 70, 80 and 90 
mg/ml, and HA/GE composites of equal ratios (6.25:6.25, 12.5:12.5, 25:25, 50:50 
and 100:100 HA to GE, respectively) were performed. The samples were all 
formulated in 1.5 ml cryotubes at 1 ml volumes, and the T1pre-Gd values of this 
series of samples measured. Then the samples placed in individual dialysis bags 
and equilibrated in one of three Gd-DTPA bath s in PBS of 0.5, 1 or 2 mM ([Gd-
DTPA]bath) for approximately 48 h while stirring at 4ºC. Once the samples 
reached equilibrium with the bath solution, the samples were removed from the 
dialysis bags, blotted dry, weighed, and subjected to another set of T1 
measurements to obtain T1post-Gd values. The gadolinium concentration of each 
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sample after bath equilibration ([Gd-DTPA]material) was then calculated using 
Equation 5.1 and the measured T1pre-Gd, and T1post-Gd values and the R1 for Gd-
DTPA in each material determined through a separate series of experiments 
described below. A theoretical GAG concentration for each sample was 
calculated using Equation 5.2, and the [Gd-DTPA]bath and [Gd-DTPA]material 
values. A comparison of R1 among the samples was made, and a comparison of 
the actual and theoretical GAG concentrations for each sample was performed. 
 
5.3 Materials and Methods 
5.3.1 Samples Preparation and Gd-DTPA Equilibration 
The materials and methods for the synthesis of TS-HA, TS-GE and TS-CO 
samples, and their formation into TB-hydrogels are described in Appendix A. 
After post cross-linking equilibration of the materials in PBS, the TB-hydrogels 
were arranged in a rack to form a grid composed of 3 groups of 14 samples (5 
TB-HA only, 4 TB-GE only, and 5 HA/GE composites) plus 5 Gd-DPTA and 3 
PBS controls for a total of 45 samples (Fig 5.1) with each group representing one 
of the three Gd-DTPA bath concentrations to be used (A = 2 mM, B = 1 mM and 
C = 0.5 mM). 
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Figure 5.1. Grid of Samples Imaged for dGEMRIC. In the grid, columns A, D and G 
contain the cross-linked hyaluronan (TB-HA) samples, columns B, E and H contain 
the cross-linked gelatin (TB-GE) samples, and columns C, F and I contain the cross-
linked HA/GE composite (TB-CO) samples arranged into three replicate groups (A, B 
and C). Five Gd-DPTA (column J), and three PBS (column K) samples were also 
included as internal controls. All samples were at the initial concentrations indicated. 
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Two liters of Gd-DTPA bath in PBS at concentrations of 0.5, 1 and 2 mM were 
made from a stock solution of Gd-DTPA (Magnevisit, Bayer Healthcare 
Pharmaceuticals, Park Ridge, NJ) at 522.495 mM, and cooled to 4°C. Each 
cross-linked hydrogel was removed from its container and transferred to a 4 cm 
long piece of dialysis membrane tubing of MWCO = 6-8,000 daltons, 3.3 ml/cm of 
volume/length, and 32 mm diameter (Spectrum Laboratories, Inc) as shown in 
Figure 5.2.  Next, each sample group (A, B and C in Figure 5.1) was immersed 
in its corresponding Gd-DTPA bath (2, 1 and 0.5 mM, respectively). Equilibration 
occurred with constant mixing at 4°C over 48h. 
  
 
 
 
 
Figure 5.2. TB-Hydrogel Plug in Dialysis Tubing Prior 
to Gd-DTPA-2 Bath Equilibration.  
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To corroborate that the samples reached equilibrium in the 3 different Gd baths 
(0.5, 1 and 2 mM), the [Gd-DTPA]bath values were plotted versus the pre- and 
post-Gd T1 values to confirm a linear relationship with  the slope or R1 of Gd-
DTPA for each sample (Figure 5.3). 
 
5.3.2 Measurement of Gadolinium (Gd) Concentration using Inductively 
Coupled Plasma – Mass Spectroscopy (ICP-MS) 
To calculate the R1 for the Gd-DTPA for each sample the equilibrium 
concentration of Gd-DTPA in the biopolymers ([Gd-DTPA]material) must be 
determined. Therefore, once the samples were imaged for the second time or 
after equilibration in the Gd baths, an aliquot of 200 µl out of the 1 ml volume of 
the samples was sent to the Trace Element Research Laboratory at Ohio State 
University for ICP-MS analysis.  
A Perkin Elmer Optima 3000DV Inductively Coupled Optical Emission 
Spectrometer was used with the following settings: power: 1300w, plasma gas: 
15 L/min, auxillary gas: 0.5 L/min, nebulizer gas: 0.6 L/min, sample uptake:  0.5 
ml/min pumped via peristaltic pump. 
Sample preparation: 
The samples were treated by adding 0.2 ml concentrated Certified ACS+ nitric 
acid to each 0.2 ml sample (as submitted to TERL) and allowed to sit undisturbed 
for ~40 h. The samples were then quantitatively transferred to 8 ml LDPE bottles 
(bottles were rinsed 3x with deionized water before use) and diluted to 5 ml total 
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with deionized water (Millipore Milli-Q deionizer).   The samples were 4% v/v 
nitric acid after the dilution. 
All sample and standard preparation performed in a HEPA filtered class 10 
laminar flow exhausting hood. Calibration standards were made by diluting a 
1000 ug/ml (ppm) Gd standard stock solution purchased from Inorganic Ventures 
(IVStandards.com) via serial dilutions to the intended concentration.  The 
standards were all prepared in 4% v/v Certified ACS+ nitric acid to match the 25x 
diluted samples.  A calibration blank of 4% v/v Certified ACS+ nitric acid in 
deionized water was used. 
 
5.3.3 Pre and Post Gd-DTPA MRI Measurements 
For each sample, or series of samples, the T1 was mapped twice, first before 
equilibration with Gd-DTPA (T1pre-Gd) and then after equilibration with Gd-DTPA 
(T1post-Gd). An inversion recovery fast (turbo) spin echo sequence was used to 
measure T1 with TR = 6000 msec; TI = 23 msec, 75 msec, 150 msec, 300 msec, 
750 msec, 1,400 msec, 2,000 msec and 2,800 msec; TE = 10 msec; FOV = 270 
x 130 mm; slice thickness = 1.9 mm; matrix = 256 x 128. As described in 
Chapter IV, the eight images were curve-fit to generate T1 maps using a three-
parameter exponential fit SI = M0 (1–2Ae–TI/T1 + e–TR/T1) with MRIMapper 
(MIT, Cambridge, MA) and MATLAB (MathWorks, Natick, MA) [47]. The regions 
of interests (ROI) to be mapped were selected as 4x4 set of pixels from the 
center of each hydrogel sample. The calculated T1pre-Gd and T1post-Gd values were 
an average of the pixels from the ROI from each sample. The color-coded T1 
maps were displayed superimposed on the TI = 23 msec image. 
 
5.3.4 Fixed Charge Density (FCD) and Glycosaminoglycan (GAG) content 
Computation  
As described below in Results and Discussion, the [Gd-DTPA]material values 
obtained using ICP-MS were not reliable. Therefore, in order to determine the 
[Gd-DTPA]material values necessary to calculate the matrix fixed charge density 
(FCD) per Equation 5.2, we used Equation 5.1. In addition to the T1pre-Gd and 
T1post-Gd values acquired as described above, Equation 5.1 requires 
determination of the R1 value for Gd-DTPA in the materials composition of 
interest. Therefore, T1 values were obtained for HA and GE samples at 
concentrations of 100 mg/ml containing Gd-DTPA at concentrations of 0.125, 
0.25, 0.5, 1 and 2 mM. These T1 values were then used to calculate the R1 for 
Gd in the HA and GE at 100 mg/ml as previously described in Chapter 4. These 
R1 values together with the T1pre-Gd and T1post-Gd values were then used to 
calculate the Gd concentration inside the 100 mg/ml samples (Gd-DTPAmaterial) 
through Equation 5.1, the derivation of which was explained in Chapter I. 
Equation 5.1: 
[Gd‐DTPA] material = 1
R1
1       ‐ 1 
T1post‐Gd  T1pre‐Gd
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Once the [Gd-DTPA]material values had been calculated through Equation 5.1, 
they were used to calculate the fixed charge density (FCD) for each sample 
using the “quasi-theoretical” model Equation 5.2 the derivation of which is also 
explained in Chapter I [54]. 
Equation 5.2: 
FCD =  [Na+]bath
[Gd‐DTPA]material
[Gd‐DTPA]bath
½
[Gd‐DTPA]bath
[Gd‐DTPA]material
½
−
 
 
After the FCD were calculated, they were converted to a theoretical GAG 
concentration by assuming a molecular weight of 400 g/mole, the molecular 
weight of the HA disaccharide, and also similar to those of the chondroitin sulfate 
disaccharide in cartilage. 
 
5.4 Results and Discussion 
The T1pre-Gd and T1post-Gd values as 1/T1pre – 1/T1post for all of the samples 
imaged in Figure 5.1 is shown in Table XVII. Plots of T1pre-Gd and T1post-Gd values 
versus Gd-DTPA bath concentration verified that the TB-HA, TB-GE and TB-CO 
had reached equilibrium by virtue of a linear relationship with coefficients of 
correlation >0.9 as shown in Figs 5.3 – 5.5. 
  146
   147
 
 
 
 
 
 
 
              
100 50 25 12.5 6.25
Gd(M) 1/T1pre ‐ 1/T1post 1/T1pre ‐ 1/T1post 1/T1pre ‐ 1/T1post 1/T1pre ‐ 1/T1post 1/T1pre ‐ 1/T1post
0.002 0.0051 0.0042 0.0068 0.0083 0.0100
0.001 0.0021 0.0035 0.0042 0.0046 0.0050
0.0005 0.0011 0.0013 0.0024 0.0026 0.0027
100 50 25 12.5 6.25
Gd(M) 1/T1pre ‐ 1/T1post 1/T1pre ‐ 1/T1post 1/T1pre ‐ 1/T1post 1/T1pre ‐ 1/T1post 1/T1pre ‐ 1/T1post
0.002 0.0038 0.0076 0.0081 0.0093 0.0098
0.001 0.0027 0.0043 0.0038 0.0050 0.0052
0.0005 0.0014 0.0022 0.0021 0.0026 0.0028
90 80 70 60
Gd(M) 1/T1pre ‐ 1/T1post 1/T1pre ‐ 1/T1post 1/T1pre ‐ 1/T1post 1/T1pre ‐ 1/T1post
0.002 0.0138 0.0143 0.0143 0.0117
0
0.
.001 0.0068 0.0078 0.0078 0.0070
0005 0.0038 0.0045 0.0041 0.0047
TB‐HA (mg/ml)
TB‐CO (mg/ml)
TB‐GE (mg/ml)
Table XVII. The T1pre-Gd and T1post-Gd values as 1/T1pre – 1/T1post for each Gd-
DTPA Bath Concentration (0.5, 1 and 2 mM) for TB-HA, TB-GE and TB-CO 
samples described in Figure 5.1. 
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Figure 5.3. TB-HA Samples Equilibrated in Gd-DTPA Baths. T1pre-Gd and T1post-Gd values 
as 1/T1pre – 1/T1post plotted versus the Gd-DTPA bath concentrations (0.5, 1 and 2 mM) for 
TB-HA concentrations of 6.25, 12.5, 25, 50 and 100 mg/ml. 
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Figure 5.4. TB-CO Samples Equilibrated in Gd-DTPA. T1pre-Gd and T1post-Gd values as 
1/T1pre – 1/T1post plotted versus the Gd-DTPA bath concentrations (0.5, 1 and 2 mM) for 
TB-CO concentrations of 6.25, 12.5, 25, 50 and 100 mg/ml. 
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Figure 5.5. TB-GE Samples Equilibrated in Gd-DTPA. T1pre-Gd and T1post-Gd values as 
1/T1pre – 1/T1post plotted versus the Gd-DTPA bath concentrations (0.5, 1 and 2 mM) for TB-
GE concentrations of 60, 70, 80 and 90 mg/ml. 
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Gd-DTPA is negatively charge distributing into areas in cartilage that are 
depleted of GAG at a higher concentration than in areas of high GAG content. As 
expected, the Gd-DTPA did the same for our materials and distribute in high 
concentrations in the hydrogels with low GAG content and in low concentration in 
the hydrogel high GAG content. Gd-DTPA has a concentration-dependent effect 
on the MR parameter T1, thus T1 images in the presence of this contrast agent 
reflect the GD-DTPA concentration, and hence GAG concentration. The T1 map 
pre-Gd and post-Gd clearly shows the shortening of T1 in the presence of Gd-
DTPA (Fig 5.6).  
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Figure 5.6. Pre and Post Gd-DTPA T1 maps of TB-HA, TB-GE and TB-CO. A, B, and C 
indicates the Gd-DTPA bath concentration in which the samples were equilibrated, which 
were 2, 1, and 0.5 mM, respectively.  Left: T1 map before Gd equilibration showing the TB-
HA and TB-CO samples within a T1 map range of 684 up to 2730 msec; while the TB-GE 
samples remained in the lower range of 684 to 2050 msec. Right: T1 map after Gd 
equilibration showing a shortening of T1 to low range of 0 to 360 approximately. The 
controls behaved as expected as both Agar and water were in the higher T1 range. Also, the 
inhomogeneity observed in the post-Gd T1 map for some of the samples is due to the 
samples breaking in the process of transferring them back to the cryotubes.  
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A = Gd at 2mM B = Gd at 1mM C = Gd at 0.5 mM
Sample 
Pre 
[mg/ml] T1pre Post (mg/ml) T1post Sample 
Pre 
[mg/ml] T1pre
Post  
(mg/ml) T1post Sample 
Pre 
[mg/ml] T1pre
Post 
(mg/ml) T1post
TB‐HA 6.25  6.3 2524 4.5 96 TB‐HA 6.25  6.3 2607 4.1 186 TB‐HA 6.25  6.3 2556 3.5 324
TB‐HA 12.5  12.5 2358 10.4 115 TB‐HA 12.5  12.6 2416 9.0 199 TB‐HA 12.5  12.4 2416 7.9 333
TB‐HA 25  25 2143 24.7 138 TB‐HA 25  25.6 2176 20.7 216 TB‐HA 25  25.3 2168 20.0 350
TB‐HA 50  50 1701 47.3 208 TB‐HA 50  50 1963 47.5 247 TB‐HA 50  50 1674 41.6 523
TB‐HA 100  100 1709 68.8 176 TB‐HA 100  100 1665 78.6 368 TB‐HA 100  100 1655 82.8 572
Sample 
Pre 
[mg/ml] T1pre Post (mg/ml) T1post Sample 
Pre 
[mg/ml] T1pre Post (mg/ml) T1post Sample 
Pre 
[mg/ml] T1pre
Post 
(mg/ml) T1post
TB‐ GE 60  61 1862 69.1 82 TB‐ GE 60  61 1774 71.1 132 TB‐ GE 60  61 1717 62.4 190
TB‐GE 70 71 1553 87.9 67 TB‐GE 70 71 1675 73.7 119 TB‐GE 70 71 1470 69.4 208
TB‐GE 80 79 1711 90.5 67 TB‐GE 80 79 1795 88.7 119 TB‐GE 80 79 1841 83.3 199
TB‐GE 90 91 1360 102.6 69 TB‐GE 90 91 1432 87.1 133 TB‐GE 90 91 1465 84.0 222
Sample 
Pre 
[mg/ml] T1pre Post (mg/ml) T1post Sample 
Pre 
[mg/ml] T1pre Post (mg/ml) T1post Sample 
Pre 
[mg/ml] T1pre
Post 
(mg/ml) T1post
TB‐ CO 6.25 6.2 2437 4.3 98 TB‐ CO 6.25 6.4 2451 3.8 177 TB‐ CO 6.25 6.2 2507 3.7 317
TB‐CO 12.5  12.3 2255 9.2 103 TB‐CO 12.5  12.5 2259 9.0 184 TB‐CO 12.5  12.1 2233 8.6 333
TB‐CO 25  25.9 1665 26.9 115 TB‐CO 25  26 1647 26.1 225 TB‐CO 25  26 1706 23.9 371
TB‐CO 50  50 1570 42.3 122 TB‐CO 50  50 1601 37.5 203 TB‐CO 50  50 1520 36.9 355
TB‐CO 100  100 1076 80.9 211 TB‐CO 100  100 1089 64.9 273 TB‐CO 100  100 943 57.0 402
 
Table XVIII. Pre-Gd and post-Gd T1 values and initial and final concentrations for all 
the samples that were imaged.  
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The T1 pre and post–Gd values for each sample examined in this research are 
shown in Table XVIII. The above table demonstrates how the T1 post-Gd 
dramatically dropped compared to the T1 pre-Gd. Also, as expected, the T1 post-
Gd became shorter as the concentration of the Gd-DTPAbath increased since the 
higher the concentration of the negatively charged Gd-DTPA, the greater are the 
repulsion forces of negatively charged GAG, causing the drop in T1. 
Furthermore, the pre and post-Gd concentration of the materials were included in 
this table in order to account for the fact that most of the samples experienced 
either shrinking or swelling, which would therefore change their concentrations.  
ICP-MS measured Gd concentration values lower than the known Gd 
concentrations in the materials as demonstrated for the samples at 100 mg/ml 
HA or GE made in Gd at 0.125, 0.25, 0.5,1, 2 mM (Table XIX). Then, it 
measured Gd concentration values higher for the Gd-DTPA concentration curve 
of 0.125, 0.25, 0.5, 1, 2 mM and for the 3 Gd bath concentrations of 0.5, 1, and 
2mM (Table XX). The Gd concentrations in the TB-HA, TB-GE, and TB-CO 
samples measured by ICP-MS are included in Table XXI.  This study found ICP 
measurements of Gd-DTPA differed about 50% from the known concentrations. 
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 Sample  [mM] [Gd]material (mM) Sample [mM] [Gd]material (mM)
100 HA+Gd 0.125 0.125 < 0.01 100 GE+Gd 0.125 0.125 < 0.01
100 HA+Gd 0.25 0.25 0.12 100 GE+Gd 0.25 0.25 0.13
100 HA+Gd 0.5 0.5 0.23 100 GE+Gd 0.5 0.5 0.31
100 HA+Gd 0.1 1 0.62 100 GE+Gd 0.1 1 0.66
100 HA+Gd 2 2 1.23 100 GE+Gd 2 2 1.28
 
Table XIX. Results of [Gd]material concentration measured by ICP-MS in 
100 mg/ml HA and GE made in different concentrations of Gd-DTPA. 
The T1pbs value on this imaging day was 2,730.2 ± 188.4. 
 
 
 
Sample  [mM] [Gd]material (mM) Sample  [mM] [Gd]material (mM)
Gd 0.125 0.125 0.30 Gd 0.5 0.5 1.03
Gd 0.25 0.25 0.53 Gd 1 1 1.94
Gd 0.5 0.5 0.93 Gd 2 2 4.78
Gd 1 1 1.99
Gd 2 2 2.73
Table XX. Results of [Gd]material concentration measured by ICP-MS in 
Gd-DTPA at 0.125, 0.25, 0.5, 1, and 2 mM, and in the Gd-DTPA bath 
concentrations at 05, 1, and 2 mM. The T1pbs value on this imaging day 
was 2,730.2 ± 188.4. 
 
 
 
 
 
Sample  [mg/ml] [Gd]material (mM) Sample  [mg/ml] [Gd]material (mM) Sample  [mg/ml] [Gd]material (mM)
TB‐HA 6.25  6.3 1.39 TB‐HA 6.25  6.3 0.64 TB‐HA 6.25  6.3 0.32
TB‐HA 12.5  12.5 1.18 TB‐HA 12.5  12.6 0.56 TB‐HA 12.5  12.4 0.29
TB‐HA 25  25 0.83 TB‐HA 25  25.6 0.52 TB‐HA 25  25.3 0.27
TB‐HA 50  50 0.59 TB‐HA 50  50 0.37 TB‐HA 50  50 0.13
TB‐HA 100  100 0.94 TB‐HA 100  100 0.27 TB‐HA 100  100 0.13
Sample  [mg/ml] [Gd]material (mM) Sample  [mg/ml] [Gd]material (mM) Sample  [mg/ml] [Gd]material (mM)
TB‐ GE 60  61 1.48 TB‐ GE 60  61 0.82 TB‐ GE 60  61 0.38
TB‐GE 70 71 1.44 TB‐GE 70 71 0.79 TB‐GE 70 71 0.40
TB‐GE 80 79 1.53 TB‐GE 80 79 0.82 TB‐GE 80 79 0.40
TB‐GE 90 91 1.45 TB‐GE 90 91 0.69 TB‐GE 90 91 0.41
Sample  [mg/ml] [Gd]material (mM) Sample  [mg/ml] [Gd]material (mM) Sample  [mg/ml] [Gd]material (mM)
TB‐ CO 6.25 6.2 1.30 TB‐ CO 6.25 6.4 0.67 TB‐ CO 6.25 6.2 0.34
TB‐CO 12.5  12.3 1.24 TB‐CO 12.5  12.5 0.58 TB‐CO 12.5  12.1 0.30
TB‐CO 25  25.9 0.91 TB‐CO 25  26 0.41 TB‐CO 25  26 0.25
TB‐CO 50  50 0.89 TB‐CO 50  50 0.42 TB‐CO 50  50 0.23
TB‐CO 100  100 0.43 TB‐CO 100  100 0.28 TB‐CO 100  100 0.15
A = Gd at 2mM B = Gd at 1mM C = Gd at 0.5 mM
 
 
 
 
 Table XXI. Results of [Gd]material concentration measured by ICP-MS in TB-HA, 
TB-GE, and TB-CO. The T1pbs value on this imaging day was 2,730.2 ± 188.4. The 
T1 value of Gd at 2 mM was 91 ± 5, at 1 mM was 174 ± 15, and at 0.5 mM was 335 
± 8.  
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Moreover, the [Gd]material values obtained by ICP-MS were used to calculate FCD 
and convert it into GAG concentration, and as expected the values did not match 
those of the original concentrations in the materials, as exemplified in Table XXII 
for the TB-HA and TB-CO that were immersed in the 2 mM Gd-DTPA bath. 
Next, the T1 values obtained from imaging the samples of 100 mg/ml HA or GE 
made in Gd at 0.125, 0.25. 0.5,1, 2 mM, and the R1 of Gd-DTPA calculations are 
included in Table XXIII.  This table also includes the results for the Gd-DTPA 
control curve. The R1 (7.02 mM-1s-1) of Gd-DTPA in 100 mg/ml HA and the R1 of 
Gd-DTPA in 100 mg/ml GE (6.57mM-1s-1) was then used to calculate the Gd 
concentration in the material [Gd]material (Table XXIV), followed by the FCD and 
GAG index computation (Table XXIV).   
Sample  Intial [mg/ml] Final (mg/ml) [Gd]material (M) FCD(mol/L) [GAG](mg/ml)
TB‐HA 6.25  6.3 4.5 0.0014 ‐0.056 22.33
TB‐HA 12.5  12.5 10.4 0.0012 ‐0.082 32.91
TB‐HA 25  25 24.7 0.0008 ‐0.139 55.58
TB‐HA 50  50 47.3 0.0006 ‐0.199 79.73
TB‐HA 100  100 68.8 0.0009 ‐0.118 47.39
Sample  Initial [mg/ml] Final (mg/ml) [Gd]material (mM) FCD(mol/L) [Asp , Glut](mg/ml)
TB‐ CO 6.25 6.2 4.3 0.0013 ‐0.067 26.93
TB‐CO 12.5  12.3 9.2 0.0012 ‐0.075 29.85
TB‐CO 25  25.9 26.9 0.0009 ‐0.125 50.00
TB‐CO 50  50 42.3 0.0009 ‐0.129 51.56
TB‐CO 100  100 80.9 0.0004 ‐0.262 104.67
A = Gd at 2mM 
 
 
 
Table XXII. Fixed charge density (FCD) and glycosaminoglycans (GAG) 
calculations based on the [Gd]material concentration measured by ICP-MS.  
 Sample1  [mM] T1 1/T1‐ 1/T1HA R1  Sample  [mM] T1 1/T1‐ 1/T1PBS R1 
100 HA2+Gd 0.125 0.125 658 ± 23 0.0009 7.02 Gd 0.125 0.125 910 ± 26 0.0007 5.23
100 HA+Gd 0.25 0.25 409 ± 7 0.0018 r2 = 1 Gd 0.25 0.25 553 ± 14 0.0014 r2 = 1
100 HA+Gd 0.5 0.5 235 ± 6 0.0036 Gd 0.5 0.5 312 ± 6 0.0028
100 HA+Gd 0.1 1 130 ± 3 0.0070 Gd 1 1 169 ± 3 0.0055
100 HA+Gd 2 2 68 ± 3 0.0140 Gd 2 2 92 ± 2 0.0104
Sample [mM] T1 1/T1‐ 1/T1HA R1 Sample 4 [mM] T1 1/T1‐ 1/T1PBS R1 
100 GE3+Gd 0.125 0.125 685 ± 22 0.0008 6.57 Gd 0.125 0.125 927 ± 24 0.0007 5.23
100 GE+Gd 0.25 0.25 454 ± 13 0.0015 r2 = 1 Gd 0.25 0.25 556 ± 12 0.0014 r2 = 1
100 GE+Gd 0.5 0.5 244 ± 8 0.0034 Gd 0.5 0.5 313 ± 9 0.0028
100 GE+Gd 0.1 1 132 ± 4 0.0069 Gd 1 1 172 ± 4 0.0054
100 GE+Gd 2 2 73 ± 3 0.0130 Gd 2 2 92 ± 4 0.0104
1T1pbs value on this imaging day was 2,346.25±124
2T1 value of HA at 100 mg/ml was 1,519 ± 55
3T1 value of GE at 100 mg/ml was 174±15
4Gd was heated. No change observed compared to non-heated Gd
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 Table XXIII.  T1 and R1 values of a 100 mg/ml HA or GE made in different 
concentrations of Gd-DTPA. 
 
Sample1 Pre [mg/ml] Post (mg/ml) T1pre T1post 1/T1pre‐ 1/T1post R1  [Gd]material FCD(mol/L) [GAG](mg/ml)
TB-HA 100 100 68.83 1709 176 0.0051 7.02 0.0007 -0.163 65.12
TB-GE 90 91 102.56 1360 69 0.0138 6.57 0.0021 0.002
Sample  Pre [mg/ml] Post (mg/ml) T1pre T1post 1/T1pre‐ 1/T1post R1  [Gd]material FCD(mol/L) [GAG](mg/ml)
TB-HA 100 100 78.59 1665 368 0.0021 7.02 0.0003 -0.196 78.35
TB-GE 90 91 87.13 1432 133 0.0068 6.57 0.0010 0.0003
Sample  Pre [mg/ml] Post (mg/ml) T1pre T1post 1/T1pre‐ 1/T1post R1  [Gd]material FCD(mol/L) [GAG](mg/ml)
TB-HA 100 100 82.77 1655 572 0.0011 7.02 0.0002 -0.182 72.73
TB-GE 90 91 84.00 1465 222 0.0038 6.57 0.0006 0.018
1T1pbs value on this imaging day was 2,730.2±188.4
2T1 value of Gd at 2 mM was 91±5
3T1 value of Gd at 1 mM was 174±15
4T1 value of Gd at 0.5 mM was 335±8
A = Gd at 2mM2
B = Gd at 1mM3
C = Gd at 0.5 mM4
 
 
 
 
 
Table XXIV. Calculation of Gd concentration in the material (Gd material), fixed charged 
density (FCD), and glycosaminoglycans (GAG) content for the 100 mg/ml HA and the 
100 mg/ml GE at the three Gd-bath concentrations of 2, 1, and 0.5 mM.  
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The GAG content estimation was only done for the HA samples at 100 mg/ml, 
since the FCD of GE turned out to be positive (yellow in Table XXIV) impeding 
the estimate of the concentration in these materials. The outcome of a positive 
FCD for GE is in agreement with the calculated concentrations of Gd in the 
material (Gdmaterial) being slightly higher than the Gd-bath concentration (yellow in 
Table XXIV). Furthermore, these results is in agreement with the basic or 
positively charged characteristics found in the human type I collagen sequence 
described in Chapter I. Furthermore, these results confirm that collagen does not 
contribute to or interfere with the assessment of GAG content using dGEMRIC.  
The GAG content of  the 100 mg/ml HA closely matched the post-Gd GAG 
content in the materials, which are highlighted in red in Table XXIV and also 
plotted in Fig 5.7. As expected, the three Gd-bath concentrations (0.5, 1, 2 mM) 
estimated GAG content (Fig 5.7) equally well. Also, although the R1 of Gd was 
obtained only for the 100 mg/ml of HA, the R1 of Gd should be very similar within 
a range of concentrations and composition as shown by Table XXIV. 
Additionally, it was verified that heating of the Gd-DTPA did not change the 
relaxivity of this contrast agent (Fig 5.8). This confirmation was needed as the 
100 mg/ml HA and GE samples that were made in the different concentrations of 
Gd required heating at 60ºC for 2 hours in order for the samples to go into 
solution.  
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Figure 5.7. [GAG]actual vs. [GAG]calculated. This figure compares how closely the GAG 
content calculated (red) by means of finding the R1 of Gd in the material at 100 mg/ml of HA 
to the GAG content (blue) that was originally in the samples. The GAG content assessment 
was repeated in 0.5, 1, and 2 mM Gd-bath concentrations.   
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 Figure 5.8. Effect of Heating on Gd-DTPA.  Gd-DTPA with and without heating was 
plotted at concentrations of 0.125, 0.25, 0.5, 1, and 2 mM. As seen in this figure, heating 
has no effect on Gd-DTPA. 
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 Figure 5.9. Effect of HA and GE Macromolecular Content on the Relaxivity (R1) of 
Gd-DTPA. The R1 of Gd increased in the presence of HA or GE content compared to Gd 
without HA or GE.  
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The final verification that was done referred to the dependency of the R1 of Gd-
DTPA on GAG and collagen content. The R1 for Gd-DTPA in intact cartilage and 
in solution has been previously determined at 8.45 T and shown to be 
independent of GAG concentration [52]. Nevertheless, our results in TB-
hydrogels suggest that relaxivity is sensitive to macromolecular content (Fig 4.5) 
at lower field strengths (3 T), which agrees with the findings of recent work by 
Stanisz [53]. Figure 5.9 shows that R1 of Gd-DTPA is reliant on molecular 
concentration since the relaxivity of Gd increased slightly in the presence of both 
the HA and GE materials. The data plotted in Figure 5.9 originates from Table 
XXV.  
Lastly, the variability of T1 and T2 values from day to day due to the MR shift 
was previously discussed in Chapter IV.  This experiment allowed to image three 
replicates of TB-HA, TB-GE, and TB-CO samples in one day, thus we can now 
compare variability of reproduced samples from one single day (Table XXV).  
The R1 and R2 values displayed narrower standard deviations compared to 
those values from day to day; except for TB-CO, which maybe due to 
inhomogeneities of these materials at higher concentrations.  
  
 
 
 
  A‐TB‐HA  B‐TB‐HA  C‐TB‐HA  Average R  SD (±) 
R1  0.0023  0.0023  0.0025  0.0024  0.0001
R2 (15)  0.0213  0.0229  0.0208  0.0217  0.0009
R2 (30)  0.0229  0.0238  0.0222  0.0230  0.0007
   A‐TB‐CO  B‐TB‐CO  C‐TB‐CO  Average R  SD (±) 
R1  0.0055  0.0053  0.0068  0.0059  0.0007
R2 (15)  0.0561  0.0455  0.0719  0.0578  0.0109
R2 (30)  0.0599  0.0447  0.0744  0.0596  0.0121
   A‐TB‐GE  B‐TB‐GE  C‐TB‐GE  Average R  SD (±) 
R1  0.0036  0.0032  0.0032  0.0034  0.0002
R2 (15)  0.0159  0.0173  0.0146  0.0159  0.0011
R2 (30)  0.0174  0.0174  0.0147  0.0165  0.0013
 
Table XXV. Average of R values for three replicates (A, B, and C) of TB-HA, 
TB-GE, and TB-CO all imaged the same day. 
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In summary, dGEMRIC has been shown to be able to determine the GAG 
concentrations both in cartilage and the TB-HA hydrogels. This study also 
validated the Donnan theory of FCD as the collagen contributions could be 
ignored relative to GAG due to its positive FCD, as also verified by Maroudas 
[29].  Additionally, our results indicate that ICP-MS measurements of Gd 
concentration in the materials greatly differed from the known concentrations; 
hence the ability to use this technique for assessing Gd concentrations may not 
be the most efficient. On the contrary, determining the Gd concentration by 
means of finding the R1 of Gd in the materials resulted in a more effective 
method, as the GAG index calculated closely matched the GAG in the original 
samples.  
Currently, there is a dispute in the literature as to whether or not the relaxivity of 
Gd-DTPA is dependent on GAG content. Our data indicates that the relaxivity of 
Gd-DTPA is dependent on macromolecular content. Previous studies have been 
done in cartilage to test this premise, in which the GAG and collagen cannot be 
separated. The outcome of this investigation can be dependable as GAG and 
collagen could be tested alone.  Finally, these biomaterials have demonstrated to 
be sufficiently stable to serve as an imaging system to test future MRI contrast 
agents.  
CHAPTER VI 
 
T1 AND T2 MRI MEASUREMENTS OF TYRAMINE-BASED HYDROGELS 
IMPLANTED IN CARTILAGE TISSUE. 
 
6.1 Introduction 
The development of a non-invasive, non-destructive technique to detect and 
characterize TB-HA, TB-GE and TB-CO hydrogels in tissues is desirable to 
facilitate the product development and regulatory approval of these biomaterials 
for a variety of clinical applications. The purpose of this study is to use the T1-
weighted and T2-weighted image contrast and T1 and T2 mapping, which were 
determined best suited for detection and differentiation of the TB-hydrogels in 
Chapter IV, to detect and distinguish select formulations of the TB-hydrogels 
from surrounding tissue in cadaveric goat and sheep joints.  This would be an 
extremely valuable tool for following the progress of these hydrogels with time 
after implantation, and thus improving the animal models and future clinical trials 
involving these biomaterials. 
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6.2 Experimental Design 
Based on the results from the experiments presented in Chapter IV, T1 and T2 
mapping are suitable for detecting, distinguishing, and characterizing TB-
hydrogels. Pre-formed plugs of 6.25 and 100 mg/ml TB-HA hydrogels and TB-
CO materials composed of 6.25 mg/ml HA and GE and 100 mg/ml HA and GE 
were implanted into cadaveric sheep and goat knee articular cartilage. The GE 
only materials were not tested because in the absence of the HA they do not 
have the necessary mechanical properties to serve as a potential cartilage 
replacement material. The 6.25 and 100 mg/ml concentrations were chosen as 
they represent the concentration extremes allowing assessment of the minimum 
detection limit based on material concentration on the one extreme (6.25 mg/ml), 
and assessment of the of the minimum detection limit based on signal 
differences with native cartilage (100 mg/ml). Furthermore, the 100 mg/ml 
concentration was selected as this concentration of TB-HA was recognized to 
posses a compressive aggregate modulus most closely resembling that of 
articular cartilage, as shown in Table II. Additionally, the 100 mg/ml 
concentration of the HA/GE composite approximates the concentration of GAG 
and collagen in cartilage, which composite material (TB-CO) was found to have a 
T1 value representative of cartilage in Chapter IV. Six healthy knees from 4 
sheep and 2 goats were obtained after sacrifice from ongoing IACUC approved 
protocols at the Cleveland Clinic. The femur was dissected from the knee joint 
immediately before implantation of the hydrogel into the trochlear notch of the 
femur. The implanted specimen was wrapped in parafilm and evaluated with MRI 
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shortly after. All specimens were subjected to T1 and T2 mapping as well as T1-
weighted and T2 weighted acquisitions. MR imaging of the specimens were 
performed using size proportional spatial resolution. Additionally, volumetric 
measurements of the implanted hydrogel plugs were performed using MicroView 
(GE Healthcare) at the Biomedical Imaging and Analysis Core at CCF. 
 
6.3 Materials and Methods 
6.3.1 Implantation Procedures 
Implantation was performed after excising the femur from the knee joint. Cross-
linked TB-HA and TB-CO hydrogels were formed in vitro as explained in 
Appendix A, and used in a manner similar to an autograft or allograft repair, 
where the preformed hydrogel is simply press fit into the defect space. Two 
circular full thickness chondral defects (10 mm in diameter, and approximately 
12.7 mm thick) were created in the trochlear notch of the femur using a drill bit so 
as to provide a defect volume of 1 ml (Fig 6.1) similar to the sample volumes 
used for imaging in Chapter IV. In some cases, the joint anatomy of the femoral 
trochlear notch prevented drilling to the desired 12.7 mm depth. Therefore, some 
defect volumes were less than 1 ml.   The two concentrations of either TB-HA or 
TB-CO cylindrical plugs were then press fit into the defect space as shown 
below, and trimmed to fit those defect volumes less than 1 ml. The excess 
material not implanted was recovered so as to calculate the volume added. 
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Figure 6.1. Hydrogel Implantation into Cartilage Defects. I: Two ~12.7 mm full 
thickness defects created in the trochlear notch. II: Left (L) and right (R) chondyl from 
two sheep (A and B) and one goat (C). The specimens in the left column were filled 
with the TB-CO hydrogel and in the right column with the TB-HA hydrogel with the 100 
mg/ml plugs at the top and the 6.25 mg/ml plugs at the bottom for each. 
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6.3.2 T1 and T2 Measurements 
 
The MRI measurements were done at room temperature as specified in previous 
chapters and utilizing the following instrument settings for T1 and T2: 
T1 Measurement: An inversion recovery fast (turbo) spin echo sequence was 
used to create T1 maps with repetition time (TR) = 11,000 msec; inversion time 
(TI) = 23 msec, 75 msec, 150 msec, 300 msec, 750 msec, 1,400 msec, 2,000 
msec, and 2,800 msec; echo time (TE) = 10 msec; field of view (FOV) = 260 mm; 
slice thickness = 4 mm, matrix = 256 x 204, and 1 average. The inversion 
recovery imaging sequence produced 8 images from each set of multiple slices 
(9 for the sheep and 7 for the goat specimens) each with a different TI. 
T2 Measurement: T2 relaxation time of the specimens was conducted using a 
spin echo imaging sequence with a TR = 11,000 msec and 20 echoes with 15 
msec echo spacing (e.g TE: 15 to 300 msec), FOV = 260 mm, slice thickness = 4 
mm, matrix size = 256 X 204, and 1 average. 
The TR, TE, matrix size and slice thickness parameters for the above T1 and T2 
acquisitions are different to those described in Chapter IV. These changes had 
to be made in order to accommodate the geometry of the specimens as well as 
the position of the plugs once implanted on the concave joint surfaces. T1 and T2 
maps were calculated using MRIMapper as described in Chapter IV. The regions 
of interests (ROI) were selected from the hydrogel implant, the native articular 
cartilage, and bone. 
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6.3.3 Volumetric Measurements 
To test whether or not we could extract volumetric measurements of the 
implanted TB-hydrogel plugs, the volumes of the six TB-HA and six TB-CO plugs 
were measured from T2 images. The volumetric measurements were calculated 
by using the MicroView (GE Healthcare) program. First, splining or drawing ROIs 
around the hydrogel plugs was performed, followed by interpolation of the ROIs 
in the planes to create a spline set. A 3-dimensional ROI of the spline set was 
generated. A threshold of 90 -100 units was determined from a histogram 
performed on the samples, which corresponded with the shortest T2 values 
measured in Chapter IV for the TB-hydrogels. An iso-surface of each hydrogel 
plug was generated. The iso-surface rendered the plugs overlaid onto a 
maximum intensity of the cartilage tissue, from which the volume could be 
calculated. 
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6.4 Results and Discussions 
The T1 and T2 values for the 6.25 and 100 mg/ml TB-HA and TB-CO hydrogel 
plugs for the six cadaveric chondyles (Tables XXVI and XXVII, respectively) as 
well as the same material formulations from the experiments described in 
Chapter IV (Table XXVIII) are tabulated below. As examples, color T1 and T2 
maps for the sheep specimen (A) 100 mg/ml TB-HA and TB-CO hydrogel plug 
implants are shown in Figs 6.2 and 6.3, respectively. As shown in Tables 
XXVI-XXVIII, the T1 and T2 values for the 100 mg/ml TB-CO and the T1 values 
of the TB-HA plugs correlated well with those values determined in Chapter IV, 
with the relaxation times of TB-HA always longer than those of TB-CO.  In the 
case of the 6.25 mg/ml TB-HA and TB-CO hydrogel plugs, the T1 and T2 are 
much shorter compared to those determined in Chapter IV (Tables XXVI-
XXVIII), which may be due to the necessary change in the acquisition 
parameters that seemed to have prevented the measurement of longer T1 and 
T2 relaxation times that are typical of low concentration hydrogels such as the 
6.25 mg/ml TB-HA and TB-CO. The T2 values for the 100 mg/ml TB-HA were 
also shorter compared to those determined in Chapter IV (Tables XXVII, XXVIII) 
since measurement of longer T2 relaxation times was limited for the same 
reasons explained above. The 100 mg/ml TB-CO hydrogels have T1 values in 
the ~ 700 - 1000 msec range at 3.0 T and are consistent between in situ and ex 
vivo measurements of cartilage. The 100 mg/ml TB-CO hydrogels have T1 
values similar to that of the native cartilage (Table XXVI and Fig 6.2), and if 
implanted in human cartilage, are predicted to closely resemble cartilage in a T1 
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map or on a T1-weighted acquisition. However, the T2 values measured for the 
100 mg/ml TB-CO hydrogels both in situ (Table XXVII and Fig. 6.3) and ex vivo 
(Table XXVIII) are considerably greater than that for native articular cartilage 
(20–40 msec, [50]) and thus these hydrogels can be clearly visualized using a 
range of mapping and image contrast techniques. T1 and T2 maps of the entire 
sheep specimens (A) were measured, in which the hydrogel plugs are clearly 
distinguishable from the surrounding tissues (Figs 6.2 B and 6.3 B). 
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 Plugs A‐R A‐L B‐R B‐L C‐R C‐L
TB‐HA 6.25 1577±683 ‐ 1867±377 ‐ 1926±395 ‐
TB‐HA 100 1138±636 ‐ 1422±158 ‐ 1609±604 ‐
TB‐CO 6.25 ‐ 760±391 ‐ 1446±237 ‐ 1878±536
TB‐CO 100 ‐ 1101±201 ‐ 707±153 ‐ 1145±156  
 
 
 
  
Table XXVI. T1 values (msec) for hydrogels implanted in the sheep (A and B) 
and goat (C) cadaveric joints. A-L and A-R represent the first pair of sheep 
specimens left and right, respectively. B-L and B-R represent the second 
pair of sheep specimens left and right, respectively. C-L and C-R represent 
the pair of goat specimens left and right, respectively. 
Plugs A‐R A‐L B‐R B‐L C‐R C‐L
TB‐HA 6.25 471±66  ‐ 462±56 ‐ 336±77
TB‐HA 100 95±6 ‐ 144±8 ‐ 149±12
TB‐CO 6.25 ‐ 497±50 ‐ 511±97 ‐ 457±112
TB‐CO 100 ‐ 158±9 ‐ 128±11 ‐ 144±7  
Table XXVII. T2 values (msec) for hydrogels implanted in the sheep (A and B) 
and goat (C) cadaveric joints. A-L and A-R represent the first pair of sheep 
specimens left and right, respectively. B-L and B-R represent the second pair 
of sheep specimens left and right, respectively. C-L and C-R represent the 
pair of goat specimens left and right, respectively. 
 
 
 
 
 
 
Plugs Day 1 Day 2 Day 3 Day 4 Day 5
TB‐HA 6.25 ‐ 2220 ± 168 2241 ± 183 2509±170 2395±242
TB‐HA 100 ‐ 1366 ± 66 1251 ± 72 1390±111 1381±81
TB‐CO 6.25 ‐ ‐ ‐ 2485±106 2288±242
TB‐CO 100 ‐ ‐ ‐ 978±38 948±32
Plugs Day 1 Day 2 Day 3 Day 4 Day 5
TB‐HA 6.25 ‐ 1114 ± 44 1090 ± 26 1096±38 1047±22
TB‐HA 100 ‐ 198 ± 16 244 ± 19 264±257 208±13
TB‐CO 6.25 ‐ ‐ ‐ 991±100 922±44
TB‐CO 100 ‐ ‐ ‐ 139±62 140±10
T1
T2 
 
 
 
 
Table XXVIII. T1 and T2 values (msec) for 6.25 and 100 mg/ml TB-
HA and TB-CO materials formed ex vivo as part of experiments 
described in Chapter IV. 
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Figure 6.2. T1 Maps for Both Chondyles of Sheep A that Image the 100 mg/ml 
Hydrogel Plugs. A: On the left, chondyle with a 100 mg/ml TB-CO plug, and on the 
right, chondyle with a 100 mg/ml TB-HA plug showing the ROI used to measure the 
T1 values of 1,101 ± 201 and 1,138 ± 636 msec, respectively. The bone was also 
measured in both specimens as a control (279 ± 34 and 288 ± 33, respectively). B: 
T1 map for the entire specimen.
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A158±9 95±6
59±361±5
100 mg/ml TB‐CO 100 mg/ml TB‐HA
 
 
 
Figure 6.3. T2 Maps for Both Chondyles of Sheep A that Image the 100 mg/ml 
Hydrogel Plugs. A: On the left, chondyle with a 100 mg/ml TB-CO plug, and on the 
right, chondyle with a 100 mg/ml TB-HA plug showing the ROI used to measure the 
T2 values of 158 ± 9 and 95 ± 6 msec, respectively. The bone was also measured 
in both specimens as a control (61 ± 5 and 59 ± 3 msec, respectively). B: T2 map 
for the entire specimen. 
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The iso-surface rendering for the implanted TB-hydrogel plugs is shown in 
Figure 6.4. This technique allowed 3-D visualization of the contours of the plugs 
implanted in the specimens by highlighting the plugs that measured above 90-
100 msec compared to the cartilage or bone that are below this threshold at ~30-
40 [50] and ~ 50 msec [51], respectively. As shown in Table XXIX, the volumetric 
measurements approximated the volumes originally implanted. Hence, we are 
able to successfully measure the volume of hydrogel implanted in the articular 
cartilage specimens. 
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Figure 6.4. Iso-surface Rendering for the TB-HA and TB-CO Hydrogel Plugs. Panel I 
represents the top view of the TB-hydrogel plugs implanted in sheep chondyles (A and B), 
and goat chondyles (C) with the implanted TB-CO hydrogel plugs in the chondyles on the left 
column, and the implanted TB-HA hydrogel plugs in the chondyles on the right column (I). The 
TB-hydrogels at 6.25 and 100 mg/ml are represented in green and yellow, respectively. Panel 
II represents the side view similarly colored. 
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Plugs
Actual 
Volume
Measured 
Volume
Actual 
Volume
Measured 
Volume
Percent 
Change
A‐R A‐R A‐L A‐L
TB‐HA 6.25 467.4 486.4 4.1
TB‐HA 100 403.5 449.9 11.5
TB‐CO 6.25 423.5 439.8 3.8
TB‐CO 100 427.2 458.3 7.3
B‐R B‐R B‐L B‐L
TB‐HA 6.25 390.0 355.2 ‐8.9
TB‐HA 100 100.0 89.2 ‐10.8
TB‐CO 6.25 451.0 481.6 6.8
TB‐CO 100 620.3 638.8 3.0
C‐R C‐R C‐L C‐L
TB‐HA 6.25 454.0 451.6 ‐0.5
TB‐HA 100 179.3 165.1 ‐7.9
TB‐CO 6.25 407.7 414.3 1.6
TB‐CO 100 922.0 894.9 ‐2.9  
Table XXIX. Actual volume compared to the measured volume 
of the TB-Hydrogels implanted in cartilage and the percent 
changes between the two. 
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The TB-HA and TB-CO plugs at 100 mg/ml had T1 and T2 values comparable to 
those found ex vivo in Chapter IV (Table XXVIII), while the same materials at 
6.25 mg/ml did not match those in Chapter IV due to the need to change the T1 
and T2 acquisition parameters as explained above. Implanted hydrogels plugs 
should therefore be easily distinguished from endogenous host cartilage using 
either T1 or T2 mapping as the materials’ T1 and T2 values are greater than that 
of native articular cartilage. The exception is the TB-CO at 100 mg/ml, which has 
T1 values similar to that of cartilage, and is expected to be indistinguishable from 
surrounding cartilage in a T1 map. However, because its T2 value is significantly 
greater than that for articular cartilage, these hydrogel implants should be 
identifiable from surrounding cartilage using T2 mapping techniques. Hence, T1-
weighted and T2-weighted MRI measurements should be able to detect and 
differentiate the TB-hydrogels from the surrounding tissues, including the 
composite materials.  Having the ability to differentiate and possibly quantitate 
these TB implants will improve future animal models and clinical trials involving 
these biomaterials. For instance, a 100 mg/ml TB-HA hydrogel could be 
implanted in a rabbit model, as the one described in Chapter II, and its biologic 
fate followed with time without sacrificing the animal. Since we can now 
determine the shape and volume of the implanted hydrogel, any changes in 
shape or loss of material volume could be detected non-invasively. Furthermore, 
a loss in material concentration from the implant due to in vivo degradation could 
be identified and measured non-invasively. Standards of the TB-hydrogels at 
various concentrations similar to those used in Chapter IV could be included 
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within the imaging field with the animal in order to provide T1 and T2 values for 
generation of a standard curve (i.e. relaxivity value). By imaging the standards 
with the animal variations in the magnet based on imaging date or magnet design 
could be controlled. Then the concentration of the implant calculated from the 
implant T1 and T2 values and the relaxivity value calculated for that imaging 
session. Finally, if the implant material is being replaced or augmented by either 
in vivo GAG or collagen synthesis, these changes could be measured non-
invasively as changes in T1 or T2 values, through once again, inclusion of 
standards as described above. 
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CHAPTER VII 
 
CONCLUSIONS AND FUTURE INVESTIGATIONS 
 
 
7.1 Conclusions 
Tyramine-based (TB) hydrogels possess advantageous physical properties, 
providing for synthetic, implantable biomaterials suitable for a wide range of 
tissue types. The aggregate moduli of TB-HA hydrogels at 100 mg/ml and 50 
mg/ml exhibit values that are equal to or exceed those of previously reported 
values for articular cartilage in confine mechanical compression [36-39]. Hence, 
the excellent biocompatibility of these TB-hydrogels along with their ability to 
provide similar structural and mechanical properties to normal tissues calls for 
the development of a non-destructive technique to detect and characterize TB- 
hydrogels in tissues. Magnetic Resonance Imaging (MRI) is a broadly used non-
invasive clinical imaging modality that allows direct visualization of soft tissues. 
Determining the MRI contrast best suited to identify, distinguish, quantify and 
trace these TB-hydrogels both in vitro and in vivo, may facilitate the product
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development and regulatory approval of these biomaterials as functional 
synthetic, implantable tissue matrices to replace/repair various tissue types. This 
dissertation work has identified MRI contrast and acquisitions that can be used to 
characterize TB-hydrogels both in vitro and in vivo. Furthermore, this research 
provided insight and clarification as to the appropriateness of these MRI 
techniques to measure GAG and collagen content. 
 
This study determined that both T1 and T2 mapping could be used to detect and 
measure tyramine-based hyaluronan (TB-HA), tyramine-based collagen in the 
form of gelatin (TB-GE), and combinatorial materials composed of both HA and 
collagen (TB-CO). T1 and T2 displayed relatively equivalent sensitivity to 
changes in both HA and collagen concentration. The greatest impact on both T1 
and T2 was produced by the combination of HA and collagen in the composite 
materials. 
 
The T1 and T2 values decreased with increasing concentration of the materials. 
The difference in T1 or T2 values between 6.25 and 12.5 mg/ml concentrations 
dropped by about 30-90 msec. However, once the concentration reached 25, 50 
and 100 mg/ml the T1 or T2 values dropped by 200-900 msec as their influence 
on the imbibed water became significant. This transition in the material properties 
between the low and high concentration of these materials correspond with the 
results seen in the mechanical properties of these biomaterials.  The aggregate 
modulus for the 6.25 and 12.5 mg/ml TB-HA hydrogels is between 20-70 Kpa, 
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while the 25, 50 and 100 mg/ml have moduli of 400-1,200 Kpa, as shown in 
Table I.  Hence, a pronounced change in the mechanical properties of these 
materials is observed around the 25 mg/ml concentration and this can also be 
observed in the imaging properties of these materials. The dramatic transition in 
mechanical and imaging properties observed at the 25 mg/ml concentration 
occur as a result of changes in matrix porosity associated with an increase in 
material concentration that dramatically influence at a molecular level the 
imbibed water. 
 
Characteristic of a MRI contrast agent, Magnevist (Gd-DTPA-2), demonstrated an 
ability to produce a significant effect on relaxation time, T1, requiring 800 to 
1,500 times less material to produce a given change in T1 than for all of the other 
non-MRI contrast agent materials tested. Agar and the HA, GE and CO hydrogel 
materials all had a relatively similar concentration effect on T1 requiring 800 to 
1,500 times the concentration of Magnevist to produce the same change in T1 
value. 
 
It was also established that the chemistry (both tyramine substitution and di-
tyramine cross-linking) used to formulate TB-hydrogels had a predictable but 
modest effect on the MRI properties of these biomaterials. All of the TB-hydrogel 
formulations possess T1 and T2 values that are measurably higher than those 
reported in cartilage, except for the 100 mg/ml TB-CO that only possess T2 
values higher than cartilage. Consequently, these biomaterials could be readily 
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distinguished from the surrounding tissue. The composite materials (TB-CO) at 
100 mg/ml, which concentration is typical of the molecular content in cartilage, 
have a T1 value in the ~1,000 msec range that is also characteristic of cartilage. 
By measuring the T1 and T2 values of defined synthetic HA and collagen 
materials, this work has provided a better understanding of the relationship 
between these MRI methods and tissue composition as well as MRI techniques 
to detect, distinguish, and characterize the TB-hydrogels. 
 
The delayed Gadolinium Enhanced MRI of Cartilage (dGEMRIC) was identified 
as a technique that could be employed to quantify the glycosaminoglycan (GAG) 
content of TB-HA hydrogels in a fashion similar to that previously reported for 
GAG content in cartilage [48]. dGEMRIC relies on the Donnan theory that relates 
fixed charge density (FCD) to GAG content in cartilage. This work validated the 
Donnan theory and the relationship between FCD and GAG concentration with 
its application to the TB-hydrogels. This study also confirmed that collagen had 
no measurable contribution to the FCD of cartilage and thus no influence on the 
partitioning of the negatively charged Gd-DTPA contrast agent. 
 
Furthermore, our results indicate that the relaxivity of Gd-DTPA is dependent on 
macromolecular content. This premise has been tested in previous studies; 
however, these studies used cartilage as the imaging substrate, in which GAG 
and collagen cannot be tested separately providing inconclusive results. The 
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outcome of this investigation is definitive as GAG and collagen were tested in 
separate imaging constructs. 
 
The TB-based biomaterials have demonstrated sufficient stability to serve as a 
controlled system of synthetic ECM composed of HA (GAG) and collagen 
molecules that could be used to test future MRI contrast agents developed for 
measuring matrix composition. 
 
Confirmation of standard MRI imaging methodologies to detect and distinguish 
TB-hydrogels from surrounding tissue was obtained in this investigation. The TB-
HA and TB-CO at 6.25 mg/ml and TB-HA at 100 mg/ml demonstrated T1 and T2 
values that were greater than that of native articular cartilage. Hence, these 
biomaterials could easily be differentiated from cartilage. TB-CO at 100 mg/ml 
had T1 value similar to that of cartilage, but a T2 value significantly different. 
Hence, we have identified MRI techniques to detect and differentiate the TB-
hydrogels from the surrounding tissues. We now have the ability to evaluate in 
vivo performance of TB-hydrogels with time without the need to sacrifice 
experimental animals; hence providing us with the capacity to improve future 
animal models and clinical trials involving these biomaterials. Once the TB-
hydrogel is implanted, we can identify any changes in the shape, contours or 
volume of the implant by volumetric measurements using MicroView. Any 
changes in concentration induced by loss of material (HA or collagen) could be 
measured through T1 and T2 MRI techniques and compared to  the T1 and T2 
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values of the concentration curves for the phantoms we have established. 
Additionally, if the material is being augmented by GAG or collagen synthesized 
by cells from the surrounding tissues, we may be able to detect these 
modifications as well, as we have characterized these components of cartilage 
individually with T1 and T2 mapping. 
 
7.2 Future Investigations 
T1ρ is another MRI technique sensitive to the loss of PGs, which is detected as 
an increase in T1ρ. Contrary to T1 and T2, which are primarily the outcome of 
processes that occur at the resonant frequency (64 MHz at 1.5 T) or some small 
integral multiple thereof, T1ρ is mainly affected by processes (in particular, 
chemical exchange) that occur in the kilohertz region, as is more typical of 
macromolecules such as PG [31]. This technique was initially included as one of 
the MRI methods to be evaluated in this study. However, this software is not 
included in standard MR system software, and even though we obtained the 
license for installation, the installation has to date not been done due to 
administrative reasons.  Hence, we would like to evaluate this technique once 
installed in the MR system, in order to test its sensitivity to PG content, and 
potentially identify another perhaps more sensitive technique to characterize the 
TB-HA hydrogels. Additionally, to establish a better assessment of TB-hydrogels 
in tissues, the experiments in Chapter VI will be repeated in species with thicker 
cartilage such as porcine. This will improve the quantitative and qualitative 
characterization of TB-hydrogels in vivo. Finally, we would apply all of the MRI 
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techniques evaluated in this dissertation in an animal cartilage repair model 
similar to the rabbit model described in Chapter II. This animal model would be 
followed over time (a year or more) and be the ultimate validation of our MRI 
techniques for evaluating the progress of physical and chemical changes to the 
implanted TB-hydrogels. 
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Tyramine-Based Hydrogels Synthesis and Characterization 
 
A.1 Introduction 
This appendix provides in detail the fundamental methods utilized to formulate 
and characterized the tyramine-based hydrogels that were evaluated through the 
various experiments conducted in this dissertation work. 
 
A.2 Synthesis of Tyramine-Substituted Hyaluronan (TS-HA) and Gelatin 
(TS-GE) 
The TS-HA used in our experiments was provided by Lifecore Biomedical Inc. 
(LCBM), using their proprietary manufacturing process that is based on the 
procedure described below. LCBM has licensed the tyramine-based hydrogel 
technology from the Cleveland Clinic with the license including exclusive rights to 
their manufacture. Obtaining a single lot of TS-HA from LCBM provided us the 
opportunity to conduct our experiments with materials identical to those that will 
be used for future animal and clinical work. The TS-GE was formulated in our 
laboratory using the protocol described below and made as one single 
preparation. 
HA (Acros, Pittsburgh, PA; MW = ~1,500,000 daltons) or GE (Sigma, St. Louis, 
MO; 300 bloom) at 5 mg/ml were dispersed in 250 mM 2-(N-morpholino) 
ethanesulfonic acid (MES), 75 mM NaOH, 150 mM NaCl, pH 6.5 containing a 2 
fold molar excess of tyramine to the moles of carboxyl groups. Substitution of 
tyramine commenced with the addition of a 10 fold molar amount of 1-ethyl-3-(3-
dimethylaminopropyl) carbodiimide (EDC), to the moles of carboxyl group. The 
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catalyst was a 1/10th molar ratio of N-hydroxysuccinimide (NHS) to the EDC. The 
substitution reactions were done stirring continuously at room temperature for 24 
hours, resulting in production of either TS-HA or TS-GE, which were purified 
through dialysis versus 150 mM NaCl and then ultrapure water. Lastly, the 
dialyzed TS-HA and TS-GE were lyophilized, followed by re-suspension to the 
desired working concentrations in ultra-purified water. For the making of 
composite materials, the process is exactly the same as described above, except 
that the TS-HA and TS-GE being mixed together, lyophilized and re-suspended 
to the desired concentrations. 
 
A.3 Formation of Tyramine-Based Hyaluronan (TB-HA) and Gelatin (TB   
GE) Hydrogels 
Lyophilized TS-HA or TS-GE was dissolved at the corresponding concentrations 
in ultra-purified water containing 10 U/ml of type II horseradish peroxidase 
(HRP). The solution was thoroughly mixed by vortex, and allowed to fully hydrate 
for 24 h at 4ºC in the case of TS-HA, and at 37ºC in the case of TS-GE, so as to 
fully melt and hydrate the gelatin. Cross-linking to TB-HA hydrogels from various 
TS-HA solutions containing HRP commenced by introduction of 40 µl of 0.3% 
hydrogen peroxide (H2O2) per 1 ml of TS-HA, followed by centrifugation of the 
solution at 12,000 rpm for 5 min. The formation of TB-GE hydrogels followed the 
same steps as for TB-HA, except that the samples are kept cold on ice to 
promote gellation, as it facilitates diffusion of the H2O2 through the material. This 
method of cross-linking relies on the ability of H2O2 to diffuse throughout the 
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entire volume of the material, which is limited by the concentration and volume of 
the material as described in Chapter III. Therefore, only the lower end (6.25 and 
12.5 mg/ml) concentrations were cross-linked using this method. The TB-HA and 
TB-GE hydrogels at 25, 50 and 100 mg/ml as well as the TB-CO at 6.25, 12.5, 
25, 50 and 100 mg/ml were cross-linked using the dual syringe/needle injector 
device described in Chapter II. 
 
A.4 Characterization of TB-HA and TB-GE 
To validate the samples’ characteristics, the molar concentration of total carboxyl 
groups and the percent tyramine substitution in the HA materials were measured 
spectrophotometrically. Amino Acid Analysis (AAA) using Cation Exchange 
Chromatography measured the molar concentration of total carboxyl groups and 
tyramine in the GE materials. The details of these analyses are provided below. 
Additionally, the formation of dityramine cross-links was assessed through their 
fluorescence properties. 
 
A.4.1 Measurement of Percent Tyramine Substitution and Molar 
Concentration of TS-HA and TS-GE 
The amount of tyramine covalently bound within a TS-HA was calculated by 
measuring the tyramine absorption at 275 nm of a 1mg/ml TS-HA solution in 
ultrapure water based on hexuronic acid assay [9] by means of SpectraMax Plus 
Spectrophotometer (Molecular Devices, Inc.). The absorbance measured was 
compared relative to a tyramine standard curve consisting of 20, 40, 60, 80 and 
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100 µg/ml of tyramine in ultrapure water. The percent tyramine substitution within 
a TS-HA solution was then calculated from the molar ratio of covalently bound 
tyramine residues to total carboxyl groups on HA, based on hexuronic acid assay 
[9].  The molar concentration of total carboxyl groups in a TS-HA formulation was 
also measured spectrophotometrically using the hexuronic acid assay routinely 
used for quantification of µg quantities of GAG. The hexuronic acid was 
performed in concentrated sulfuric acid and heating to 100oC , which allows 
measurement of even those carboxyl groups on glcA residues that are amide 
bonded to tyramine because of the acid labile nature of the amide bond. 
The amount of tyramine covalently bound within a TS-GE and the molar 
concentration of total carboxyl groups in a TS-GE was calculated through the 
recovery of nanomoles of amino acids obtained from Amino Acid Analysis (AAA) 
utilizing Cation Exchange Chromatography at the University of Oklahoma, 
Molecular Biology-Proteomics Facility. The AAA procedure consisted in two main 
sequences: 
Standard Amino Acid Chromatography 
For the common amino acids elution was accomplished by a two buffer system 
(program name: AAA-REG).  Samples were injected onto the column equilibrated 
with 0.2 N sodium citrate, pH 3.28 with this buffer eluting the first nine amino 
acids.  Next, 1.0 N NaCl, pH 7.4 was used to elute the remaining amino acids.  
Amino acids were detected by on-line post column reaction with ninhydrin.  
Derivatized amino acids were quantified by their absorption at 570 nm, except for 
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glutamic acid and proline, which are detected at 440 nm.  This procedure was 
performed on an automated Beckman Gold HPLC amino acid analyzer system. 
Tyramine Chromatography 
Elution of tyramine required a much more aggressive buffer system (program 
name: AAA-TYRA).  Again a two solvent system-step elution was utilized.  The 
first solvent is 0.3 M sodium chloride, 0.2 N sodium citrate, pH 5.55 with 5.5% 
ethanol at a column temperature of 66°C.  This eluted most amino acids, 
including arginine.  The second solvent consists of 2.6 M sodium chloride, 0.2 N 
sodium citrate, pH 5.73 with 2.5% ethanol and 9.0% isopropanol.  This solvent 
eluted any polyamines and tyramine.  The column temperature during this 
solvent step was 73°C. 
Each sample was run under both chromatography conditions. The data from 
each chromatographic run was normalized using the recovery of arginine. 
 
A.4.2 Detection of Dityramine Cross-links 
Similar to tyramine, the dityramine cross-links also have advantageous 
spectrophotometric properties in that dityramine bridges fluoresce blue-green 
upon exposure to UV light with an excitation maximum of 285 nm and emission 
of 415 nm. This property was used to assess the degree of cross-linking within 
TB-hydrogels. Subsequently, all of the TB-HA and TB-GE hydrogels made 
through out this research were exposed to UV light right after addition of the 
hydrogen peroxide to initiate cross-linking and centrifugation of the samples. This 
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step served to verify that cross-linking had proceeded uniformly throughout the 
entire hydrogel volume as evidence of full cross-linking. 
 
A.5 Equilibration of Hydrogels in Saline 
While the uncross-linked samples were made by rehydration directly in PBS, all 
of the cross-linked materials (i.e. hydrogels) were first cross-linked in water 
followed by equilibration in saline. The equilibration process started by first 
weighing the cross-linked plugs (initial weight) followed by addition of a volume of 
10X PBS to the hydrogel plug sufficient to produce a 1X PBS concentration after 
equilibration at 4ºC for 24 h. Afterward; the plugs were removed from the 
cryotubes, blotted dry and weighted again (final weight). The percent changes 
and new concentrations were calculated, assessing the shrinking and swelling 
effects. This data was utilized to produce a standard curve that allowed 
determining the starting concentration required to obtain the desired or final 
concentration of the material. 
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Table B- I.  T1 and R1, MRI Day 1 
 
 
 
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
HA 6.25  6.25 2556 ± 201 0.00001 0.0025 1
HA 12.5  12.5 2409 ± 139 0.00004
HA 25  25 2167 ± 176 0.00008
HA 50  50 2011 ± 79 0.00012
HA 100 100 1573 ± 86 0.00026
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
GE  6.25 6.25 2486 ± 213 0.00002 0.0023 0.99
GE 12.5 12.5 2370 ± 154 0.00004
GE 25  25 2111 ± 108 0.00010
GE 50  50 2011 ± 109 0.00012
GE 100 100 1612 ± 149 0.00024
Sample  Weight % T1 1/T1‐ 1/T1PBS R1  r2
Agar 0.5 0.5 2469 ± 162 0.00003 0.0182 0.87
Agar 1 1 2288 ± 220 0.00006
Agar 2 2 2243 ± 166 0.00007
Agar 4 4 2174 ± 176 0.00008
Sample  [mM]  T1 1/T1‐ 1/T1PBS R1  r2
Gd 0.125 0.125 1036 ± 30 0.00059 4.92 1
Gd 0.25 0.25 634 ± 13 0.00120
Gd 0.5 0.5 352 ± 7 0.00246
Gd 1 1 189 ± 4 0.00491
Gd 2 2 98 ± 3 0.00983
1 All Samples in water
2 T1PBS value on this imaging day was 2613.5± 231
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Table B- II. T2 (15 msec echo spacing) and R2, MRI Day 1 
 
 
 
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
HA 6.25  6.25 1214 ± 43 0.0001 0.028 1
HA 12.5  12.5 1054 ± 21 0.0003
HA 25  25 822 ± 17 0.0005
HA 50  50 537 ± 8 0.0012
HA 100 100 289 ± 5 0.0028
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
GE  6.25 6.25 1341 ± 30 0.0001 0.016 0.99
GE 12.5 12.5 1222 ± 28 0.0001
GE 25  25 1035 ± 27 0.0003
GE 50  50 832 ± 12 0.0005
GE 100 100 441 ± 65 0.0016
Sample  Weight % T2 1/T2‐ 1/T2PBS R2  r2
Agar 0.5 0.5 267 ± 2 0.0031 6.23 1
Agar 1 1 149 ± 2 0.0060
Agar 2 2 79 ± 2 0.0120
Agar 4 4 39 ± 2 0.0250
Sample  [mM]  T2 1/T2‐ 1/T2PBS R2  r2
Gd 0.125 0.125 739 ± 10 0.0007 5.49 1
Gd 0.25 0.25 480 ± 7 0.0014
Gd 0.5 0.5 285 ± 3 0.0028
Gd 1 1 158 ± 1 0.0057
Gd 2 2 86 ± 1 0.0110
1 All Samples in water
2 T2PBS value on this imaging day was 1483.5±36.5
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Table B – III. T2 (30 msec echo spacing) and R2,   MRI Day 1 
 
 
 
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
HA 6.25  6.25 1204 ± 23 0.0002 0.029 1
HA 12.5  12.5 1016 ± 15 0.0003
HA 25  25 778 ± 17 0.0006
HA 50  50 512 ± 8 0.0013
HA 100 100 277 ± 7 0.0029
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
GE  6.25 6.25 1318 ± 20 0.0001 0.015 0.99
GE 12.5 12.5 1190 ± 22 0.0002
GE 25  25 1007 ± 14 0.0003
GE 50  50 819 ± 12 0.0006
GE 100 100 449 ± 67 0.0016
Sample  Weight % T2 1/T2‐ 1/T2PBS R2  r2
Agar 0.5 0.5 273 ± 4 0.0030 6.06 1
Agar 1 1 158 ± 4 0.0057
Agar 2 2 85 ± 6 0.0111
Agar 4 4 40 ± 7 0.0243
Sample  [mM]  T2 1/T2‐ 1/T2PBS R2  r2
Gd 0.125 0.125 733 ± 7 0.0007 5.14 1
Gd 0.25 0.25 478 ± 5 0.0014
Gd 0.5 0.5 296 ± 3 0.0027
Gd 1 1 169 ± 3 0.0052
Gd 2 2 91 ± 3 0.0103
1 All Samples in water
2 T2PBS value on this imaging day was 1496±21.5  
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Table B - IV.  T1 and R1 for Unsubstituted Materials, MRI Day 2 
 
 
 
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
HA 6.25  6.25 2194 ± 128 0.00003 0.0023 1
HA 12.5  12.5 2198 ± 147 0.00003
HA 25  25 2058 ± 144 0.00006
HA 50  50 1856 ± 97 0.00011
HA 100 100 1519 ± 55 0.00023
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
GE  6.25 6.25 2335 ± 122 0.00000 0.0026 0.99
GE 12.5 12.5 2166 ± 130 0.00004
GE 25  25 2085 ± 130 0.00005
GE 50  50 1937 ± 152 0.00009
GE 100 100 1441 ± 125 0.00027
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
CO  6.25  12.5 2226 ± 129 0.00002 0.0027 0.97
CO 12.5 25 2056 ± 194 0.00006
CO 25  50 2016 ± 140 0.00007
CO 50  100 1497 ± 133 0.00024
CO 100  200 1050 ± 253 0.00053
1 T1PBS value on this imaging day was 2346.25±124
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Table B – V. T1 and R1 for Tyramine - Substituted Materials and 
 Magnevist (Gd), MRI Day 2 
 
 
 
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
TS‐HA 6.25  6.25 2282 ± 156 0.00001 0.0026 1
TS‐HA 12.5  12.5 2104 ± 128 0.00005
TS‐HA 25  25 2004 ± 122 0.00007
TS‐HA 50  50 1800 ± 131 0.00013
TS‐HA 100  100 1458 ± 58 0.00026
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
TS‐GE 6.25  6.25 2272 ± 131 0.00001 0.0016 1
TS‐GE 12.5  12.5 2173 ± 177 0.00003
TS‐GE 25  25 2100 ± 183 0.00005
TS‐GE 50  50 1947 ± 151 0.00009
TS‐GE 100  100 1695 ± 127 0.00016
Sample  [mM]  T1 1/T1‐ 1/T1PBS R1  r2
Gd 0.125 0.125 910 ± 26 0.0007 5.23 1
Gd 0.25 0.25 553 ± 14 0.0014
Gd 0.5 0.5 312 ± 6 0.0028
Gd 1 1 169 ± 3 0.0055
Gd 2 2 92 ± 2 0.0104
1 T1PBS value on this imaging day was 2346.25±124
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Table B – VI. T1 and R1 for Cross-linked Materials and Agar, MRI Day 2 
 
 
 
 
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
TB‐HA 6.25  6.3 2220 ± 168 0.00002 0.0029 1
TB‐HA 12.5  12.5 2048 ± 177 0.00006
TB‐HA 25  25.3 1983 ± 142 0.00008
TB‐HA 50  50 1754 ± 108 0.00014
TB‐HA 100  100 1366 ± 66 0.00031
Sample 1 [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
TB‐ GE 6.25  6.25 2215 ± 161 0.00003 0.0020 0.98
TB‐GE 12.5  12.5 2096 ± 141 0.00005
TB‐GE 25  25 2051 ± 140 0.00006
TB‐GE 50  50 1765 ± 89 0.00014
TB‐GE 100  100 1593 ± 152 0.00020
Sample  Weight % T1 1/T1‐ 1/T1PBS R1  r2
Agar 0.5 0.5 2295 ± 156 0.00001 0.0164 0.99
Agar 1 1 2210 ± 123 0.00003
Agar 2 2 2130 ± 135 0.00004
Agar 4 4 1902 ± 134 0.00010
1 All Samples in water
2 T1PBS value on this imaging day was 2346.25±124
2 T1water value on this imaging day was 2397±123  
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Table B – VII. T2 (15 msec echo spacing) and R2 for  
Unsubstituted Materials, MRI Day 2 
 
 
 
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
HA 6.25  6.25 1160 ± 39 0.00015 0.026 1
HA 12.5  12.5 1027 ± 36 0.00026
HA 25  25 810 ± 21 0.00052
HA 50  50 532 ± 18 0.00117
HA 100 100 299 ± 6 0.00263
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
GE  6.25 6.25 1255 ± 36 0.00009 0.020 0.97
GE 12.5 12.5 1178 ± 36 0.00014
GE 25  25 1025 ± 30 0.00026
GE 50  50 819 ± 77 0.00051
GE 100 100 368 ± 64 0.00201
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
CO  6.25  12.5 1229 ± 57 0.00010 0.046 1
CO 12.5 25 910 ± 112 0.00039
CO 25  50 609 ± 17 0.00093
CO 50  100 320 ± 30 0.00241
CO 100  200 100 ± 13 0.00929
1 T2PBS value on this imaging day was 1405.25±53.5
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Table B – VIII. T2 (15 msec echo spacing) and R2 for Tyramine - Substituted 
Materials and Magnevist (Gd), MRI Day 2 
 
 
 
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TS‐HA 6.25  6.25 1245 ± 58 0.00009 0.028 0.99
TS‐HA 12.5  12.5 1066 ± 39 0.00023
TS‐HA 25  25 839 ± 35 0.00048
TS‐HA 50  50 552 ± 15 0.00110
TS‐HA 100  100 282 ± 10 0.00283
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TS‐GE 6.25  6.25 1254 ± 51 0.00009 0.014 0.99779
TS‐GE 12.5  12.5 1122 ± 26 0.00018
TS‐GE 25  25 987 ± 23 0.00030
TS‐GE 50  50 754 ± 31 0.00061
TS‐GE 100  100 476 ± 22 0.00139
Sample  [mM]  T2 1/T2‐ 1/T2PBS R2  r2
Gd 0.125 0.125 705 ± 23 0.0007 5.84 1
Gd 0.25 0.25 462 ± 13 0.0015
Gd 0.5 0.5 272 ± 10 0.0030
Gd 1 1 149 ± 3 0.0060
Gd 2 2 81 ± 2 0.0116
1 T2PBS value on this imaging day was 1405.25±53.5  
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Table B – IX. T2 (15 msec echo spacing) and R2 for  
Cross - linked Materials and Agar, MRI Day 2 
 
 
 
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TB‐HA 6.25  6.3 1114 ± 44 0.00019 0.044 0.97
TB‐HA 12.5  12.5 914 ± 160 0.00038
TB‐HA 25  25.3 744 ± 52 0.00063
TB‐HA 50  50 514 ± 45 0.00123
TB‐HA 100  100 198 ± 16 0.00434
Sample 1 [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TB‐ GE 6.25  6.25 1183 ± 22 0.00017 0.014 0.99
TB‐GE 12.5  12.5 1269 ± 30 0.00011
TB‐GE 25  25 1048 ± 36 0.00028
TB‐GE 50  50 690 ± 48 0.00077
TB‐GE 100  100 483 ± 75 0.00139
Sample  Weight % T2 1/T2‐ 1/T2PBS R2  r2
Agar 0.5 0.5 280 ± 8 0.0029 5.93 1
Agar 1 1 156 ± 3 0.0057
Agar 2 2 81 ± 2 0.0116
Agar 4 4 41 ± 2 0.0237
1 All Samples in water
2 T2PBS value on this imaging day was 1405.25±53.5
2 T2water value on this imaging day was 1475 ± 32  
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 Table B – X. T2 (30 msec echo spacing) and R2 for  
Unsubstituted Materials, MRI Day 2 
 
 
 
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
HA 6.25  6.25 1183 ± 34 0.00017 0.028 1
HA 12.5  12.5 1027 ± 25 0.00029
HA 25  25 800 ± 25 0.00057
HA 50  50 509 ± 13 0.00129
HA 100 100 286 ± 8 0.00282
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
GE  6.25 6.25 1302 ± 31 0.00009 0.020 0.97
GE 12.5 12.5 1219 ± 25 0.00014
GE 25  25 1046 ± 22 0.00028
GE 50  50 816 ± 56 0.00055
GE 100 100 363 ± 58 0.00208
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
CO  6.25  12.5 1246 ± 41 0.00012 0.048 0.97
CO 12.5 25 911 ± 106 0.00042
CO 25  50 603 ± 19 0.00098
CO 50  100 309 ± 25 0.00256
CO 100  200 98 ± 11 0.00953
1 T2PBS value on this imaging day was 1472.75±50  
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Table B – XI. T2 (30 msec echo spacing) and R2 for Tyramine – Substituted 
Materials and Magnevist (Gd), MRI Day 2 
 
 
 
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TS‐HA 6.25  6.25 1295 ± 49 0.00009 0.031 0.99
TS‐HA 12.5  12.5 1064 ± 24 0.00026
TS‐HA 25  25 832 ± 30 0.00052
TS‐HA 50  50 527 ± 14 0.00122
TS‐HA 100  100 266 ± 11 0.00308
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TS‐GE 6.25  6.25 1316 ± 31 0.00008 0.014 1
TS‐GE 12.5  12.5 1171 ± 29 0.00017
TS‐GE 25  25 1024 ± 26 0.00030
TS‐GE 50  50 769 ± 29 0.00062
TS‐GE 100  100 483 ± 17 0.00139
Sample  [mM]  T2 1/T2‐ 1/T2PBS R2  r2
Gd 0.125 0.125 735 ± 23 0.0007 5.78 1
Gd 0.25 0.25 473 ± 10 0.0014
Gd 0.5 0.5 278 ± 8 0.0029
Gd 1 1 153 ± 4 0.0059
Gd 2 2 82 ± 4 0.0115
1 T2PBS value on this imaging day was 1472.75±50  
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Table B – XII. T2 (30 msec echo spacing) and R2 for  
Cross – Linked Materials and Agar, MRI Day 2 
 
 
 
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TB‐HA 6.25  6.3 1124 ± 42 0.00021 0.048 0.98
TB‐HA 12.5  12.5 907 ± 182 0.00042
TB‐HA 25  25.3 719 ± 54 0.00071
TB‐HA 50  50 488 ± 41 0.00137
TB‐HA 100  100 183 ± 19 0.00479
Sample 1 [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TB‐ GE 6.25  6.25 1233 ± 35 0.00018 0.015 0.99
TB‐GE 12.5  12.5 1320 ± 34 0.00013
TB‐GE 25  25 1069 ± 32 0.00030
TB‐GE 50  50 698 ± 51 0.00080
TB‐GE 100  100 477 ± 70 0.00146
Sample  Weight % T2 1/T2‐ 1/T2PBS R2  r2
Agar 0.5 0.5 275 ± 6 0.0030 6.25 1
Agar 1 1 154 ± 5 0.0058
Agar 2 2 79 ± 4 0.0120
Agar 4 4 39 ± 5 0.0250
1 All Samples in water
2 T2PBS value on this imaging day was 1472.75±50
2 T2water value on this imaging day was 1582 ± 22  
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Table B - XIII.  T1 and R1 for Unsubstituted Materials, MRI Day 3 
 
 
 
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
HA 6.25  6.25 2183 ± 122 0.00004 0.0031 0.99
HA 12.5  12.5 2039 ± 139 0.00008
HA 25  25 1957 ± 69 0.00010
HA 50  50 1696 ± 75 0.00018
HA 100 100 1342 ± 16 0.00033
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
GE  6.25 6.25 2385 ± 145 0.00000 0.0027 1
GE 12.5 12.5 2318 ± 123 0.00002
GE 25  25 2177 ± 108 0.00004
GE 50  50 1840 ± 79 0.00013
GE 100 100 1487 ± 105 0.00026
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
CO  6.25  12.5 2193 ± 117 0.00004 0.0028 0.99
CO 12.5 25 1953 ± 134 0.00010
CO 25  50 1946 ± 143 0.00010
CO 50  100 1415 ± 126 0.00029
CO 100  200 1026 ± 136 0.00056
1 T1PBS value on this imaging day was 2412±148.75  
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Table B – XIV. T1 and R1 for Tyramine - Substituted Materials and 
Magnevist (Gd), MRI Day 3 
 
 
 
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
TS‐HA 6.25  6.25 2208 ± 133 0.00004 0.0035 1
TS‐HA 12.5  12.5 2114 ± 128 0.00006
TS‐HA 25  25 1904 ± 68 0.00011
TS‐HA 50  50 1658 ± 71 0.00019
TS‐HA 100  100 1296 ± 26 0.00036
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
TS‐GE 6.25  6.25 2321 ± 138 0.00002 0.0024 1
TS‐GE 12.5  12.5 2335 ± 180 0.00001
TS‐GE 25  25 2130 ± 155 0.00005
TS‐GE 50  50 1916 ± 87 0.00011
TS‐GE 100  100 1533 ± 62 0.00024
Sample  [mM]  T1 1/T1‐ 1/T1PBS R1  r2
Gd 0.03125 0.03125 1703 ± 46 0.00017 5.82 1
Gd 0.0625 0.0625 1229 ± 38 0.00040
Gd 0.125 0.125 839 ± 15 0.00078
Gd 0.25 0.25 509 ± 14 0.00155
Gd 0.5 0.5 297 ± 7 0.00295
Gd 1 1 158 ± 4 0.00591
Gd 2 2 83 ± 2 0.01163
1 T1PBS value on this imaging day was 2412±148.75
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Table B – XV. T1 and R1 for Cross-linked Materials and Agar, MRI Day 3 
 
 
 
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
TB‐HA 6.25  6.3 2241 ± 183 0.00003 0.0037 1
TB‐HA 12.5  12.5 2034 ± 137 0.00008
TB‐HA 25  25.3 1868 ± 82 0.00012
TB‐HA 50  50 1633 ± 43 0.00020
TB‐HA 100  100 1251 ± 72 0.00038
Sample 1 [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
TB‐ GE 6.25  6.25 2273 ± 144 0.00002 0.0030 0.99
TB‐GE 12.5  12.5 2211 ± 135 0.00004
TB‐GE 25  25 2044 ± 154 0.00007
TB‐GE 50  50 1666 ± 59 0.00018
TB‐GE 100  100 1403 ± 125 0.00030
Sample  Weight % T1 1/T1‐ 1/T1PBS R1  r2
Agar 0.5 0.5 2469 ± 162 0.00003 0.03 0.99
Agar 1 1 2288 ± 220 0.00003
Agar 2 2 2243 ± 166 0.00008
Agar 4 4 2174 ± 176 0.00012
1 All Samples in water
2 T1PBS value on this imaging day was 2412±148.75  
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Table B – XVI. T2 (15 msec echo spacing) and R2 for  
Unsubstituted Materials, MRI Day 3 
 
 
 
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
HA 6.25  6.25 1192 ± 18 0.00010 0.021 1
HA 12.5  12.5 1075 ± 21 0.00019
HA 25  25 870 ± 24 0.00041
HA 50  50 600 ± 17 0.00093
HA 100 100 353 ± 9 0.00209
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
GE  6.25 6.25 1226 ± 25 0.00008 0.016 0.98
GE 12.5 12.5 1160 ± 35 0.00012
GE 25  25 1026 ± 20 0.00024
GE 50  50 790 ± 32 0.00053
GE 100 100 426 ± 45 0.00161
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
CO  6.25  12.5 1154 ± 44 0.00013 0.044 0.97
CO 12.5 25 848 ± 101 0.00044
CO 25  50 599 ± 17 0.00093
CO 50  100 314 ± 22 0.00245
CO 100  200 104 ± 10 0.00888
1 T2PBS value on this imaging day was 1352.5 ±28  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 213
Table B – XVII. T2 (15 msec echo spacing) and R2 for Tyramine - 
Substituted Materials and Magnevist (Gd), MRI Day 3 
 
 
 
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TS‐HA 6.25  6.25 1208 ± 26 0.00009 0.024 1
TS‐HA 12.5  12.5 1070 ± 27 0.00020
TS‐HA 25  25 851 ± 15 0.00044
TS‐HA 50  50 587 ± 12 0.00096
TS‐HA 100  100 323 ± 8 0.00236
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TS‐GE 6.25  6.25 1200 ± 28 0.00009 0.016 1
TS‐GE 12.5  12.5 1100 ± 21 0.00017
TS‐GE 25  25 942 ± 19 0.00032
TS‐GE 50  50 705 ± 20 0.00068
TS‐GE 100  100 423 ± 8 0.00162
Sample  [mM]  T2 1/T2‐ 1/T2PBS R2  r2
Gd 0.03125 0.03125 1142 ± 20 0.00014 6.62 1
Gd 0.0625 0.0625 931 ± 14 0.00033
Gd 0.125 0.125 691 ± 15 0.00071
Gd 0.25 0.25 453 ± 11 0.00147
Gd 0.5 0.5 257 ± 6 0.00315
Gd 1 1 137 ± 4 0.00656
Gd 2 2 72 ± 3 0.01315
1 T2PBS value on this imaging day was 1352.5 ±28  
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Table B – XVIII. T2 (15 msec echo spacing) and R2 for  
Cross - linked Materials and Agar, MRI Day 3 
 
 
 
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TB‐HA 6.25  6.3 1090 ± 26 0.00018 0.033 0.98
TB‐HA 12.5  12.5 912 ± 129 0.00036
TB‐HA 25  25.3 743 ± 30 0.00061
TB‐HA 50  50 551 ± 17 0.00108
TB‐HA 100  100 244 ± 19 0.00336
Sample 1 [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TB‐ GE 6.25  6.25 1164 ± 29 0.00018 0.014 0.99
TB‐GE 12.5  12.5 1249 ± 35 0.00012
TB‐GE 25  25 1018 ± 17 0.00030
TB‐GE 50  50 684 ± 30 0.00078
TB‐GE 100  100 477 ± 72 0.00142
Sample  Weight % T2 1/T2‐ 1/T2PBS R2  r2
Agar 0.5 0.5 310 ± 7 0.0025 5.26 1
Agar 1 1 173 ± 3 0.0050
Agar 2 2 91 ± 2 0.0102
Agar 4 4 46 ± 2 0.0210
1 All Samples in water
2 T2PBS value on this imaging day was 1352.5 ±28  
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Table B – XIX. T2 (30 msec echo spacing) and R2 for  
Unsubstituted Materials, MRI Day 3 
 
 
 
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
HA 6.25  6.25 1223 ± 22 0.00012 0.023 1
HA 12.5  12.5 1091 ± 26 0.00021
HA 25  25 865 ± 26 0.00045
HA 50  50 570 ± 12 0.00105
HA 100 100 330 ± 10 0.00233
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
GE  6.25 6.25 1286 ± 17 0.00008 0.016 0.98
GE 12.5 12.5 1218 ± 29 0.00012
GE 25  25 1054 ± 15 0.00025
GE 50  50 806 ± 42 0.00054
GE 100 100 432 ± 46 0.00161
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
CO  6.25  12.5 1203 ± 24 0.00013 0.045 0.98
CO 12.5 25 873 ± 90 0.00044
CO 25  50 599 ± 18 0.00097
CO 50  100 304 ± 18 0.00259
CO 100  200 103 ± 8 0.00901
1 T2PBS value on this imaging day was 1423.75±24  
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Table B – XX. T2 (30 msec echo spacing) and R2 for  
Tyramine – Substituted Materials and Magnevist (Gd), MRI Day 3 
 
 
 
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TS‐HA 6.25  6.25 1252 ± 23 0.00010 0.026 1
TS‐HA 12.5  12.5 1071 ± 17 0.00023
TS‐HA 25  25 840 ± 12 0.00049
TS‐HA 50  50 565 ± 14 0.00107
TS‐HA 100  100 301 ± 5 0.00262
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TS‐GE 6.25  6.25 1253 ± 18 0.00010 0.016 1
TS‐GE 12.5  12.5 1159 ± 17 0.00016
TS‐GE 25  25 981 ± 20 0.00032
TS‐GE 50  50 729 ± 19 0.00067
TS‐GE 100  100 431 ± 10 0.00162
Sample  [mM]  T2 1/T2‐ 1/T2PBS R2  r2
Gd 0.03125 0.03125 1171 ± 19 0.00015 6.53 1
Gd 0.0625 0.0625 971 ± 20 0.00033
Gd 0.125 0.125 704 ± 18 0.00072
Gd 0.25 0.25 451 ± 12 0.00151
Gd 0.5 0.5 255 ± 7 0.00322
Gd 1 1 139 ± 5 0.00649
Gd 2 2 73 ± 5 0.01300
1 T2PBS value on this imaging day was 1423.75±24  
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Table B – XXI. T2 (30 msec echo spacing) and R2 for 
Cross – Linked Materials and Agar, MRI Day 3 
 
 
 
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TB‐HA 6.25  6.3 1131 ± 26 0.00018 0.036 0.98
TB‐HA 12.5  12.5 916 ± 146 0.00039
TB‐HA 25  25.3 733 ± 33 0.00066
TB‐HA 50  50 533 ± 21 0.00117
TB‐HA 100  100 229 ± 15 0.00366
Sample 1 [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TB‐ GE 6.25  6.25 1210 ± 21 0.00019 0.015 0.99
TB‐GE 12.5  12.5 1340 ± 62 0.00011
TB‐GE 25  25 1059 ± 32 0.00031
TB‐GE 50  50 693 ± 33 0.00081
TB‐GE 100  100 477 ± 71 0.00146
Sample  Weight % T2 1/T2‐ 1/T2PBS R2  r2
Agar 0.5 0.5 307 ± 6 0.0026 5.27 1
Agar 1 1 174 ± 5 0.0050
Agar 2 2 90 ± 4 0.0104
Agar 4 4 46 ± 5 0.0210
1 All Samples in water
2 T2PBS value on this imaging day was 1423.75±24
2 T2water value on this imaging day was 1582 ± 22  
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Table B - XXII.  T1 and R1 for Unsubstituted Materials and Agar, MRI Day 4 
 
 
 
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
HA 6.25  6.25 2553±148 0.00003 0.0029 1.00
HA 12.5  12.5 2436±164 0.00004
HA 25  25 2238±216 0.00008
HA 50  50 1968±111 0.00014
HA 100 100 1507±71 0.00030
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
GE  6.25 6.25 2621±120 0.00002 0.0034 0.97
GE 12.5 12.5 2403±122 0.00005
GE 25  25 2224±122 0.00008
GE 50  50 2145±276 0.00010
GE 100 100 1378±75 0.00036
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
CO  6.25  12.5 2522±124 0.00003 0.0035 0.99
CO 12.5 25 2174±219 0.00009
CO 25  50 2288±189 0.00007
CO 50  100 1448±281 0.00032
CO 100  200 942±295 0.00070
Sample  Weight % T1 1/T1‐ 1/T1PBS R1  r2
Agar 0.5 0.5 2826±169 ‐0.00001 0.021 0.96
Agar 1 1 2739±154 0.00000
Agar 2 2 2568±209 0.00002
Agar 4 4 2264±182 0.00008
1 T1PBS value on this imaging day was 2730.2±188.4  
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Table B – XXIII. T1 and R1 for Tyramine - Substituted Materials and 
Magnevist (Gd), MRI Day 4 
 
 
 
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
TS‐HA 6.25  6.25 2556±161 0.00002 0.0030 1.00
TS‐HA 12.5  12.5 2408±166 0.00005
TS‐HA 25  25 2205±125 0.00009
TS‐HA 50  50 1901±63 0.00016
TS‐HA 100  100 1498±50 0.00030
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
TS‐GE 6.25  6.25 2536±179 0.00003 0.0023 1.00
TS‐GE 12.5  12.5 2404±170 0.00005
TS‐GE 25  25 2275±132 0.00007
TS‐GE 50  50 2024±126 0.00013
TS‐GE 100  100 1646±115 0.00024
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
TS‐CO 6.25  12.5 2495±149 0.00003 0.0042 1.00
TS‐CO 12.5  25 2277±91 0.00007
TS‐CO 25  50 1948±116 0.00015
TS‐CO 50  100 1318±61 0.00039
TS‐CO 100  200 836±41 0.00083
Sample  [mM]  T1 1/T1‐ 1/T1PBS R1  r2
Gd 0.125 0.125 958±28 0.00068 5.31 1.00
Gd 0.25 0.25 573±20 0.00138
Gd 0.5 0.5 335±8 0.00262
Gd 1 1 174±15 0.00538
Gd 2 2 91±5 0.01062
1 T1PBS value on this imaging day was 2730.2±188.4  
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Table B – XXIV. T1 and R1 for Cross-linked Materials, MRI Day 4 
 
 
 
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
TB‐HA 6.25  6.3 2509±170 0.00003 0.0034 0.99
TB‐HA 12.5  12.5 2284±196 0.00007
TB‐HA 25  25.3 2223±114 0.00008
TB‐HA 50  50 1891±131 0.00016
TB‐HA 100  100 1390±111 0.00035
Sample 1 [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
TB‐ GE 6.25  6.25 2479±155 0.00004 0.0028 0.98
TB‐GE 12.5  12.5 2344±180 0.00006
TB‐GE 25  25 2133±132 0.00010
TB‐GE 50  50 1765±112 0.00020
TB‐GE 100  100 1529±237 0.00029
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
TB‐ CO 6.25 12.5 2485±106 0.00004 0.0061 0.93
TB‐CO 12.5  25 2065±276 0.00012
TB‐CO 25  50 1360±158 0.00037
TB‐CO 50  100 1627±126 0.00025
TB‐CO 100  200 978±38 0.00066
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
TB‐ GE 60  61 1671±114 0.00023 0.0034 0.95
TB‐GE 70 71 1541±308 0.00028
TB‐GE 80 79 1749±174 0.00021
TB‐GE 90 91 1443±156 0.00033
1 All Samples in water
2 T1PBS value on this imaging day was 2730.2±188.4
2 T1water value on this imaging day was 2716±198  
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Table B – XXV. T2 (15 msec echo spacing) and R2 for  
Unsubstituted Materials and Agar, MRI Day 4 
 
 
 
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
HA 6.25  6.25 1171±89 0.00013 0.027 1
HA 12.5  12.5 1036±72 0.00024
HA 25  25 802±22 0.00052
HA 50  50 512±11 0.00123
HA 100 100 299±5 0.00262
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
GE  6.25 6.25 1259±64 0.00007 0.018 0.98
GE 12.5 12.5 1167±28 0.00013
GE 25  25 1026±41 0.00025
GE 50  50 784±53 0.00055
GE 100 100 390±39 0.00184
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
CO  6.25  12.5 1147±20 0.00015 0.051 0.97
CO 12.5 25 892±94 0.00040
CO 25  50 531±19 0.00116
CO 50  100 279±43 0.00286
CO 100  200 91±14 0.01026
Sample  Weight % T2 1/T2‐ 1/T2PBS R2  r2
Agar 0.5 0.5 280±11 0.0028 6.62 1
Agar 1 1 150±4 0.0059
Agar 2 2 76±3 0.0124
Agar 4 4 37±2 0.0263
1 T2PBS value on this imaging day was 1380 ± 61.8  
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Table B – XXVI. T2 (15 msec echo spacing) and R2 for  
Tyramine - Substituted Materials and Magnevist (Gd), MRI Day 4 
 
 
 
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TS‐HA 6.25  6.25 1180±25 0.00012 0.029 0.99
TS‐HA 12.5  12.5 1031±38 0.00025
TS‐HA 25  25 790±17 0.00054
TS‐HA 50  50 531±15 0.00116
TS‐HA 100  100 273±11 0.00294
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TS‐GE 6.25  6.25 1234±100 0.00009 0.016 1
TS‐GE 12.5  12.5 1103±25 0.00018
TS‐GE 25  25 935±21 0.00034
TS‐GE 50  50 715±18 0.00067
TS‐GE 100  100 426±14 0.00162
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TS‐CO 6.25  12.5 1063±19 0.00022 0.049 0.98
TS‐CO 12.5  25 864±20 0.00043
TS‐CO 25  50 607±31 0.00092
TS‐CO 50  100 245±16 0.00336
TS‐CO 100  200 96±14 0.00969
Sample  [mM]  T2 1/T2‐ 1/T2PBS R2  r2
Gd 0.125 0.125 713±26 0.00068 6.0915781 1
Gd 0.25 0.25 481±14 0.00135
Gd 0.5 0.5 280±10 0.00285
Gd 1 1 148±6 0.00603
Gd 2 2 78±2 0.01210
1 T2PBS value on this imaging day was 1380 ± 61.8  
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Table B – XXVII. T2 (15 msec echo spacing) and R2 for  
Cross - linked Materials, MRI Day 4 
 
 
 
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TB‐HA 6.25  6.3 1096±38 0.00019 0.030 0.99
TB‐HA 12.5  12.5 917±190 0.00037
TB‐HA 25  25.3 745±87 0.00062
TB‐HA 50  50 513±35 0.00122
TB‐HA 100  100 264±257 0.00306
Sample 1 [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TB‐ GE 6.25  6.25 1176±40 0.00021 0.014 0.99
TB‐GE 12.5  12.5 1259±28 0.00015
TB‐GE 25  25 1038±44 0.00032
TB‐GE 50  50 711±168 0.00076
TB‐GE 100  100 475±61 0.00146
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TB‐ CO 6.25 12.5 991±100 0.00028 0.062 0.98
TB‐CO 12.5  25 745±126 0.00062
TB‐CO 25  50 417±99 0.00167
TB‐CO 50  100 376±62 0.00193
TB‐CO 100  200 139±62 0.00647
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TB‐ GE 60  61 579±58 0.00100 0.016 0.97
TB‐GE 70 71 506±77 0.00125
TB‐GE 80 79 576±82 0.00101
TB‐GE 90 91 438±35 0.00156
1 All Samples in water
2 T2PBS value on this imaging day was 1380 ± 61.8
2 T2water value on this imaging day was 1556±103  
 
 
 
 
 
 
 
 
 
 
 224
Table B – XXVIII. T2 (30 msec echo spacing) and R2 for  
Unsubstituted Materials and Agar, MRI Day 4 
 
 
 
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
HA 6.25  6.25 1177±69 0.00017 0.026 1
HA 12.5  12.5 1027±43 0.00029
HA 25  25 803±21 0.00056
HA 50  50 512±11 0.00127
HA 100 100 302±16 0.00263
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
GE  6.25 6.25 1299±27 0.00009 0.019 0.98
GE 12.5 12.5 1196±21 0.00015
GE 25  25 1040±17 0.00028
GE 50  50 790±56 0.00058
GE 100 100 385±51 0.00192
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
CO  6.25  12.5 1148±27 0.00019 0.053 0.98
CO 12.5 25 850±116 0.00049
CO 25  50 497±17 0.00133
CO 50  100 269±36 0.00304
CO 100  200 89±12 0.01055
Sample  Weight % T2 1/T2‐ 1/T2PBS R2  r2
Agar 0.5 0.5 279±9 0.0029 6.62 1
Agar 1 1 152±4 0.0059
Agar 2 2 77±6 0.0123
Agar 4 4 37±5 0.0263
1 T2PBS value on this imaging day was 1466.4±34.2  
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Table B – XXIX. T2 (30 msec echo spacing) and R2 for  
Tyramine – Substituted Materials and Magnevist (Gd), MRI Day 4 
 
 
 
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TS‐HA 6.25  6.25 1206±35 0.00015 0.031 0.99
TS‐HA 12.5  12.5 1027±35 0.00029
TS‐HA 25  25 784±20 0.00059
TS‐HA 50  50 524±13 0.00123
TS‐HA 100  100 266±10 0.00308
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TS‐GE 6.25  6.25 1284±31 0.00010 0.017 1.00
TS‐GE 12.5  12.5 1147±19 0.00019
TS‐GE 25  25 961±18 0.00036
TS‐GE 50  50 718±18 0.00071
TS‐GE 100  100 417±12 0.00172
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TS‐CO 6.25  12.5 1013±23 0.00031 0.050 0.99
TS‐CO 12.5  25 811±26 0.00055
TS‐CO 25  50 567±29 0.00108
TS‐CO 50  100 234±12 0.00359
TS‐CO 100  200 95±24 0.00984
Sample  [mM]  T2 1/T2‐ 1/T2PBS R2  r2
Gd 0.125 0.125 728±21 0.00069 6.19 1
Gd 0.25 0.25 474±13 0.00143
Gd 0.5 0.5 273±7 0.00298
Gd 1 1 145±8 0.00621
Gd 2 2 77±7 0.01231
1 T2PBS value on this imaging day was 1466.4±34.2  
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Table B – XXX. T2 (30 msec echo spacing) and R2 for  
Cross – Linked Materials, MRI Day 4 
 
 
 
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TB‐HA 6.25  6.3 1073±40 0.00025 0.034 0.99
TB‐HA 12.5  12.5 882±161 0.00045
TB‐HA 25  25.3 712±75 0.00072
TB‐HA 50  50 503±33 0.00131
TB‐HA 100  100 236±171 0.00356
Sample 1 [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TB‐ GE 6.25  6.25 1241±28 0.00019 0.015 0.99
TB‐GE 12.5  12.5 1337±26 0.00014
TB‐GE 25  25 1077±52 0.00032
TB‐GE 50  50 714±162 0.00079
TB‐GE 100  100 475±62 0.00149
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TB‐ CO 6.25 12.5 949±79 0.00037 0.053 0.99
TB‐CO 12.5  25 719±163 0.00071
TB‐CO 25  50 388±88 0.00190
TB‐CO 50  100 358±55 0.00211
TB‐CO 100  200 160±129 0.00557
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TB‐ GE 60  61 573±61 0.00106 0.016 0.97
TB‐GE 70 71 513±84 0.00127
TB‐GE 80 79 588±93 0.00102
TB‐GE 90 91 453±85 0.00153
1 All Samples in water
2 T2PBS value on this imaging day was 1466.4±34.2
2 T2water value on this imaging day was 1637±39  
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Table B - XXXI.  T1 and R1 for Unsubstituted Materials and Agar, MRI Day 5 
 
 
 
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
HA 6.25  6.25 2219±112 0.00005 0.0025 0.99
HA 12.5  12.5 2183±132 0.00005
HA 25  25 2051±158 0.00008
HA 50  50 1835±133 0.00014
HA 100 100 1482±48 0.00027
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
GE  6.25 6.25 2332±126 0.00002 0.0049 0.98
GE 12.5 12.5 2305±195 0.00003
GE 25  25 2177±218 0.00005
GE 50  50 1751±84 0.00017
GE 100 100 1122±49 0.00049
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
CO  6.25  12.5 2311±204 0.00003 0.0046 0.98
CO 12.5 25 2137±138 0.00006
CO 25  50 2257±107 0.00004
CO 50  100 1371±135 0.00032
CO 100  200 760±279 0.00091
Sample  Weight % T1 1/T1‐ 1/T1PBS R1  r2
Agar 0.5 0.5 2173±177 0.00006 0.046 0.98
Agar 1 1 2033±105 0.00009
Agar 2 2 1942±191 0.00011
Agar 4 4 1646±78 0.00020
1 T1PBS value on this imaging day was 2469±178.8  
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Table B – XXXII. T1 and R1 for Tyramine - Substituted Materials and 
Magnevist (Gd), MRI Day 5 
 
 
 
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
TS‐HA 6.25  6.25 2388±209 0.00001 0.0028 1.00
TS‐HA 12.5  12.5 2228±124 0.00004
TS‐HA 25  25 2108±104 0.00007
TS‐HA 50  50 1809±65 0.00015
TS‐HA 100  100 1461±56 0.00028
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
TS‐GE 6.25  6.25 2244±124 0.00004 0.0021 0.99
TS‐GE 12.5  12.5 2226±132 0.00004
TS‐GE 25  25 2067±125 0.00008
TS‐GE 50  50 1913±59 0.00012
TS‐GE 100  100 1590±56 0.00022
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
TS‐CO 6.25  12.5 2327±118 0.00002 0.0043 1.00
TS‐CO 12.5  25 2115±88 0.00007
TS‐CO 25  50 1829±96 0.00014
TS‐CO 50  100 1266±34 0.00038
TS‐CO 100  200 809±27 0.00083
Sample  [mM]  T1 1/T1‐ 1/T1PBS R1  r2
Gd 0.125 0.125 938±30 0.00066 5.31 1.00
Gd 0.25 0.25 573±16 0.00134
Gd 0.5 0.5 324±9 0.00268
Gd 1 1 171±5 0.00544
Gd 2 2 91±2 0.01058
1 T1PBS value on this imaging day was 2469±178.8  
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Table B – XXXIII. T1 and R1 for Cross-linked Materials, MRI Day 5 
 
 
 
 
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
TB‐HA 6.25  6.3 2395±242 0.00001 0.0031 1.00
TB‐HA 12.5  12.5 2125±123 0.00007
TB‐HA 25  25.3 2025±112 0.00009
TB‐HA 50  50 1774±91 0.00016
TB‐HA 100  100 1381±81 0.00032
Sample 1 [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
TB‐ GE 6.25  6.25 2134±156 0.00004 0.0033 1.00
TB‐GE 12.5  12.5 2018±100 0.00007
TB‐GE 25  25 1914±146 0.00010
TB‐GE 50  50 1647±81 0.00018
TB‐GE 100  100 1290±104 0.00035
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
TB‐ CO 6.25 12.5 2288±242 0.00003 0.0031 0.99
TB‐CO 12.5  25 1870±145 0.00013
TB‐CO 25  50 1679±48 0.00019
TB‐CO 50  100 1495±81 0.00026
TB‐CO 100  200 948±32 0.00065
Sample  [mg/ml] T1 1/T1‐ 1/T1PBS R1  r2
TB‐ GE 60  61 1383±51 0.00032 0.0024 0.65
TB‐GE 70 71 1640±111 0.00020
TB‐GE 80 79 1431±75 0.00029
TB‐GE 90 91 1855±120 0.00013
1 All Samples in water
2 T1PBS value on this imaging day was 2469±178.8
2 T1water value on this imaging day was 2343±116  
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Table B – XXXIV. T2 (15 msec echo spacing) and R2 for  
Unsubstituted Materials and Agar, MRI Day 5 
 
 
 
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
HA 6.25  6.25 1144±26 0.00012 0.025 1
HA 12.5  12.5 1008±22 0.00024
HA 25  25 821±13 0.00046
HA 50  50 536±7 0.00111
HA 100 100 309±5 0.00248
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
GE  6.25 6.25 1169±33 0.00010 0.030 0.97
GE 12.5 12.5 1075±27 0.00018
GE 25  25 976±17 0.00027
GE 50  50 607±24 0.00089
GE 100 100 264±9 0.00303
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
CO  6.25  12.5 1079±20 0.00017 0.060 0.96
CO 12.5 25 855±67 0.00041
CO 25  50 474±6 0.00135
CO 50  100 287±31 0.00273
CO 100  200 77±10 0.01223
Sample  Weight % T2 1/T2‐ 1/T2PBS R2  r2
Agar 0.5 0.5 288±5 0.0027 5.50 1
Agar 1 1 162±3 0.0054
Agar 2 2 85±2 0.0110
Agar 4 4 44±3 0.0220
1 T2PBS value on this imaging day was 1324.6.6±48  
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Table B – XXXV. T2 (15 msec echo spacing) and R2 for  
Tyramine - Substituted Materials and Magnevist (Gd), MRI Day 5 
 
 
 
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TS‐HA 6.25  6.25 1110±31 0.00012 0.028 0.99
TS‐HA 12.5  12.5 988±18 0.00024
TS‐HA 25  25 808±16 0.00046
TS‐HA 50  50 551±7 0.00111
TS‐HA 100  100 282±11 0.00248
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TS‐GE 6.25  6.25 1134±32 0.00013 0.017 1.00
TS‐GE 12.5  12.5 1039±20 0.00021
TS‐GE 25  25 886±10 0.00037
TS‐GE 50  50 679±13 0.00072
TS‐GE 100  100 409±9 0.00169
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TS‐CO 6.25  12.5 1000±17 0.00025 0.049 0.98
TS‐CO 12.5  25 790±19 0.00051
TS‐CO 25  50 568±32 0.00101
TS‐CO 50  100 237±4 0.00346
TS‐CO 100  200 95±3 0.00977
Sample  [mM]  T2 1/T2‐ 1/T2PBS R2  r2
Gd 0.125 0.125 661±15 0.00076 6.22 1
Gd 0.25 0.25 441±8 0.00151
Gd 0.5 0.5 260±4 0.00309
Gd 1 1 142±3 0.00629
Gd 2 2 76±3 0.01240
1 T2PBS value on this imaging day was 1324.6.6±48  
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Table B – XXXVI. T2 (15 msec echo spacing) and R2 for  
Cross - linked Materials, MRI Day 5 
 
 
 
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TB‐HA 6.25  6.3 1047±22 0.00020 0.039 0.98
TB‐HA 12.5  12.5 799±147 0.00050
TB‐HA 25  25.3 640±52 0.00081
TB‐HA 50  50 503±16 0.00123
TB‐HA 100  100 208±13 0.00405
Sample 1 [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TB‐ GE 6.25  6.25 1118±36 0.00022 0.018 0.99
TB‐GE 12.5  12.5 1203±34 0.00016
TB‐GE 25  25 972±26 0.00036
TB‐GE 50  50 654±33 0.00086
TB‐GE 100  100 396±51 0.00185
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TB‐ CO 6.25 12.5 922±44 0.00033 0.030 0.97
TB‐CO 12.5  25 640±73 0.00081
TB‐CO 25  50 455±48 0.00144
TB‐CO 50  100 399±47 0.00175
TB‐CO 100  200 140±10 0.00639
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TB‐ GE 60  61 606±77 0.0009 0.018 0.97
TB‐GE 70 71 465±52 0.0014
TB‐GE 80 79 517±41 0.0012
TB‐GE 90 91 413±19 0.0017
1 All Samples in water
2 T2PBS value on this imaging day was 1324.6.6±48
2 T2water value on this imaging day was 1487±111  
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Table B – XXXVII. T2 (30 msec echo spacing) and R2 for  
Unsubstituted Materials and Agar, MRI Day 5 
 
 
 
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
HA 6.25  6.25 1195±35 0.00015 0.027 1
HA 12.5  12.5 1057±20 0.00026
HA 25  25 816±14 0.00054
HA 50  50 516±8 0.00125
HA 100 100 294±5 0.00272
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
GE  6.25 6.25 1247±26 0.00012 0.033 0.98
GE 12.5 12.5 1146±15 0.00019
GE 25  25 980±15 0.00034
GE 50  50 584±27 0.00103
GE 100 100 249±12 0.00333
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
CO  6.25  12.5 1182±25 0.00016 0.062 0.97
CO 12.5 25 879±71 0.00045
CO 25  50 468±7 0.00145
CO 50  100 274±26 0.00296
CO 100  200 76±10 0.01247
Sample  Weight % T2 1/T2‐ 1/T2PBS R2  r2
Agar 0.5 0.5 283±5 0.0028 5.52 1
Agar 1 1 157±4 0.0057
Agar 2 2 82±3 0.0115
Agar 4 4 44±6 0.0220
1 T2PBS value on this imaging day was 1459.6±28.4  
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Table B – XXXVIII. T2 (30 msec echo spacing) and R2 for  
Tyramine – Substituted Materials and Magnevist (Gd), MRI Day 5 
 
 
 
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TS‐HA 6.25  6.25 1217±18 0.00015 0.033 0.99
TS‐HA 12.5  12.5 1041±19 0.00026
TS‐HA 25  25 807±18 0.00054
TS‐HA 50  50 522±7 0.00125
TS‐HA 100  100 251±22 0.00272
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TS‐GE 6.25  6.25 1242±26 0.00012 0.017 1
TS‐GE 12.5  12.5 1092±12 0.00023
TS‐GE 25  25 925±22 0.00040
TS‐GE 50  50 701±14 0.00074
TS‐GE 100  100 405±10 0.00178
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TS‐CO 6.25  12.5 1072±11 0.00025 0.054 0.99
TS‐CO 12.5  25 808±20 0.00055
TS‐CO 25  50 558±35 0.00111
TS‐CO 50  100 223±4 0.00380
TS‐CO 100  200 88±4 0.01068
Sample  [mM]  T2 1/T2‐ 1/T2PBS R2  r2
Gd 0.125 0.125 708±10 0.00073 6.09 1
Gd 0.25 0.25 459±10 0.00149
Gd 0.5 0.5 268±6 0.00305
Gd 1 1 146±5 0.00616
Gd 2 2 78±4 0.01214
1 T2PBS value on this imaging day was 1459.6±28.4  
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Table B – XXXIX. T2 (30 msec echo spacing) and R2 for  
Cross – Linked Materials, MRI Day 5 
 
 
 
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TB‐HA 6.25  6.3 1122±23 0.00021 0.049 0.97
TB‐HA 12.5  12.5 814±186 0.00054
TB‐HA 25  25.3 620±59 0.00093
TB‐HA 50  50 477±14 0.00141
TB‐HA 100  100 172±18 0.00513
Sample 1 [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TB‐ GE 6.25  6.25 1207±22 0.00022 0.019 1
TB‐GE 12.5  12.5 1278±28 0.00017
TB‐GE 25  25 1008±17 0.00038
TB‐GE 50  50 647±30 0.00094
TB‐GE 100  100 393±50 0.00193
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TB‐ CO 6.25 12.5 970±46 0.00035 0.034 0.97
TB‐CO 12.5  25 663±77 0.00082
TB‐CO 25  50 431±38 0.00164
TB‐CO 50  100 378±46 0.00196
TB‐CO 100  200 129±9 0.00707
Sample  [mg/ml] T2 1/T2‐ 1/T2PBS R2  r2
TB‐ GE 60  61 632±96 0.0009 0.018 0.97
TB‐GE 70 71 475±55 0.0014
TB‐GE 80 79 532±51 0.0012
TB‐GE 90 91 413±26 0.0017
1 All Samples in water
2 T2PBS value on this imaging day was 1459.6±28.4
2 T2water value on this imaging day was 1639±62  
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Fig B – I. R2 for Agar on the 5 MRI Days. 
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